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ABSTRACT
Growing demand for cytotoxic chemotherapy has led to restructuring of cancer services in the 
UK. The majority of patients who receive chemotherapy now do so in the out­
patient/ambulatory setting. Ambulatoiy care is now the fastest growing health-care service 
deliveiy model in industrialised nations. The expansion of ambulatoiy chemotherapy has led to 
an increase in the use of Peripherally hiserted Central Catheters (PICC lines) which are seen as 
a cost-effective way of safely administering chemotherapy in the ambulatoiy setting. The 
Modified de Gramont (MdG) regimen is one such commonly used ambulatoiy chemotherapy 
regimen which requires insertion of a PICC line or other Central Venous Access Device 
(CVAD) to undertake. Despite the additional care requirements of ambulatoiy chemotherapy 
patients, little is known about the ways in which PICC lines impact on the lives of patients and 
the challenges they face in coping at home with a PICC line in situ.
It was the aim of this study to examine the views and experiences of patients receiving 
ambulatory MdG chemotherapy via a PICC line, to discover which aspects of living with a 
PICC line caused most difficulty and to determine if patients viewed PICC lines as a benefit or a 
burden when receiving ambulatoiy chemotherapy.
The study was conducted in a large oncology unit in Scotland. A triangulated descriptive study 
was implemented in two phases over two years. Phase 1 used semi-structured interviews with a 
convenience sample of 10 MdG patients. The qualitative data were analysed using content 
analysis and emerging themes identified. The themes were used to construct the questionnaire 
used in Phase 2 with a convenience sample of 62 MdG patients (response rate 90%). The 
quantitative data were subject to analysis using Confidence Interval estimation to deteimine 
which views were most likely to be held by the population represented by the sample in this 
study.
The key findings were that the majority of MdG PICC-line patients held favourable views 
towards having a PICC line and generally adapted well to the experience. The main reported 
benefits in having a PICC line were the reduced need for venepuncture and cannulation, the ease 
of chemotherapy administration and not requiring hospital admission to receive chemotherapy. 
Bathing, showering, hair washing and sleeping caused patients most difficulty when living with 
a PICC line. The most common fears when living with a PICC line were of the chemotherapy 
spilling, PICC-line malfunction and the PICC line falling out. Furthermore, a number of 
challenges in providing informational support to this group of patients were evident as patients 
reported high information needs yet found the information given overwhelming and at times
XI
unhelpful. Despite this, the biggest majority of patients viewed the PICC line as a benefit not a 
burden when receiving MdG ambulatory chemotherapy.
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CHAPTER ONE - INTRODUCTION
Having spent more than 10 years working within an Oncology setting, I have witnessed first 
hand how the experience of a diagnosis of cancer impacts upon patients and their loved ones. 
Furthermore, the associated treatment journey can be a complex and both a physically and 
emotionally demanding experience. One of the main treatment modalities used in the 
management of cancer is cytotoxic chemotherapy (Souhami and Tobias 2003), which hereafter 
is referred to as “chemotherapy”.
The number of patients receiving chemotherapy in Scotland has increased greatly over recent 
years and is predicted to increase even further (Twelves 2001); that is chemotherapy usage 
increased by 80% between 1993 and 1995 and is predicted to double again in Scotland between 
2000 and 2010 (Twelves 2001).
hi response to evidence from clinical trials, the use of chemotherapy for a number of common 
tumour types not previously routinely treated including oesophageal, gastric, pancreatic and non 
small-cell lung cancer, looks set to expand (Chu and DeVita 2001). In addition, increased 
understanding of the molecular biology of cancer cells and the ways in which anti-cancer agents 
affect them, has resulted in a number of advancements in the use of novel treatments such as 
biological agents, which can be used in combination with existing chemotherapy regimens to 
improve the efficacy of treatment (Chu and DeVita 2001).
Restructuring of cancer seiwices in the United Kingdom has been necessaiy to cope with the 
growing demand for chemotherapy (Twelves 2001) and the majority of patients who receive 
chemotherapy now do so in the out-patient/ambulatory setting (Young and Kerr 2001; Sitzia 
and Wood 1998a). Ambulatoiy chemotherapy involves the administration of chemotherapy in 
the patient’s home. Insertion of a central venous access device (CVAD) such as a Peripherally 
Inserted Central Catheter (PICC line) is necessary before iiifusional (IV) therapy can be given 
safely in the ambulatory setting (Scottish Executive Health Department 2000; Aston 2000). 
This has meant a huge increase in the use of PICC lines, which are seen as a cost-effective way 
of safely administering chemotherapy in the ambulatory setting (Galloway 2002; Aston 2000). 
In the unit where this study took place, PICC line usage is now in excess of 500 per year since 
they began being used in November 2001. The majority of these patients have a PICC line 
inserted to undergo the Modified de Gramont (MdG) ambulatory chemotherapy regimen.
The needs of ambulatory chemotherapy patients differ from in-patients since not only do they 
require additional information regarding the administration of their treatment but also because
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they are much more likely to experience difficulties or side effects at home and without expert 
help close to hand (McCaughan and Thompson 2000; Dougherty, Viner and Young 1998). 
Furthermore, despite the increase in the number of patients receiving chemotherapy and the 
increasing complexity of the regimens, there does not appear to have been an associated 
improvement in the information given to patients (McCaughan and Thompson 2000; Sitzia and 
Wood 1998a). There may be many reasons for this including the patient’s ability to take in 
information at times of stress and anxiety. However it is concerning that a significant number 
of patients appear dissatisfied with the information given to them about their cancer diagnosis 
and chemotherapy treatment despite all the available evidence regarding communicating with 
people with cancer (Jenkins, Fallowfield and Saul 2001; Jones, Pearson, McGregor, Gilmour, 
Atkinson, Barrett, Cawsey and McEwen 1999; Mills and Sullivan 1999; Wilkinson 1991).
It was whilst dealing with ambulatoiy chemotherapy patients with PICC lines that I became 
aware of what I would describe as additional anxieties in patients. That is to say, patients still 
had the usual questions and queries regarding their chemotherapy, side effects and so forth that I 
was used to encountering but they also appeared to have ongoing worries and concerns 
regarding their PICC lines. Some patients appeared veiy anxious when the lines were being 
manipulated and the dressings changed despite the fact that the nurses dealing with the PICC 
lines were highly skilled and competent in this area. On gentle questioning, patients admitted to 
being “scared” of the PICC line as the “end of it is in my heart” and they were “frightened of it 
falling out”. One particular patient expressed his disquiet that he was expected to know when 
something was wrong with the PICC line despite having no medical or nursing experience. 
Furthermore, some of the issues raised by patients were not necessarily those I would have 
anticipated; for example, fear of hugging grandchildren and fear of going out shopping in case 
someone “bumped the line”. Another patient had not bathed or showered for more than a month 
despite recollecting the advice from the nurse who had placed the PICC line that baths were 
okay provided the affected arm was not fully submerged in the water. Some patients spoke of 
additional worries associated with having their chemotherapy at home such as the chemotherapy 
spilling or children and pets coming into contact with the chemotherapy.
This concerned me greatly as it appeared to me that we were not preparing patients adequately 
for the experience of ambulatory chemotherapy, despite the fact that they would spend most of 
their time “home alone” with the PICC line/ chemotherapy and away from specialist help and 
support.
Taking into account the already existing difficulties in giving information to patients 
undergoing chemotherapy this was not entirely surprising.
In addition, since many of these patients were terminally ill, it was of crucial importance that 
their lives were as good as they possibly could be and therefore the PICC-line experience 
needed to be as free from anxiety as possible.
It was my objective to investigate the impact of a PICC line on patients receiving ambulatoiy 
chemotherapy in order to contribute to the current understanding and research on the subject 
matter. The research objectives were thus developed to determine which aspects of living with 
a PICC line caused patients the most difficulty and what the important issues were for patients. 
An integrated research design was employed to collect both qualitative and quantitative data to 
address the research aims. Subsequent discussion of the research findings would add to the 
existing knowledge base and would enable nurses and other health care practitioners caring for 
ambulatory chemotherapy patients with PICC lines to make care decisions based on the 
evidence described.
The aim of this study was to examine the views and experiences of patients receiving 
ambulatoiy MdG chemotherapy via a PICC line. The objectives of the study were:
1. To determine which aspects of living with a PICC line cause patients most difficulty.
2. To explore patients’ views of the PICC line experience.
3. To determine if patients view PICC lines as a benefit or a burden when receiving ambulatoiy 
MdG chemotherapy.
CHAPTER TWO -  LITERATURE REVIEW
2.1 Introduction
The overall purpose of this literature review was to explore the impact of a PICC line on 
patients requiring Modified de Gramont (MdG) chemotherapy in the ambulatory setting. The 
dearth of literature initially retrieved meant that it was necessaiy to extrapolate fi'om the wider 
literature relating to central venous access devices (CVADs) and ambulatoiy therapy generally. 
The rationale for this was that PICC lines and other types of CVAD share a number of 
similarities and both are used in ambulatory therapy. Furthermore, the review demonstrated that 
similar themes were found in the literature relating to the impact of both PICC lines and other 
types of CVAD.
The review begins with a brief overview of the MdG chemotherapy regimen and discussion of 
the commonalities and differences in CVADs to provide context for the study. The impact of 
CVADs on patients is explored and common themes presented. This is linked to an exploration 
of the issues surrounding patients undergoing ambulatoiy chemotherapy and the resulting 
information needs of patients. The review then concludes with a summary of the review 
findings and statement of the research aims and objectives.
2.2 Search parameters
The literature search commenced in 2002 using several electronic databases -  MEDLINE, 
Medline In Process and Other Non-Indexed Citations, MEDLINE Daily Update, CINAHL, 
CancerLit, EMBASE, Cochrane Library, Psyclnfo, British Nursing hidex. Evidence Based 
Medicine Reviews and Journals@OVID. The search was limited to articles written in English 
and was updated on a continual basis. A number of journals were targeted including The British 
Journal of Cancer, Cancer Nursing, Cancer Nursing Practice, European Journal of Cancer Care, 
Seminars in Oncology Nursing, Journal of TV Nursing and Journal of Infusion Nursing. The 
generic internet search engine ‘Google’ thttp://www.google.co.ukl was also utilised as a 
potential source of literature. Government and health organisation websites were accessed and a 
hand search conducted of the reference lists of papers and documents retrieved for additional 
literature. In addition, the services of a librarian were used to set up “auto-alerts” from the NFIS 
Scotland e-libraiy to ensure any newly published articles were identified.
Owing to the wide variation in terminology used when referring to CVADs, PICC lines and 
ambulatory therapy, a number of keywords were searched; peripherally inserted central catheter, 
PICC line, central venous catheter, tunnelled catheter, Hickman line, non-tunnelled catheter.
central venous access device, central line, implanted port, port-a-cath, patient, psychosocial, 
education, experience, coping, information, impact, cytotoxic, chemotherapy, de Gramont, 
modified de Gramont, fluorouracil, 5 FU, ambulatoiy, home, domiciliary, out-patient, therapy, 
treatment, oncology and cancer.
The literature retrieved comprised a mix of opinion-based literature, research evidence, 
educational papers and official reports.
2.3 Quality of existing literature
The literature search produced a wealth of papers in relation to both CVADs generally and 
PICC lines specifically although it quickly became apparent that there was very little written 
about how chemotherapy patients cope with or feel about their devices and the impact PICC 
lines and other CVADs have upon their lives. The literature is replete with papers relating to 
the technical aspects of PICCs/CVADs including general educational articles (Philpot and 
Griffiths 2003; Todd 1998; Intravenous Nurses Society 1997; Ryder 1993); the selection and 
management of CVADs (Aston 2000; Cole 1999; Macklin 1997; Herbst 1996); problems and 
complication rates (Moreau, Poole, Murdock, Gray and Semba 2002; Walshe, Malak, Eagan 
and Sepkowitz 2002; Snelling, Jones, Figueredo and Major 2001); placement of PICC lines 
(Carlson 1999; Goh 1999; Oakley 1997; Cardella, Cardella, Bacci, Fox and Post 1996); drug 
infusion problems (Collins 2004) and cost implications associated with CVADs (Galloway 
2002; Loughran and Borzatta 1995).
The majority of these papers were North American or European where the health care systems 
differ from that in the UK. Furthermore as PICC lines and CVADs have been used routinely in 
clinical practice in North America since the 1970s (Aston 2000; Ryder 1993) it was 
disappointing to find a dearth of nursing resear ch into the ways in which PICC lines and other 
types of CVAD impact on patients’ lives. Very few studies assessed the impact of a CVAD on 
patients receiving chemotherapy in the out-patient or ambulatory setting. In addition, no studies 
were identified that specifically examined which aspects of the PICC line/CVAD experience 
caused patients the most difficulty and the ways in which daily life is affected. This may in part 
be due to the emphasis placed on measurable outcomes and clinical data prevalent in the field of 
intravenous (IV) nursing (Hanchett 2001). Hanchett (2001) in a paper whieh explored the need 
for infusion nursing theory, stated that IV nursing therapy is considered a technical speciality 
and that research in this area focused on device placement, site care and drug administration to 
the neglect of the humanistic aspects of IV nursing. In relation to the UK, it may be that since 
the insertion, management and ongoing care of PICC lines has been largely developed by nurses 
(Philpot and Griffiths 2003; Aston 2000; Oakley 1997), the initial focus of research was on
demonstrating safe and effective practice in PICC-line service development and the production 
of clinical guidelines for managing PICC lines.
Moreover, there was a dearth of UK-based literature which focussed on patients’ needs whilst 
undergoing ambulatoiy chemotherapy with a CVAD in situ. Many organisations referred to the 
increase in ambulatory chemotherapy and the importance of supporting patients (Scottish 
Executive Health Department 2000). Yet there was no evidence-based research as to what the 
needs of these patients were or the type of support they required. Similarly while Sewell, 
Summerhayes and Stanley (2002) stated that home-based chemotherapy reduced the stress on 
patients, afforded them the opportunity to be active in their treatment and encouraged a more 
positive attitude to chemotherapy, the evidence for these statements was not presented.
The Management and Awareness of the Risk of Cytotoxics Group (marc) produce guidelines on 
the safe handling of chemotherapy in the ambulatory setting based on the review of research 
findings and expert opinion (marc 2005). Marc recognised the increase in ambulatoiy 
chemotherapy and stated that patients and their carers involved in ambulatory chemotherapy 
should receive training in the handling and disposal of cytotoxic drugs and what to do in the 
event of spillage (marc 2005). Whilst evidence existed regarding the safest way to handle 
chemotherapy drugs, reduce exposure to chemotherapy drugs and safely manage a spill (marc 
2005), no evidence was provided as to the most effective way to train patients/carers in safe 
handling of chemotherapy or how to cope with the added responsibility.
Papers which focussed solely on the technical-management aspects of the devices were rejected 
in favour of work which focussed on patient-related aspects of living with a PICC line/CVAD 
and those dealing with the issues concerning ambulatory chemotherapy and the information 
needs of such patients. Papers concerning paediatric patients or their parents were also rejected.
This left the researcher with a limited number of papers for inclusion in the review. There was 
no consistency between papers in terms of study design or methods employed. The nursing 
research tended to involve small, qualitative studies from which the findings were not 
generalizable. It was necessaiy to keep these in this literature review since they formed the bulk 
of the literature available. In addition, it was necessary to extrapolate from the wider literature 
relating to central venous access devices (CVADs) and ambulatoiy therapy generally and a 
number of common themes were identified.
2.4 Overview of central venous access devices
For the pm*poses of this study it should be noted that a PICC line is a type of central venous 
access device (CVAD). CVADs are devices whose tip resides in the superior vena cava and are 
used for the administration of a variety of intravenous (IV) medical therapies (Galloway 2002). 
Other types of CVAD are implanted ports, tunnelled central venous catheters (CVC), and non- 
tunnelled central venous catheters (Galloway 2002; Hamilton 2000 and Cole 1999).
The use of CVADs has increased as medical therapies become more complex and ambulatory 
therapy increases (Moureau et al 2002). Moureau et al (2002) conducted an observational study 
to determine outcomes in patients undergoing home infusion therapy. They analysed data from 
a national health care database in California, USA relating to a study population of 50,470 
patients from 37 USA states over an 18 month period. The primaiy study objectives were to 
identify the types of CVADs in use in home infusion therapy, the types and rates of CVAD 
complications and the outcomes in managing CVAD complications. It was reported that 93% 
of patients receiving ambulatory therapy in the home had a CVAD in situ compared with 13% 
of hospitalised patients and that 51% of the CVADs in situ were PICC lines (Moureau et al 
2002).
hi excess of five million CVADs are placed in the USA each year (Macklin, Chernecky, Nugent 
and Waller 2003). No figures could be found relating to the numbers inserted in the UK 
annually. However individual writers have commented that the number of CVADs generally 
and PICC lines specifically continue to increase (Aston 2000). Aston (2000) in a paper outlining 
information for community nurses on how to clinically maintain PICC lines states that in excess 
of 1,000 PICC lines have been placed in her unit since the conception of a nurse-led service in 
the late 1990s. FurtheiTnore, activity data from the unit where this study took place also 
demonstrates such an increase in PICC line usage: that is a steady increase has occurred since 
November 2001 when PICC lines were first used with in excess of 500 PICC lines now being 
placed each year, increasing on average by 20% eveiy year.
2.4.1 Tunnelled central venous catheters
Most tunnelled CVCs are made of silicone or polyurethane and are usually inserted under local 
anaesthetic via the subclavian or jugular vein and tlireaded though to the superior vena cava 
(Hamilton 2000). The proximal end of the catheter is tunnelled under the skin to its exit site on 
the chest wall where a Dacron cuff prevents the device from falling out. Several inches of the 
catheter thus protrude from the body in this area (Hamilton 2000; Herbst 1996). The end of the 
catheter has a valve attached which allows the administration of therapies via a needle-free 
system (Herbst 1996).
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2.4.2 Non-tuimelied central venous catheters
These silicone or polyurethane catheters are traditionally used in the critical care setting and are 
inserted under local anaesthetic via the jugular and subclavian veins (Herbst 1996). Again a 
length of catheter protrudes from the body and owing to their relative ease of dislodgement, 
their use is limited to patients who are immobile and require short term central venous access 
(Hamilton 2000). The administration of therapy is via a needle-free system (Herbst 1996).
2.4.3 Implanted ports
These devices consist of a silicone or polyurethane catheter attached to a reservoir or port made 
of stainless steel, titanium or plastic (Herbst 1996). Implanted ports are surgically inserted via 
the cephalic vein under general anaesthetic. A subcutaneous pocket is formed by the surgeon to 
house the port in position in the chest and the catheter is threaded via the subclavian vein to the 
superior vena cava (Hamilton 2000). After implantation, access to the patient’s venous system 
is achieved by insertion of a special needle through the patient’s skin into the port itself (Herbst 
1996). Implanted ports are contained completely within the body although the outline of the 
sub-cutaneous port can be seen on the chest wall. Furthermore, the needle attachment is visible 
during the administration of treatment and insertion of the device leaves a visible scar 
(Hamilton 2000; Herbst 1996).
2.4.4 PICC lines
These silicone or polyurethane catheters are inserted under local anaesthetic via the basilic, 
cephalic or median antecubital veins in the patient’s arm and threaded upwards into the superior 
vena cava (Oakley, Wright and Ream 2000; Herbst 1996). A length of catheter exits the 
patient’s body from the antecubital space and as with all other CVADs with the exception of an 
implanted port, therapy is administered via a needle-free system (Herbst 1996).
PICC lines have been available for use in the UK since 1994 although they have been widely 
used in the USA since the 1970s (Aston 2000). PICC line use in the UK is largely within the 
specialties of haematology, oncology, parenteral nutrition and HIV/AIDS (Todd 1998) but other 
disciplines such as cardiology and orthopaedics are showing interest in using PICC lines to treat 
patients on medium to long-term antibiotics (Aston 2000).
In the chemotherapy setting, cytotoxic agents are administered via PICC lines by intermittent 
bolus injection, intermittent infusion and continuous infusion (in conjunction with an infusional 
pump).
2.4.5 Commonalities of CVADs
All CVADs must be placed by an appropriately trained practitioner and constitute a medical 
device which breaches the body’s boundaries (Macklin et al 2002; Cole 1999). All CVADs 
have the potential to cause complications and require ongoing care and maintenance. Thus 
CVADs impact on the patient’s life although the extent and nature of this varies with the device 
inserted. Informed consent must be obtained prior to placement (Cole 1999).
2.4.6 Differences of CVADs
The main differences between CVADs relate to the following areas.
Direct and associated costs
CVADs vary in terms of the actual cost of the device, its associated paraphernalia and insertion 
and maintenance costs (Galloway 2002; Dobson 2001; Cole 1999). hisertion costs are greater 
with implanted ports than with tunnelled CVCs, non-tunnelled CVCs and PICC lines since 
implanted port insertion requires the use of an operating theatre, surgeon and supporting staff 
(Aston 2000; Cole 1999; Herbst 1996). Similarly, implanted ports are the most expensive 
devices per se with PICC lines being the least expensive. The ongoing care and maintenance 
costs vaiy not only with device, but also with provider and are beyond the scope of this 
literature review but require consideration by service providers (Galloway 2002; Dobson 2001 
and Todd 1998).
Placement/siting
The method of placement for each type of CVAD has been described above. Tunnelled CVCs 
usually exit the chest area, non-tunnelled CVCs the neck and PICC lines, the arm. Implanted 
ports have no exit site and thus are the least visible of all CVADs. Implanted ports are the only 
CVAD which require the use of an operating theatre and general anaesthetic for insertion/ 
removal as all others can be placed/removed ‘by the bedside’ or in the X-ray department under 
local anaesthetic (Galloway 2002; Dobson 2001; Aston 2000).
Longevity
Although variations occur with individual patients, the accepted lifetimes of the CVADs are as 
follows;
Non-tunnelled CVCs: less than three months
PICC lines: less than 12 months
Tunnelled CVCs: approximately one year
Implanted ports: up to two years
(Galloway 2002; Dobson 2001; Cole 
1999; Herbst 1996).
Treatment associated differences
PICC lines have a narrow lumen and are less suited to frequent blood sampling and 
administration of blood and blood products (Aston 2000; Herbst 1996). If multiple 
interventions such as these are likely to be required, a tunnelled CVC is recommended (Aston 
2000; Todd 1998).
Associated complications
PICC insertion avoids several of the potential difficulties associated with the placement of 
tunnelled and non-tunnelled CVCs such as pneumothorax and great vessel perforation and the 
general risks of surgery associated with implanted port insertion (Todd 1998). No clinical trials 
or meta-analyses could be found which systematically compared different CVADs in terms of 
associated complications although individual studies presented data on commonly reported 
complications. Commonly reported complications for all CVADs include device-related 
infection, CVAD occlusion, CVAD displacement/migration and venous thrombosis (Moureau et 
al 2002; Herbst 1996). The nature and frequency of associated complications varies with 
CVAD type and occurs in part due to the differing mechanics and workings of the devices 
(Moureau et al 2002). PICC lines and non-tunnelled CVCs are associated with higher rates of 
dislodgement than tunnelled CVCs and implanted ports owing to their narrower lumen and 
relative instability (Moureau et al 2002; Dobson 2001; Cole 1999 and Herbst 1996). Similarly, 
occlusion is more of a risk with PICC lines owing to their narrow lumen (Herbst 1996). 
Infection rates are also reported to vary widely (Snelling et al 2001) between different devices 
in individual studies but since none of these have been randomised, it is not possible to rule out 
other factors such as the patients’ underlying disease status as contributory factors (Snelling et 
al 2001).
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Owing to the differences between CVADs, a number of considerations are given to device 
placement and are summarised below.
Treatment-related considerations: the type and duration of treatment prescribed and the
frequency of access required. PICC lines are not recommended for therapies lasting more than 
12 months or if frequent blood sampling/infusion of blood products is anticipated (Dobson 
2001; Cole 1999; Herbst 1996). In these instances, an implanted port or a tunnelled CVC is 
recommended (Dobson 2001; Cole 1999; Herbst 1996).
Organisational- related considerations: the availability of appropriately trained staff to place 
the CVAD and provide ongoing care, the associated costs and the CVADs available in the 
clinical area all influence the range of CVADs available to patients who require them (Dobson 
2001; Cole 1999; Herbst 1996). Choice is restricted if appropriately trained staff are not 
available to place a particular device or if a device is deemed to expensive to be purchased by 
the service provider (Galloway 2002).
Patient-related considerations: physical and anatomical contra-indications to a particular 
CVAD may rule out its use. For example, anatomical distortions such as bulky axillaiy lymph 
nodes or iymphoedema may contra-indicate a PICC line (Todd 1998) whereas an allergy to 
available dressings may necessitate an implanted port (Dobson 2001). In addition, the ability 
and willingness to participate in ongoing care and monitoring of the CVAD, patient lifestyle and 
patient preference also influence the type of device placed (Dobson 2001; Cole 1999; Herbst 
1996) and this is discussed in more detail in subsequent sections.
hi summary, CVADs share a number of commonalities and differences and have associated 
advantages and disadvantages. The decision as to which CVAD to employ during the course of 
a patient’s treatment is made on the grounds of the duration of therapy, therapy to be 
administered, ongoing care requirements and patient choice issues (Herbst 1996). Furthermore, 
CVADs differ in terms of how they are placed and where they exit the body. Therefore patient 
preference may draw them towards a particular type of CVAD (Dobson 2001). Non-timnelled 
CVCs are excluded from the remainder of this review since their use is confined to the acute 
hospital in-patient setting and this in not the focus of this study.
2.5 Modified de Gramont chemotherapy regimen
Colorectal cancer remains the second most common cause of cancer-related death in Europe 
since it is incurable once the disease has spread (Leonard, Seymour, James, Hochhaiiser and
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Ledermann 2002). The cytotoxic agent 5-Fluorouracil (5-FU) is relatively non-toxic and has 
been the mainstay of chemotherapy for colorectal cancer for more than 20 years (Souhami and 
Tobias 2003; Leonard et al 2002). The National Institute for Health and Clinical Excellence 
(NICE 2005) and the Scottish Intercollegiate Guidelines Network (SIGN 2003) both 
recommend ‘5-FU containing’ regimens as first line treatment in colorectal cancer. Newer 
cytotoxic agents such as Irinotecan and Oxaliplatin showed promise in increasing survival in 
advanced colorectal cancer but as yet none have been shown in clinieal trials to be superior to 5- 
FU (NICE 2005; Souhami and Tobias 2003).
Treatment with 5-FU can be given in a variety of ways (Souhami and Tobias 2003) and it is 
known that the response to 5-FU in advanced colorectal cancer is increased by the concomitant 
administration of folinic acid (FA) (Leonard et al 2002; de Gramont, Louvet, Andre, 
Tournigand and Kinlik 1998). De Gramont et al (1998) reported the findings from a meta­
analysis of nine randomised controlled comparative clinical trials carried out over a decade 
which involved 1,381 patients with advanced colorectal cancer. The trials compared single 
agent 5-FU regimens with regimens containing 5-FU and FA. The regimens containing the 5- 
FU/FA combination demonstrated significantly improved tumour response rates (23% versus 
11%; odds ratio 0.45; p < 10^) although overall survival was comparable with the two treatment 
arms (11.5 months for 5-FU/FA; 11 months for 5-FU alone; p = 0.57).
A number of regimens exist incorporating both 5-FU and FA which differ in terms of the 
method of administration and doses of the drugs used (Leonard et al 2002). Two standard 
regimens are the de Gramont regimen (two-hour infusion of FA, followed by bolus injection of 
5-FU followed by 22-hour infiision of 5-FU with the same sequence repeated on the second day, 
repeated fortnightly) and the Mayo Clinic regimen (five-day bolus 5-FU/FA followed by three 
rest weeks, repeated for six cycles) (Cheeseman, Joel, Chester, Wilson, Dent, Richards and 
Seymour 2002). These two regimens were compared in a randomised controlled trial involving 
448 patients with advanced colorectal cancer which demonstrated that the de Gramont regimen 
showed better response rates (32.6% vs 14.4%; p>0.0004) and median progression-free survival 
(27.6 vs 22 weeks; p>0.001) with significantly reduced rates of diarrhoea, mucositis and 
neutropenia also in the de Gramont arm (figures not supplied in the paper) (Cheeseman et al 
2002).
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Following this trial, the de Gramont regimen was adopted as standard therapy by many 
oncologists in the UK and France (Cheeseman et al 2002). This classic ‘de Gramont’ regimen 
is administered thus;
• two-hour infusion of FA
• bolus 5-FU
• 22-hour infusion of 5-FU
This is administered on two consecutive days eveiy fortnight, usually by standard peripheral 
venous cannula, and requires admission to hospital and at least one overnight stay (Cheeseman 
et al 2002).
More recently, the de Gramont regimen has been superseded by other regimens which have 
been developed to maintain the efficacy and safety profile of de Gramont but which are more 
convenient for patients and less demanding of health care resources (Cheeseman et al 2002), 
These so called ‘modified de Gramonf regimens (MdG) also have the additional advantage of 
not requiring an overnight stay in hospital (Cheeseman et al 2002; Leonard et al 2002).
MdG regimens preserve the main elements of de Gramont by providing dose intensive exposure 
to 5-FU every two weeks (Leonard et al 2002) but are a more practical regimen which only 
require the FA infusion and 5-FU bolus to be given on day one with the infusion of 5-FU 
administered via an ambulatory pump over 46 hours (Cheeseman et al 2002). Thus patients 
need only attend hospital on day one of the regimen and no overnight stay is required. It is 
noted however that MdG regimens require the insertion of a CVAD to allow the 46-hour 
infusion of 5-FU to be administered safely in the ambulatoiy setting (Scottish Executive 2000; 
de Gramont et al 1998). MdG is a well tolerated regimen which patients find acceptable as it 
avoids admission to hospital (Cheeseman et al 2002). Cheeseman et al (2002) also stated it 
reduced hospital costs, was less intensive of human resources and promoted better working 
practices between the community and the oncology centre since community staff were more 
involved in the care of the patients (Cheeseman et al 2002). However, as discussed in section 
2.3, the evidence presented to support these statements was anecdotal.
In the unit where this study took place, patients receiving MdG have a PICC line placed in the 
week prior to chemotherapy commencement. Patients then attend the unit on day one of the 
regimen where FA is given as a two-hour infusion. This is followed by a bolus of 5-FU. 
Finally, a 46-hour 5-FU infusion pump is attached to the patient’s PICC line which they go 
home with to be disconnected by the community nurse on completion of the infusion. This 
sequence is repeated until completion of treatment.
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2.6 Impact of central venous access devices on patients
This section examines the literature regarding the impact of implanted ports, tunnelled CVCs 
and PICC lines on patients. Existing literature relating to each device is presented individually 
followed by a summaiy of the key themes which emerged.
2.6.1 Impact of CVADs on patients generally
Two papers were retrieved which discussed patient-related issues regarding having a CVAD in 
ambulatory care. These were an educational paper (Cole 1999) and a paper which reported on 
service delivery (Dobson 2001), both of which presented mainly anecdotal evidence on the 
issues the authors believed to be important. Although no data was collected, the authors based 
their views on literature review findings, personal opinion and expertise of the subject area.
Cole (1999) described the selection and management of CVADs in the ambulatory setting in the 
USA based on his expertise as a Clinical Coordinator for Home Care. Cole refers to the 
literature available and draws on personal experience to argue that issues which confront the 
patient with a CVAD in the home care setting need close examination. Cole (1999) states that 
the impact of CVADs on patients can be considerable and that patient choice should be a major 
factor in CVAD selection. Factors such as insertion procedure, ongoing care requirements, 
appearance after insertion and the patient’s activity level are discussed in relation to their 
importance in CVAD selection. Cole states that a CVAD can negatively impact on the patient’s 
body image and expose them to questions about their disease/treatment that they would rather 
not answer. Furthermore, patients may not have the necessaiy physical and cognitive ability to 
take part in the ongoing care or at least observation of a CVAD, nor have a home environment 
suitable for such a device to be managed. Cole (1999) concludes by that health care 
professionals need to be more aware of the potential patient impact of CVADs, particularly in 
the ambulatory setting owing to the complexities of the care situation. This is a laudable 
statement to make but the inclusion of evidence-based literature in Cole’s (1999) paper would 
have strengthened his argument.
Similarly, Dobson (2001) in a paper which described a model designed to outline factors to be 
considered when setting up an ambulatory therapy programme, stressed the considerable impact 
of CVADs on patients. It is not clear from the paper how the model was developed although it 
appears to be used by the ambulatory therapy team in the author’s Australian hospital. In 
keeping with Cole (1999), Dobson (2001) stated that patients required a sufficient level of 
physical and cognitive ability to cope with the demands of having a CVAD at home. Dobson’s 
experience was that the insertion of a CVAD and the resulting altered body image was a great 
concern to many patients to the extent that some refused to have a CVAD. Other patients felt
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the “attachment” was a constant reminder of their disease status and those initially accepting 
may go on to reject the device (Dobson 2001). As with Cole (1999), Dobson’s (2001) paper is 
limited by a lack of evidence-based research to back up many of her claims although again the 
content appears to be based on extensive experience within the field. Thus both Cole’s (1999) 
and Dobson’s (2001) views are worthy of consideration and both authors highlight the 
considerable impact a CVAD has on patients and the need for more research regarding the 
impact on patients of medical devices such as CVADs.
The need for more research into the challenges faced by patients when faced with health-related 
technology was also discussed by Marden (2005). The focus of Marden’s (2005) work was to 
develop a theoretical model as a fiamework for inquiry into factors affecting people’s responses 
to therapeutic health technology but several points pertinent to this literature review were 
discussed. Technology dependence was defined as reliance on any form of drugs, equipment or 
device in order to treat health problems (Marden 2005). Thus reliance on a CVAD clearly 
constitutes teclmology dependence by this definition. Marden concurred with the findings of 
Sandelowski (1997 and 1993) who conceptualized that dependence on health-related technology 
could both positively and negatively impact on a patient’s quality of life; and Locsin (1995) 
who stated that technology can potentially alienate patients from nurses and thus widen the gap 
between them. Again the papers of Marden (2005), Sandelowski (1997, 1993) and Locsin
(1995) were theoretical and based on personal obseiwations and literature review findings but 
nonetheless they all concluded that further research regarding the impact of health technology 
on patients should be considered an important focus for future nursing research.
2.6.2 Impact of implanted ports on patients
The literature search yielded four articles which considered the impact of implanted ports on 
adult patients.
Borst, de Kruif, van Dam and de Graaf (1992) used a descriptive design to evaluate the 
satisfaction of patients and their experiences with an implanted port. The study took place in an 
academic hospital in the Netherlands and involved patients receiving chemotherapy for 
advanced cancer. A convenience sample of 25 female and 15 male patients completed a 
structured questionnaire during a telephone interview. The questionnaire was adapted from a 
previous study where the instrument was used to measure satisfaction with a tunnelled CVC. 
The validity and reliability of the tool was not reported. The authors stated that “the 
psychometric properties of the instrument proved to be satisfactoiy” but provided no statistical 
evidence of how this was achieved. Borst et al found that almost all patients were veiy satisfied 
with the implanted port and that it did not interfere with daily life activities. Other advantages
15
reported by patients were that insertion of the implanted port meant they could receive 
ambulatoiy chemotherapy and that the implanted port reduced the number of peripheral 
venepunctures required. However, although the majority of patients reported that the implanted 
port conserved their body image, 23% of patients (n=9) stated that the port served as a constant 
reminder of their illness and 13% (n=5) felt frightened by the implanted port being in their 
body. Borst et al concluded that although 95% of patients (n=38) felt that the advantages 
outweighed the disadvantages, pre and post-implantation information should be reviewed as 
40% of patients (n=16) felt unprepared for certain aspects of the experience.
Bow, Kilpatrick and Clinch (1999) conducted a prospective randomized controlled trial to 
examine the safety, efficacy, costs and impact on quality of life of implanted ports in 
chemotherapy patients. The study findings regarding impact on quality of life are reported here, 
in keeping with the purpose of this review. Patients were randomly allocated at the start of 
treatment to receive chemotherapy via an implanted port (study group) or by standard peripheral 
cannula (control group) (Bow et al 1999). The Functional Living Index-Cancer (FLI-C), a well- 
validated standardized 22-item questionnaire was used with a randomized sample of 92 patients 
to address quality of life. Bow et al found that the implanted port patients reported less anxiety 
and discomfort with venous access than the control gioup. This is in keeping with Borst et al 
(1992) who reported the reduced need for peripheral venous access to be one of the main 
advantages of an implanted port. However, Bow et al found no statistical differences in the 
FLI-C scores between the implanted port group and the control group demonstrating that no 
measurable improvement in quality of life could be attributed to the implanted port. It was 
reported further that the majority of patients’ FLI-C scores indicated a chemotherapy-related 
decrease in quality of life (p< 0.0001) in both the implanted port patients and the control group.
A later study undertaken by Chernecky (2001) also addressed quality of life in implanted port 
patients. Chernecky (2001) used a descriptive design to examine cancer patients’ 
satisfaction/dissatisfaction with implanted ports and to identify positive and negative 
experiences on patients’ quality of life. The study took place in an oncology out-patient clinic 
in the USA. A convenience sample of 24 patients undergoing chemotherapy completed a 
questionnaire developed by the researcher. Data was collected on overall ‘happiness’ with the 
implanted port and likes and dislikes associated with it. Patients were also asked whether the 
implanted port had improved their quality of although no actual quality of life assessment tool 
was used.
Chernecky (2001) found that patients experienced “overwhelming” satisfaction with their 
implanted port and 22 patients (92%) stated their quality of life was improved as a result of
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having an implanted port. The top three reasons reported by patients as to why they liked the 
implanted port were reduced pain of venous access (n=7, 29%), reduced frequency of 
venepuncture (n=6, 25%) and greater ease of drawing blood (n=3, 12%). Other less frequently 
reported likes regarding the implanted port (numbers not reported in paper) were freedom of 
arms during treatment and that the implanted port was low maintenance. Although 71% of 
patients (n=17) stated that they could see no disadvantages at all with the implanted port, a 
small number of dislikes were reported. These were monthly heparinization (n=2, 8%), 
difficulty sleeping (n=l, 4%), reluctance on non-oncology personnel to access the port, pain at 
the site of the port and the psychological effects of having something foreign in the body 
(numbers not reported in paper).
Chernecky (2001) concluded that in view of the strong positive impact of the implanted port and 
the reported improvement in quality of life, nurses should encourage the use of implanted ports 
earlier in the treatment journey. This is a fairly strong recommendation to make on the basis of 
one small, descriptive study but Chernecky justified this on the grounds of the consistency and 
strength of the positive responses and because the study patients all had previous experience of 
chemotherapy administration via the peripheral route; in other words without an implanted port. 
This meant all had insight into life both with and without an implanted port yet the majority of 
patients (n-22, 92%) thought the implanted port increased their quality of life when undergoing 
chemotherapy.
This is in contrast to Bow et al (1999) who found no increase in quality of life with an 
implanted port in situ. It is interesting to note that the patients in Chernecky’s (2001) study had 
experience of receiving chemotherapy both via standard peripheral cannula and via implanted 
port whereas the patients in Bow et al’s (1999) study had experience of only one of these 
methods. Thus Chernecky’s study patients were comparing their quality of life when receiving 
chemotherapy with a port against their prior experience of chemotherapy administration without 
a port. Bow et al’s patients on the other hand were reporting their overall chemotherapy-related 
quality of life, irrespective of the method of administration, and therefore were potentially 
biased towards a negative impact on quality of life as reflected in the FLI-C scores for both the 
port and the control group.
Chernecky’s (2001) questionnaire was adapted by Goossens, Vrebos, Stas, De We ver, and 
Frederickx (2005) for use in a prospective study which aimed to collect the positive and 
negative experiences of patients with an implanted port and to investigate the impact of the 
implanted port on their overall quality of life. The study took place in the out-patient 
department of a university hospital in Belgium and used a convenience sample of 106 patients
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undergoing chemotherapy for an oncological or haematological malignancy. The questionnaire 
was completed by 98 patients (92.4% response rate). Although Goossens et al (2005) state that 
their instrument was adapted from Chernecky’s (2001) study it is not possible to comment on 
the extent of similarity or difference between the tools since neither is presented in the literature.
Goossens et aTs (2005) questionnaire comprised four questions relating to how long the 
implanted port had been in situ and whether peripheral chemotherapy had previously been 
given, problems associated with the implanted port, effect of the implanted port on quality of 
life and the positive and negative experiences in relation to implantation of the port. Content 
reliability was confirmed by comparing the patients’ responses with the researcher’s a priori 
information gained horn personal experience and the relevant literature.
In keeping with Borst et al (1992), Bow et al (1999) and Chernecky (2001), Goossens et al 
(2005) found that patients reported the positive impact of the implanted port stemmed from the 
reduced need for peripheral venepuncture and cannulation. More positive experiences in 
relation to IV access with the implanted port were reported by 49% of patients (n=48). Lesser 
reported positive experiences were the increased freedom during chemotherapy (n=5), a feeling 
of happiness with the implanted port (n=5) and also that the experience was “easy” (n=5). 
Negative experiences were reported as being the visibility of the sub-cutaneous hub of the 
implanted port (n=20, 20%), general discomfort (n= ll, 11%), sleep disturbance (n=5, 5%) and 
the association of the implanted port with the disease of cancer (n=4, 4%). Also in keeping with 
Borst et al (1992), Goossens et al found that 22% (n=22) of patients reported being unprepared 
for both the insertion procedure and the resulting post-insertion experience despite the 
information given pre-insertion.
Furthermore, consistent with Bow et al (1999), Goossens et al’s (2005) study was not able to 
demonstrate a positive impact on patients’ quality of life. Only 8% of patients (n=8) in 
Goossens et al’s study reported a positive impact on quality of life as a result of the implanted 
port. In addition, 17% of patients (n=17) in Goossens et al’s study reported a negative impact on 
quality of life associated with the implanted port. The majority of patients (88%) in Goossens et 
al’s study who reported a positive impact on quality of life were aged 54 years or more whereas 
the majority of patients (65%) who reported a negative impact on quality of life were less than 
54 years of age. The authors tentatively suggest that this tendency towards a negative impact on 
quality of life may be related to the perception of port visibility on the chest area being more 
important in younger patients. It was not possible to consider if age was a factor in Bow et al’s
(1999) or Chernecky’s (2001) studies since the ages of the study participants was not given or 
commented upon.
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Thus despite the dissimilarities in the design of studies reviewed relating to the patient-impact 
of implanted ports, a number of common themes are evident. Patients reported one of the major 
advantages of an implanted port to be the reduced need for peripheral venepuncture and 
cannulation which is a source of discomfort and distress to the majority of chemotherapy 
patients. Furthermore, implanted ports appear to have limited impact on daily life and body 
image and are generally viewed by patients as being an acceptable means of chemotherapy 
administration. The disadvantages associated with implanted ports relate mainly to general 
discomfort associated with device placement, the psychological effects of having a foreign 
medical device in the body and information giving pre and post insertion.
2.6.3 Impact of tunnelled CVCs on patients
Three studies which explored the impact of tunnelled CVCs on adult patients were retrieved.
Thompson, Kidd, McKenzie, Parker and Nixon (1989) conducted a study in a large teaching 
hospital in Edinburgh to solicit patients’ views on the effects tunnelled CVCs had on their day 
to day lives. A convenience sample of 24 haematological cancer patients with a tunnelled CVC 
in situ completed a questionnaire developed by a group of surgeons, haematologists and nurses. 
The questionnaire collected patients’ views regarding tunnelled CVC insertion, effect of 
tunnelled CVC on clothing, personal hygiene, body image, relationships, employment and 
leisure activities.
Thompson et al (1989) found that the tunnelled CVC had an impact on patients’ day to day lives 
in a number of ways. The majority of patients (n=20) reported the external component of the 
tunnelled CVC to be too bulky and the dressing to cause discomfort (n-16). More than half of 
the patients (n=14) felt the tunnelled CVC had affected the way they dressed. In terms of daily 
activities, the 12 patients who could drive continued to do so although 10 patients had to 
discontinue sporting activities. Of the 19 patients in employment, only three had stopped 
working with 16 able to continue. Other effects were that body image was negatively affected 
(n=5), partners were negatively affected (n=10), families were upset (n=4) and that the tunnelled 
CVC was a reminder of illness (n=15).
hrsertion of a tunnelled CVC proved troublesome for the majority of patients (n=20) in 
Thompson et al’s (1989) study. The main complaints were discomfort during the procedure 
(n=ll), feeling “smothered” during the procedure (n=10), post-procedure pain (n=10), suture 
discomfort (n=10) and that the insertion took too long (n=9). Positive effects however were 
reported regarding the ease of chemotherapy administration (n=20) and a reduction in
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chemotherapy-associated phlebitis (11= 17). Furthermore almost all patients (n=23) stated that 
they would accept the same device again if required; suggesting that despite the difficulties 
encountered the overall experience was acceptable.
A study which aimed to investigate complications and patient satisfaction with tunnelled CVCs 
over a six year period at the Netherlands Cancer Institute was conducted by Claessen, De Vries, 
Huisman, Dubbelman, Van Riieenen, Van Dam and De Graaf (1990). A total of 120 tunnelled 
CVCs were inserted in 104 adult patients with cancer from which a convenience sample of 30 
patients was invited to complete a quality of life questionnaire. The questionnaire was returned 
by 24 patients. No detail is given as to the content of the questionnaire other than to say it was a 
measure of quality of life.
Claessen et al (1990) found that the majority of patients (n=18) did not experience any problems 
with the tunnelled CVC that affected quality of life and/or dressing. Only four patients reported 
difficulties concerning ongoing care of the tunnelled CVC at home. The main enhancement to 
quality of life associated with the tunnelled CVC was the reduced need for venepuncture and 
cannulation as reported by 19 patients. Claessen et al concluded that tunnelled CVCs have an 
acceptable complication rate and a high degree of patient satisfaction and should be considered 
for use in the early stages of anti-cancer treatment.
Daniels (1995) reviewed the tunnelled CVC literature in relation to the physical, psychological 
and social implications of the devices following her concerns that patients’ needs were not 
being addressed. No information is given in the review paper regarding the search parameters 
used nor is mention made as to the methodologies employed in any of the articles reviewed. 
Daniels (1995) states that there was a dearth of information relating to the impact of tunnelled 
CVCs on patients and that most of the literature published concerned the medical and technical 
aspects of tunnelled CVCs such as infection control and complications. Thus it was necessary 
for Daniels to draw on the literature regarding other comparable situations in order to analyze 
the potential impact on patients. Daniels goes on to extrapolate from literature relating to allied 
concepts such as the stress on patients requiring an invasive procedure and the physical and 
psychosocial impact of cancer and the effects of treatment.
Daniels (1995) found that despite the fact that an invasive procedure such as the insertion of a 
tunnelled CVC could potentially exacerbate an already stressful situation for a patient requiring 
rv  therapy; the implications for patients were largely overlooked. The potential for tunnelled 
CVCs to impact negatively on both physical and psychosocial wellbeing is stated although 
much of the discussion is discursive and anecdotal rather than evidence-based. Daily life
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activities such as dressing, socialising and wearing a seat belt are highlighted as being 
problematic. Similarly it is proffered that tunnelled CVCs may serve as a reminder of diagnosis 
and the need for treatment and may negatively impact on body image but again the evidence is 
mainly anecdotal. Finally, the additional informational requirements for patients requiring a 
tunnelled CVC are highlighted as an area of unmet need and Daniels (1995) concludes the 
review by stating that further research into the patient impact of devices such as tunnelled CVCs 
is required.
hi terms of psychosocial/physical impact, in contrast to Claessen et aFs (1990) study, Daniels
(1996) reported that 90% (n=19) of patients felt the tunnelled CVC had affected the way they 
dressed. For example, some patients had to alter or modify existing clothing and others felt the 
need to dress in such a way as to conceal the CVC. Other difficulties included sleeping and 
bathing problems, a fear of being in crowds and difficulties participating in sports although the 
number of patients affected is not given, A change in body image as a result of the tunnelled 
CVC was not identified by the majority of patients as they reported that their body image had 
been affected by the entire cancer/treatment experience; for example, chemotherapy induced 
alopecia. A small number of patients however were discontented that the tunnelled CVC had 
left them with a physical scar and one man had been unable to engage in sexual activity as his 
partner could not accept the tunnelled CVC. Furthermore as was found with the implanted port
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Daniels (1996) went on to conduct a follow-up study to explore the impact of tunnelled CVCs 
on patients and their families in order to influence future nursing care and practice. Daniels 
(1996) developed a questionnaire for use in a ‘guided’ interview although no detail is provided 
regarding the steps taken in questionnaire development or how the questionnaire content was 
decided. A convenience sample of 12 male and nine female adult cancer patients with a 
tunnelled CVC attending a regional cancer centre in the UK took part in the study. The 
questionnaire served as an inteiwiew guide and was used to gather data relating to tunnelled 
CVC insertion, patient education, patient coping and the physical and psychosocial impact of 
the CVC. The study results demonstrated that patients had a variety of informational needs in 
relation to tunnelled CVC placement and that the tunnelled CVC impacted on patients’ lives in a 
number of ways. For example, the insertion procedure proved traumatic for the majority of 
patients (n=19) and it was further stated that the information provided pre-insertion did not 
equate with the patients’ actual experiences. Ongoing continuity of care between the regional 
centre and the community was also problematic at times and a lack of community expertise in 
relation to tunnelled CVCs meant that patients also required ongoing support from the regional 
centre.
patients (Chernecky 2001; Borst et al 1992), six patients stated that they felt anxious about the 
tunnelled CVC being in their body and about the ongoing care of the CVC.
Despite the difficulties encountered by patients, Daniels (1996) concluded that tunnelled CVCs 
had less impact than she had previously imagined and that the majority of patients coped well 
with the experience. It was noted however that some patients reported a difference between 
prior information received and the actual experience in keeping with Borst et al (1992). This 
may have been owing to the patients’ overall difficulties in coping with information at a 
stressful time. In keeping with Claessen et al (1990) the reduced need for venepuncture and 
cannulation brought about by the tunnelled CVC being in-situ was highlighted as a particular 
advantage.
Thus it can be seen that the literature relating to the patient-impact of tunnelled CVCs is 
inconclusive. The papers reviewed demonstrate that although similar themes have been 
discussed in various studies, the findings are at times inconsistent. Furthermore the common 
themes presented are in keeping with those discussed in the previous section on implanted ports 
suggesting some commonalities in patient-impact between the two types of device.
2.6.4 Impact of PICC lines on patients
Only three articles were retrieved which explored the patient-impact of PICC lines,
Oakley, Wright and Ream (2000) conducted an exploratoiy study in a UK hospital to 
investigate patients’ and nurses’ experiences of a nurse-led PICC line service. A convenience 
sample of 10 ambulatory chemotherapy patients and 10 nurses took part in the study. The 
patients were interviewed twice; once within 24 hours of PICC line insertion and then three to 
four weeks following insertion. The nurses were interviewed once to determine their 
experiences of PICC lines, collaborative working and their preparation for managing PICC 
lines. Oakley et al (2000) state that the interviews were guided by schedules of open and closed 
questions but no further detail is provided regarding the development or content of the interview 
guides.
Oakley et al (2000) found that although patients generally appeared to adapt well to having a 
PICC line in situ, a number of diffieulties were evident. The most common difficulties reported 
by patients were bathing (n=10), sleeping (n=7) and dressing (n=5). Of the six patients who 
worked prior to PICC line insertion, five had stopped as the PICC line made manual work 
impractieable. In addition, all patients stated that protection of the PICC line caused anxiety 
with two patients also reporting an impact on socialising for fear of the PICC line being
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damaged in some way. Interestingly, the majority of nurses (n=9) also reported protection of 
the PICC line to be an important consideration with 50% of nurses (n=5) further stating that the 
PICC lines were “fragile”, which could have implications on how patients view PICC lines. In 
terms of PICC line impact on body image, Oakley et al (2000) found only one female patient to 
be affected negatively which the authors’ state may have been because the study was conducted 
in the winter months when the use of long sleeved clothing makes concealment of the PICC line 
easier. Several of the nurses also believed that PICC lines could impact negatively on body 
image, especially during warm weather when less clothing was worn.
A further finding from Oakley et al’s (2000) study was that despite the education and advice 
given to patients pre PICC line insertion, the majority of patients (n=7) did not seem to know 
what to expect on discharge home. This mismatch between information given and resulting 
experience is in keeping with previously discussed findings (Goossens et al 2005; Daniels 1996; 
Borst et al 1992) and has been highlighted in educational papers on the challenges of using 
CVADs in ambulatory therapy (Macklin et al 2003; Moureau et al 2002; Cole 1999; Herbst
1996). Despite the difficulties encountered, Oakley et al (2000) concluded that patients viewed 
PICC lines as beneficial with any inconvenience encountered overridden by the necessity to 
have treatment. A limitation of Oakley et al’s (2000) study however is that four weeks is a 
relatively short period of time in which to investigate the experience of living with a PICC line, 
something recognised by the authors who suggested further research be carried out with patients 
who had PICC lines in situ over longer periods of time. As an exploratory study, Oakley et al 
(2000) provided evidence of the type of difficulty experienced by their study patients. They 
also recommended further research into how ambulatoiy chemotherapy PICC-line patients adapt 
to their situation and the best ways to educate and support patients through the experience.
A further study which found that PICC lines were well accepted by patients was that of Gabriel 
(2000). Gabriel conducted a small qualitative study using a convenience sample of 15 patients 
attending a UK hospital to identify patients’ perceptions of the effect of a PICC line on their 
quality of life. Patients with a range of conditions who required a PICC line for the 
administration of antibiotics, blood products and chemotherapy were included to eliminate the 
underlying disease and treatment as potential confounding variables. The data were collected 
from participants in three ways; by interview prior to PICC line insertion, by weekly self-report 
questioimaires for the duration of PICC placement and by a further interview 14 days after 
PICC line removal.
As with previous papers reviewed, the methodological detail provided in Gabriel’s (2000) paper 
is scant and the content of the interview schedules and questionnaires is not clear. Gabriel
23
States however that a phenomenological approach was taken in the first interviews which 
gathered data relating to the perceived effects of the PICC line on the patients’ lives, whilst 
grounded theoiy was used in the second interviews to allow patients to reflect on the impact of 
the PICC line on their quality of life. The weekly questionnaires gathered data relating to the 
patients’ wellbeing and experiences with the PICC line in situ.
In keeping with the findings of Oakley et al (2000), Gabriel (2000) found that lifestyle was 
relatively unaffected by the PICC line although one patient did comment that she was unable to 
enjoy a daily soak in the bath with the PICC line in place. The patients in Gabriel’s (2000) 
study reported that the PICC line had improved their quality of life for the duration of the 
treatment although as with other studies (Chernecky 2001; Goossens et al 2005) no actual 
validated tool for measurement was used. Furthermore, it is interesting to note that all of the 
patients in Gabriel’s (2000) study experienced prior problems with venous cannulation and were 
therefore potentially biased favourably towards a PICC line since it avoided the need for 
frequent cannulations. Indeed one of the most prominent findings of Gabriel’s study was that 
patients reported the main benefit to quality of life was the reduced need for repeated 
cannulations owing to the PICC line being in situ. It could therefore be argued that it was the 
lack of repeated cannulations that gave patients an improved sense of quality of life and not the 
actual PICC line per se. In other words, any intervention which meant they did not require 
repeated caimulations could have had the same effect.
A follow up paper by Gabriel (2003) aimed to identify the acceptability of PICC lines to 
patients undergoing chemotherapy and to ascertain if they had been involved in device 
selection. Gabriel (2003) re-examined the original interview data from the nine chemotherapy 
patients who had taken part (Gabriel 2000) using Giorgi’s approach to data analysis. Gabriel 
(2003) found that chemotherapy patients accepted PICC lines and reported PICC lines to have 
little effect on lifestyle, body image or comfort. Furthermore chemotherapy patients reported 
that they had felt involved in the decision to have a PICC line placed as opposed to continuing 
with peripheral venous cannulation or having another type of CVAD placed, Gabriel (2003) 
highlights patient choice in the CVAD decision making process as being a positive indicator for 
PICC line acceptance although again it could be argued that since patients chose the PICC line 
they are more likely to hold a favourable opinion of it once in situ. In keeping with her earlier
(2000) study, Gabriel (2003) highlights the improvement in quality of life of the chemotherapy 
PICC line patients as a result of the reduced need for peripheral venous cannulation.
Again it can be seen that a number of similar themes are discussed in the somewhat limited 
literature regarding the patient-impact of PICC lines. In keeping with the literature relating to
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patient-impact of implanted ports (Borst et al 1992; Bow et al 1999; Chernecky 2001; Goossens 
et al 2001) and tunnelled CVCs (Claessen et al 1990; Daniels 1996), the reduced need for 
venepuncture and cannulation as a result of the PICC line being is situ is highlighted as a 
positive aspect (Oakley et al 2000; Gabriel 2000, 2003). There is agreement that despite the 
difficulties, patients cope well with PICC lines and the impact on daily life is minor, although a 
limitation of many studies is the lack of data collected specifically addressing this. However, 
the literature available does appear to suggest that the impact of PICC lines is greater than that 
of implanted ports and tunnelled CVCs in relation to affect on bathing, dressing and sleeping 
and that PICC line patients are perhaps more defensive of their devices as reflected in their fears 
of line damage (Oakley et al 2000). This may be a result of the PICC line being more visible 
than the implanted port and tunnelled CVC and because the PICC line exits the body from the 
patient’s arm. Furthermore, the challenges in preparing patients for the experience of living 
with a PICC line or other CVAD are again reflected in the findings that despite the information 
given to PICC line patients prior to insertion, they still felt unprepared for the resulting 
experience (Borst et al 1992; Oakley et al 2000; Goossens et al 2001). Further research into 
how ambulatoiy chemotherapy PICC line patients adapt to their situation and the best ways to 
inform and support patients through the experience was recommended (Oakley et al 2000).
The next section extrapolates from the literature relating to patient issues in ambulatoiy therapy 
generally since very little literature was available regarding the patient-impact of the MdG 
regimen.
2.7 Ambulatory chemotherapy
For the purposes of this study, ambulatory chemotherapy refers to the administration of 
chemotherapy in the patient’s home, without on site supervision by a health care professional. 
A number of papers were retrieved which explored ambulatoiy chemotherapy although again 
there was no consistency in the study designs or methodologies employed.
2.7.1 Ambulatory versus hospital chemotherapy
The question of choice in ambulatory or hospital based chemotherapy was the focus of a study 
carried out in three cancer hospitals in Greece by Christopoulou (1993). A sample of 184 
cancer patients receiving chemotherapy were surveyed using a structured questionnaire to 
examine the biosocial factors which influence a patient’s decision to be treated at home or in 
hospital. No description of the sample method is stated although it appears to be a convenience 
sample. A number of variables were determined to represent the biosocial factors including 
gender, family status, disease status, financial status and social factors. Statistical analysis of
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the data identified the significant factors in terms of who underwent ambulatory chemotherapy 
and why patients chose ambulatoiy chemotherapy, although the statistics are not reported. The 
most important factors affecting the patient’s decision to undertake ambulatoiy chemotherapy 
were previous experience with ambulatory therapy and degree of ambulatory services 
development. Economic and financial variables and patient characteristics such as gender, 
family status and educational level did not appear to affect the decision of patients as to where 
they received their chemotherapy.
Christopoulou (1993) found that 98.1% of patients preferred ambulatory chemotherapy but that 
this preference was dependent upon level of family support at home and the degree of home 
health care development. Unfortunately Christopoulou does describe in detail what these home 
health care developments constitute although one assumes that it refers to the level and extent of 
service development relating to the provision of ambulatoiy chemotherapy. Furthermore, the 
detail provided regarding the issues surrounding patients who underwent ambulatory 
chemotherapy is scant but nonetheless, the importance of supporting patients undergoing 
ambulatory chemotherapy was stressed.
The importance of support was also reported by Dougheity, Viner and Young (1998) in a paper 
discussing the role of the clinical nurse specialist in supporting ambulatoiy chemotherapy 
patients. A convenience sample of 100 patients in a UK specialist oncology department 
completed a questionnaire designed to evaluate the education and support they had received 
when undergoing ambulatory chemotherapy. Unfortunately little detail is provided regarding 
the underlying methodology but it was shown that 95% of patients found the experience of 
ambulatory chemotherapy at home “daunting” despite the education provided being satisfactoiy. 
Dougherty et al (1998) also stated that although many patients had a desire to undertake 
ambulatory chemotherapy, not all patients could cope with this method of deliveiy and some 
prefer the security of the hospital setting, hi addition, they stated that some patients may be 
unwilling or mentally/physically unable to take on the responsibility needed and therefore 
patient selection is crucial, as previously discussed by Cole (1999) and Dobson (2001).
2.7.2 Ambulatory chemotherapy and quality of life
A randomised controlled trial to compare ambulatory versus out-patient chemotherapy in terms 
of safety, compliance, use of health services, quality of life and satisfaction with treatment was 
conducted by B orras, Sanchez-Hernaiidez, Navarro, Martinez, Mendez, Ponton, Espinas and 
Germa (2001) in a large Spanish teaching hospital. A questionnaire was developed to gather 
data on the outcome measures: treatment toxicity, patient’s compliance with treatment, quality 
of life, satisfaction with care and use of health services. The EORTC QLQ-C30, a validated
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quality of life tool commonly used in clinical trials in the cancer setting (Aaronson, Ahmedzai, 
Bergman, Bui linger, Cull, Duez, Filiberti, Flechtner, Fleishman and de Haes 1993), was used to 
gather the quality of life data. A sample of 87 patients was randomised to receive chemotherapy 
for colorectal cancer at an out-patient clinic (n=42) or in their own home (n=45). The study 
found that voluntaiy withdrawal from chemotherapy was significantly higher in the out-patient 
group than the ambulatoiy group (difference 12%, 95% Cl, 1% - 24%) but that there were no 
significant differences in use of health care services (namely unplanned visits), quality of life or 
satisfaction with health care generally. Although global satisfaction with health care was higher 
in the ambulatoiy group, the difference was not statistically significant (difference 8%, 95% Cl, 
0% - 17%). Despite the lack of significant differences in most of the outcome measures, Borras 
et al (2001) concluded that ambulatoiy chemotherapy could be advantageous for patients mainly 
by increasing compliance with treatment. Furthermore they postulated that ambulatoiy 
chemotherapy seemed an acceptable and safe alternative to out-patient treatment although there 
was little evidence of improvement on quality of life. The Borras et al study (2001) was one of 
the first studies to attempt to evaluate the impact of a change in delivery of chemotherapy (out­
patient to ambulatory) on a number of outcome measures and recognised that the impact on 
patients in terms of satisfaction with care is often neglected. Furthermore, it is important to note 
that many of the assumptions regarding ambulatoiy care, for example that it improves patients’ 
quality of life, were not upheld in the study.
More positive findings regarding quality of life with ambulatoiy chemotherapy were reported 
by Rowe, Valle, Swindell, Fitzsimmons and James (2002). Rowe et al conducted a pilot study 
in a UK-based cancer centre to assess the feasibility and patient acceptability of ambulatory 
administration of the de Gramont chemotherapy regimen normally given as in-patient. Patients 
who required de Gramont chemotherapy were assessed for suitability for ambulatoiy 
administration by a medical team comprising a doctor, research nurse and pharmacist. Those 
deemed suitable were then given information regarding the administration and side effects of 
both the in-patient and ambulatoiy regimens and then chose which regimen they wished to 
undertake. Twenty six patients were non randomly allocated to receive either standard inpatient 
(n=13) or novel ambulatory (n=13) chemotherapy. Quality of life was assessed by means of the 
EORTC QLQ-C30 questionnaire administered at baseline and weeks one, three and six. Further 
data on perceived benefits of chosen regimen and resulting experiences are also reported 
although it is not clear which method was used to collect this data.
Rowe et al (2002) found that the novel ambulatoiy treatment was feasible and highly acceptable 
to patients. Benefits reported by the ambulatory patients included a perceived increase in 
independence, a reduction in travel to the hospital, reduction in hospital-related delay and a
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reduction in the number of peripheral cannulations required. Patients choosing the in-patient 
chemotherapy perceived they would feel more secure in hospital, lacked adequate support at 
home and feared having the CVAD necessary for ambulatory chemotherapy.
In terms of overall health and quality of life, higher scores correlating with improved health or 
quality of life were seen in the ambulatory arm compared with the in-patient arm although no 
test of statistical significance was applied. In the ambulatory arm, 75% of patients (numbers not 
reported) reported an increase in overall health score at 3-6 weeks with 100% of patients 
reporting either the same or improved quality of life score. This contrasted with the in-patient 
group where 100% of patients reported a decrease in overall health score, with quality of life 
either the same or decreased at 3-6 weeks. Rowe et al (2002) concluded that the ambulatory 
regimen offered considerable quality of life benefits to patients which also led to an increase in 
patient morale. They acknowledged however a limitation of the study was that since the 
ambulatory patients were selected on the grounds of both suitability criteria and acceptance of 
the mode of deliveiy, the younger and generally fitter patients in the ambulatory arm were likely 
to have tolerated treatment better than the in-patient group.
Despite the decrease in quality of life and overall health score found in the in-patient group, 
these patients stated that if they required treatment again in the future, they would again choose 
the in-patient regimen. In keeping with others (Dobson 2001; Cole 1999; Dougherty et al 1998) 
Rowe et al (2002) stressed that patient selection for ambulatory chemotherapy is essential and in 
addition that adequate support in the community and from the hospital are vital. Furthermore, 
the authors acknowledge that there was considerable support from key members of the health 
care team in preparing and supporting the 13 patients receiving ambulatory chemotherapy since 
recruitment averaged only one patient per month into the ambulatory arm. It is feasible that the 
benefits felt by ambulatoiy patients were in part due to the intensive support available to 
patients from both hospital and community-based staff that may not be available out with the 
clinical trial setting. Rowe et al (2002) further acknowledged the importance of such support 
for patients undergoing ambulatory chemotherapy but that it is not uniformly available.
2.7.3 Safety and acceptance of ambulatory chemotherapy
The safety and acceptance of ambulatory chemotherapy is a theme prevalent throughout the 
literature and is discussed in detail by the Agence d’évaluation des technologies et des modes 
d’intervention en santé (AETMIS) in a report into home-based chemotherapy and the issues for 
patients, caregivers and the health care system (AETMIS 2004).
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AETMIS is a multi-disciplinary agency whose role is to contribute to improving the Quebec 
health-care system by supporting the Minster of Health and Social Services and health care 
providers. AETMIS (2004) produced a lengthy report into ambulatoiy chemotherapy in 
response to earlier findings of AETMIS which highlighted that ambulatoiy care was the fastest 
growing service delivery model found in industrialized nations. No similar report could be 
found in the literature relating to any UK-based organisation. Furthermore, although a 
Canadian document, a number of the findings are applicable to patients generally and therefore 
also to health care in the UK.
2.7.4 Patient preference for ambulatory chemotherapy
AETMIS (2004) reviewed the literature concerning effectiveness, safety, cost implications, 
patient preference, satisfaction and quality of life in relation to ambulatory chemotherapy from 
1975 to 2002 which was supplemented with semi-structured qualitative interviews with 
ambulatory chemotherapy providers (n=17). Detailed search parameters are provided in the 
report and demonstrate a comprehensive and substantial review of relevant literature. The 
findings regarding patients and carers are presented here.
AETMIS (2004) reviewed 11 papers which reported patient preference for and/or satisfaction 
with ambulatoiy chemotherapy. A smaller number of studies also specifically addressed quality 
of life in ambulatory chemotherapy. There was no uniformity in terms of study methodology or 
design and the papers reviewed comprised a mix of randomised controlled trials (RCTs) (n-5), 
conti'olled studies (n=2) and uncontrolled studies (n=7). A variety of patient groups were 
sampled including adults and children undergoing ambulatory chemotherapy for cancer, making 
direct comparisons impossible. The studies had varying aims and objectives in relation to 
exploring patient preference and/or satisfaction with ambulatoiy chemotherapy but the findings 
demonstrate common themes.
AETMIS found strong positive evidence favouring ambulatoiy treatment in nine of the 11 
studies reporting on patient preference. In terms of satisfaction, seven of the nine relevant 
studies showed patients were satisfied with their ambulatoiy treatment. However two studies 
failed to show any differences in satisfaction between hospital and ambulatory care. AETMIS 
highlighted that the positive evidence supporting patient preference for ambulatoiy therapy is 
not surprising since for all trials, patients had to meet strict eligibility criteria and to be willing 
to undertake ambulatory chemotherapy in order to take part in the trial. Thus there may be a 
bias towards preference in these studies. However it would not be possible to design a trial 
whereby patients who reflised ambulatory therapy were subsequently given it and therefore bias 
is unavoidable.
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A number of reasons for the acceptance or rejection of ambulatory therapy are discussed 
(AETMIS 2004). Reasons cited for preference for ambulatoiy chemotherapy included 
familiarity with the home environment, a reduction in travel to hospital, an increase in control 
over life and less disruption of family routine. A reduction in satisfaction and/or preference was 
associated with fear of malfunction of associated technology, lack of supervision when 
receiving treatment and a restriction or change in daily routine as a result of treatment regimen. 
It was also noted that some patients did not want to accept the responsibility for their own health 
care management and preferred that responsibility to lie with a health care professional.
2.7.5 Safety issues in ambulatory chemotherapy
Safety issues surrounding ambulatory chemotherapy were explored in 21 studies reviewed by 
AETMIS (2004). Again these comprised a mix of RCTs (n=4), controlled studies (n=4) and 
uncontrolled studies (n=13). Safety issues in relation to the monitoring of side effects, handling 
of waste and excreta, the use of specialised equipment and the care of children whilst 
undergoing ambulatoiy chemotherapy were highlighted as areas of difficulty for both patients 
and their informal carers, usually relatives, in all studies.
Despite this, AETMIS (2004) concluded that ambulatory chemotherapy could be provided 
safely and is an option for some cancer patients who choose it. Furthermore, AETMIS found 
that improvements in quality of life for patients receiving chemotherapy in the ambulatory 
setting are frequently reported in the literature anecdotally but with little supporting evidence. 
AETMIS recommended that further research into the views of ambulatoiy chemotherapy 
patients and their carers be conducted to evaluate quality of life.
In summaiy, the findings from AETMIS (2004) are in keeping with those previously discussed 
and demonstrate that whilst ambulatoiy chemotherapy is acceptable and safe for many patients 
(AETMIS 2004; Borras et al 2001), some patients may be unable or unwilling to take on the 
responsibility needed (Dougheity et al 1998). Although improvements in quality of life are 
documented in the literature (Rowe et al 2000), much of the evidence is anecdotal and further 
research is required to produce a robust evidence base (AETMIS 2004). Ambulatory 
chemotherapy is not without potential problems and is without doubt a challenge for patients 
and their carers (AETMIS 2004; Dougherty et al 1998; Herbst 1996). There exists an additional 
informational burden on ambulatory chemotherapy patients (AETMIS 2004) which is further 
explored in the next section.
30
2.8 Information giving to chemotherapy patients
No literature relating specifically to MdG ambulatory PICC-line patients’ information needs 
was identified. Therefore the literature relating to cancer patients’ information needs and 
chemotherapy patients’ information needs was reviewed as the MdG PICC-line patients in this 
study are both cancer and chemotherapy patients.
2.8.1 Perceptions of information need during chemotherapy
Fernsler (1986) carried out a descriptive study looking at the differences in self-care deficits as 
reported by chemotherapy patients and nurses. Fernsler used a convenience sample of 30 
chemotherapy patients and their assigned nurse to cany out open-ended, semi-structured 
interviews derived from Orem’s self-care model of nursing. Fernsler found that patients 
generally reported more self-care deficits than their nurse although nurses reported more self- 
care deficits than patients when it came to psychosocial issues: nurses perceived patients as 
being more anxious, depressed and hostile than the patients themselves did. Fernsler concluded 
that nurses failed to perceive the extent to which chemotherapy patients require assistance and 
they were therefore unable to meet the patients’ information needs. Although the findings from 
Fernsler’s (1986) study cannot be generalized, the nurses involved provided information they 
thought patients required to cope but this was not always in keeping with the patient’s perceived 
or actual information need.
2.8.2 Information needs of patients with cancer
Meredith et al (1996) conducted a cross sectional survey of patients’ views using a semi­
structured interview with questionnaire to assess the needs of patients with cancer for 
information about their condition. The questionnaire used was used in other studies although no 
comment is made regarding validity and reliability. Data on overall preference for information 
and preference for information related to specific aspects of their disease and treatment was 
collected. A sample of 250 patients from 269 approached (93% response rate) consented to take 
part in the study. The sample was stiatified by age, sex, socioeconomic status and tumour site 
to be representative of the population of West of Scotland. It was found that most patients 
wanted as much information as possible about their disease (79%, 95% Cl, 73% - 84%), chance 
of cure (91%, Cl, 87% - 94%) and side effects of treatment (94%, Cl, 90% - 97%). 
Furthermore, patients who were younger, female and/or receiving radical treatment 
demonstrated a greater need for information relating to tieatment options. Owing to the 
sampling method used, Meredith et al suggested that these results were representative of the 
population of West of Scotland and therefore it appears that the vast majority of patients with 
cancer wish to receive as much information as possible about their situation. Whilst this finding
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is important in alerting health care professionals to the patients’ need for information, it is 
limited in that it sheds no light on how patients cope with the information 
which may be complex and lengthy.
Similar findings were reported by Graydon, Galloway, Palmer-Wickham, Harrison, Rich-van 
der Bij, West, Burlein-Hall and Evans-Boyden (1997) in a study to assess the information needs 
of women undergoing treatment for breast cancer in a Canadian regional cancer centre. A 
purposive sample of 70 women receiving chemotherapy (n=25), radiotherapy (n=23) and 
surgery (n=22) completed the breast cancer version of the Toronto Informational Needs 
Questionnaire (TINQ-BC). The TINQ-BC was developed from literature review findings and 
demonstrated content validity and high internal reliability (Cronbach’s alpha 0.94) and collects 
data on the need for information about disease, investigations, treatment, physical care and 
psychosocial issues such as family concerns. Scores range from 51 to 255 with a higher score 
indicative of a high information need.
Graydon et al (1997) found that all women had high information needs regardless of treatment 
type (TINQ-BC range 148 -  253). Analysis of the results by treatment type showed that the 
highest information needs were reported in women undergoing their first course of 
chemotherapy (TINQ-BC range 201 -  253; mean 224.9). hiterestingly this group contained the 
women with the lowest average age (40.5 years) and compares with the findings of Meredith et 
al (1996) reported earlier who found that younger, female patients had a higher need for 
information relating to treatment options. Furthermore, when sub-divided by information type, 
the highest information needs were those associated with the disease itself, investigations and 
treatment with physical and psychosocial information needs scoring lower. Importantly, this 
high information need persisted as treatment progressed. The authors’ state that this may have 
been a result of either the fear associated with cancer treatment or because the information given 
at the start of treatment was not understood. As with Meredith et al (1996), Graydon et al’s
(1997) study does not address the impact of information given, only that information is desired. 
Graydon et al also recommend further study into how the needs of women undergoing breast 
cancer treatment could best be met.
2.8.3 Patient satisfaction with chemotherapy information
Sitzia and Wood (1998a) conducted a literature review drawing on three main areas of research 
in relation to chemotherapy nursing namely oncology nursing care, patients’ experiences of 
ambulatory chemotherapy and patient satisfaction. The search parameters used are not stated 
but the extensive reference list suggests a thorough evaluation of relevant literature.
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The review aimed to provide a broad overview of satisfaction with chemotherapy care as this 
was an area identified by the authors as lacking an evidence base. Although the difficulties 
associated with satisfaction studies such as the subjective nature of satisfaction and the tenuous 
link between perceived satisfaction with care and actual care provided are recognized, Sitzia and 
Wood (1998a) state that good information giving is vital to satisfaction with chemotherapy care, 
both of which are linked to compliance with treatment. This is interesting to note as Borras et al
(2001) (section 2.7) also found that home chemotherapy could be advantageous for patients 
mainly by increasing compliance with treatment and satisfaction with nursing care. Thus it 
appears there may be a link between information giving, ambulatory chemotherapy, compliance 
with treatment and satisfaction with care, Sitzia and Wood (1998a) also found that the 
provision of information to patients undergoing chemotherapy was an important determinant in 
alleviating distress and impacting positively on quality of life. However, the literature was 
inconclusive regarding the reasons for dissatisfaction with chemotherapy information. Whilst 
some studies reported a lack of information given to patients, others found poor recall of 
information given to be the reason for reported dissatisfaction. It would appear therefore that 
whilst patients desire information (Meredith et al 1996, Graydon et al 1997) they may not 
remember it and therefore information giving to chemotherapy patients continues to be 
perceived as generally poor (Sitzia and Wood 1998a).
Following their literature review Sitzia and Wood (1998b) went on to explore satisfaction with 
chemotherapy nursing care using the Worthing Chemotherapy Satisfaction Questionnaire 
(WCSQ). The WCSQ is a self-report questionnaire which collects both qualitative and 
quantitative data and which has been shown to display reasonable reliability and validity (Sitzia 
and Wood 1998b). The study was aimed at ambulatory chemotherapy patients, although it is 
not clear whether any of the patients required a particular CVAD in order to receive their 
treatment. A convenience sample of 173 patients completed the questionnaire. The findings 
from the later study (Sitzia and Wood, 1998b) confirmed the findings from the earlier literature 
review (Sitzia and Wood 1998a). It was discovered that overall satisfaction with chemotherapy- 
related nursing care was high but that dissatisfaction existed with the provision of information. 
Sitzia and Wood (1998b) postulated that this may be partly because of the relative 
unpredictability of chemotherapy and the lack of evidence based literature regarding regimen- 
specific side effects. Aspects of chemotherapy related information are therefore sometimes 
necessarily vague and patients can only be informed of what is likely to happen rather than what 
will definitely happen or not.
Also in keeping with the literature review findings (Sitzia and Wood 1998a), Sitzia and Wood 
(1998b) found an association between satisfaction and compliance. Patients who were non-
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compliant with the chemotherapy regimen were generally less satisfied with chemotherapy care 
and with all aspects of patient information. A further finding was that patients wanted different 
types and levels of information and thus information giving in this particular group of patients 
was complicated. Furthermore, ambulatory patients in particular wanted both emotional 
support and practical information regarding coping at home but were not given information they 
needed to cope with life during chemotherapy. It may be therefore that chemotherapy patients 
are being given information but it is not perceived by them to be the information they require, as 
reported by Fernsler (1986).
2.8.4 Information needs of chemotherapy patients
Knowles, Tierney, Jodrell and Cull (1999) assessed the information needs of patients receiving 
chemotherapy for colorectal cancer at a regional cancer centre in Edinburgh and reported 
positive and negative findings. All new patients (n=80) attending the centre for consideration of 
chemotherapy for surgically-resected colon cancer were recruited into the study. All patients 
who subsequently received chemotherapy (n=40) consented to take part in the study. A mixed- 
methods approach was taken whereby patients completed three information needs 
questionnaires, the State-Trait Anxiety Inventory (STAI), a quality of life questionnaire 
(EORTC QLQ-C30) and a semi-structured interview before, during and after their course of 
chemotherapy.
Knowles et al (1999) found that patients had both positive and negative perceptions of the 
information given to them regarding their chemotherapy. Although 97% (n=34) of patients 
reported appreciation at being given clear and honest information prior to chemotherapy, 68% 
(n=24) reported difficulty coping with the information, 51% (n=18) felt insufficient information 
had been given and 46% (n=16) reported “information dilemmas”. This dilemma stemmed 
from being asked to make a decision about treatment options in that patients on the whole 
wanted the specialist to decide what treatment was best for them. Knowles et al’s (1999) study 
serves to confirm Sitzia and Wood’s (1998b) conclusion that information giving in patients 
diagnosed with cancer and undergoing chemotherapy is complex and challenging. This is not 
unexpected since patients are faced not only with a life threatening diagnosis, but also lengthy 
and complex treatment regimens that are unfamiliar to them.
A later study which also specifically focussed on the information needs of cancer patients 
receiving chemotherapy in Northern fteland was carried out by McCaughan and Thompson
(2000). The aim of their study was to identify the needs of day case chemotherapy patients at 
the beginning, middle and end of their treatment. A questiomiaire which collected both 
quantitative and qualitative data was completed by a convenience sample of 42 patients from 72
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approached (56% response rate). The data were analyzed with respect to information needs, 
information received, appropriateness of information and overall satisfaction with information. 
Overall satisfaction with information received was high with 92.5% of patients stating that the 
information they had received had been “about right”. In keeping with Meredith et al (1996) 
and Graydon et al (1997), McCaughan and Thompson (2000) found that most patients (84.2%) 
wanted as much information as possible but that many patients failed to retain much of the vast 
amount of information associated with chemotherapy treatment, a key finding from Knowles et 
al (1999). Like Sitzia and Wood (1998b), McCaughan and Thompson found that patients 
wanted information about factors related to their “out-patient” status including practical advice 
and maintaining normal family relationships but this was not provided. Limitations of the study 
were highlighted as being the low response rate and the fact that it was patients’ perceptions of 
information received rather than actual information received that was measured. However, 
Sitzia and Wood (1998b) state that cancer patients’ perceptions of health status can influence 
behaviour more than actual health status thus it could be argued that perceptions of the 
information “experience” are a legitimate and justifiable area of enquiry.
More positive findings regarding information giving to patients undergoing chemotherapy were 
reported by Elf and Wikblad (2001) who investigated satisfaction with information and quality 
of life in patients undergoing chemotherapy in a Swedish county hospital. A convenience 
sample of 30 patients receiving chemotherapy for a variety of cancers was interviewed and also 
completed the Miller Behavioural Style Scale (MBSS) and the EORTC QLQ-C30 quality of life 
tool. The interviews were semi-structured and questioned patients on the information they 
perceived as important, their satisfaction with information received and whether they perceived 
that they needed more information in relation to chemotherapy. The MBSS was used to 
differentiate between information seekers (“monitors”) and information avoiders (“blunters”). 
Elf and Wikblad (2001) found that most of the patients (n=21) were satisfied with the 
information received but that no significant difference existed in quality of life score between 
those satisfied with information and those dissatisfied (statistics not provided). Of the nine 
patients dissatisfied with information, eight were female and of younger age, although the age 
difference was not significant (47+ 12.6 years 55.3 +11.9 years). Nonetheless this is 
interesting as previous studies (Graydon et al 1997; Meredith et al 1996) showed that younger, 
female patients tend to have the highest information need. Thus the dissatisfaction found in 
younger, female patients in Elf and Wikblad’s (2001) study may reflect this high information 
need not being met.
The limited sample size and heterogeneous patient group sampled mean that the findings from 
Elf and Wikblad’s (2001) study cannot be generalized to the wider chemotherapy population.
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Fiirthermore the quality of life measurement was taken only once during chemotherapy and 
therefore may not accurately reflect overall quality of life during chemotherapy which has been 
shown to vary during treatment (Bow et al 1999). Elf and Wikblad’s study does however show 
that individual patient preference for chemotherapy information may influence satisfaction with 
information more than actual information received.
2.8.5 Patient dissatisfaction with chemotherapy information
Skalla, Bakitas, Furstenberg, Ahles and Henderson (2004) conducted a study in a regional rural 
academic medical centie in New England, USA to determine patient preferences in relation to 
need for information about treatment for cancer and side effects. A convenience sample of 51 
patients and 14 spouses of patients who had either recently undergone of were undergoing 
chemotherapy or radiotherapy took part in focus groups. Patients who were considered to be 
“too ill” (no criteria given), those experiencing cognitive difficulties and the hearing-impaired 
were excluded from the study. Facilitator guideline questions were developed in conjunction 
with the study authors and six haematology/oncology advanced nurse practitioners to reflect 
appropriate content. The focus groups were led by facilitators trained in group facilitation skills 
and were audio-taped for later transcription and analysis.
Skalla et al (2004) found that patients were generally dissatisfied with the information they 
received. It was reported that although patients wanted information specific to the 
administration and impact of treatment, much of the information received was useless or not 
appropriate and that as patients, they felt ill-prepared to cope with the treatment and side effects. 
Furthermore in keeping with McCaughan and Thompson (2000) patients also stated that the 
information received was overwhelming and some could actually be described as “destructive”. 
Skalla et al (2004) concluded that patients wanted more specific information relating to how 
treatment would affect daily life and interestingly state that this may be because much more 
anti-cancer treatment is now administered out with the in-patient setting, a similar finding to 
that of McCaughan and Thompson (2000) and Sitzia and Wood (1998b). Thus it can be seen 
that patients require information to help them adjust to and cope with chemotherapy in the 
ambulatory setting.
Despite this and the importance placed on communicating with people with cancer, it would 
appear that health care professionals continue to fail to meet the needs of patients in this area 
(Rruijver, Kerkstra, Bensing and van de Wiel 2000; Jarrett and Payne 1995; Wilkinson 1991). 
Furthermore anecdotal evidence from the UK nursing press suggests that the majority of 
chemotherapy administration and PICC-line services are now nurse-led and under the remit of 
specialist nurses, hiformational support is an essential component of nursing care yet
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chemotherapy patients remain generally dissatisfied with the information given to them on 
essential aspects of their care (Skalla et al 2004; Sitzia and Wood 1998b). This may be a result 
of the variation in information desired by patients (Elf and Wikblad 2001) and that provided by 
nurses, which could reduce effectiveness of interventions (Sitzia and Wood 1998b; Graydon et 
al 1997; Fernsler 1986). Other difficulties in giving information to cancer chemotherapy 
patients include the fear of cancer that exists in both patients and nurses (Flanagan and Flolmes 
2000; Box and Anderson 1997); the volume and nature of information that can surround a 
cancer diagnosis and subsequent treatment pathway (Skalla et al 2004) and the general 
uncertainty that exists for patients which may cause them to avoid or ignore information given 
to them (Leydon, Boulton, Moynihan, Jones, Mossman, Boudioni, and McPherson 2000).
2.9 Summary of the literature review
This literature review aimed to explore the impact of a PICC line on patients requiring Modified 
de Gramont (MdG) chemotherapy in the ambulatory setting. Since no existing literature could 
be found which specifically addressed this, it was necessaiy to extrapolate from the wider 
literature relating to central venous access devices (CVADs) and ambulatory therapy generally.
The literature review demonstrated that little research regarding the impact of a PICC line on 
the patient receiving ambulatory MdG chemotherapy is available. There exists a modest 
amount of research related to the patient-impact of other types of CVAD but there is no 
uniformity in the type of study conducted nor are there any generalizable findings that can be 
applied to the patients in this study. Furthermore, the findings of the available studies are 
somewhat contradictoiy and no definite conclusions can be draw given their size and scope.
In reviewing the literature, it is clear that there is a wide body of research relating to the 
technical/medical aspects of PICC lines. However, although the limited research available 
suggests that PICC lines are generally well accepted by patients (Gabriel 2003, 2000; Oakley et 
al 2000), there is a lack of evidence-based research into the impact PICC lines have on patients 
undergoing ambulatoiy chemotherapy. One of the main reasons for the increase in PICC line 
usage in the oncology setting has been to facilitate the move towards ambulatory chemotherapy 
which itself is laden with challenges (AETMIS 2004). Furthermore, throughout the literature 
there appears to be an assumption that ambulatory chemotherapy benefits patients but there is 
little attention paid to the additional burdens placed upon them. Despite the rhetoric it would 
appear that the patient’s perspective is largely neglected. If no such evidence exists then 
arguably nurses will be unable to prepare patients adequately for the experience.
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Since there was little research relating to the impact of a PICC line on the patient receiving 
ambulatory MdG chemotherapy, it was the aim of this study to examine the views and 
experiences of patients receiving ambulatoiy MdG chemotherapy via a PICC line in order to 
contribute to the current understanding and research on the subject matter.
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CHAPTER THREE -  LITERATURE PERTAINING TO THE METHODS
3.1 Introduction
The aim of this study was to examine the views and experiences of patients receiving 
ambulatoiy MdG chemotherapy via a PICC line. The objectives of the study were:
1. To determine which aspects of living with a PICC line cause patients most difficulty.
2. To explore patients’ views of the PICC line experience.
3. To determine if patients view PICC lines as a benefit or a burden when receiving ambulatory 
MdG chemotherapy.
To address the study objectives, a multi-method triangulated study was designed resulting in a 
two-phase descriptive study employing both qualitative and quantitative methods. Phase 1 of 
the study involved the collection of qualitative data through semi-structured interviews. These 
data contributed to the development of a questionnaire to collect quantitative data in Phase 2 of 
the study to meet the research aims.
Justification of the research approach taken, review of the literature surrounding the methods 
employed, discussion the concepts of reliability and validity and exploration of the ethical 
issues raised by this study are presented in this chapter.
3.2 Justification of the research approach taken in this study
3.2.1 Introduction
Nursing research is carried out within two broad paradigms; qualitative and quantitative, and 
their associated research methods (Polit, Beck and Hungler 2001). Qualitative and quantitative 
approaches differ ontologically, epistemologically and methodologically (Bryman 2004; Polit et 
al 2001; Parahoo 1997). Qualitative researchers aim to uncover meaning rather than generalise 
to the wider population (Polit et al 2001) whereas quantitative researchers aim to make 
generalisations to the wider population (Bryman 2004). It can therefore be postulated that the 
qualitative approach is more suited to gathering information on areas of new enquiry with the 
quantitative approach more appropriate to the further examination of previously uncovered 
information regarding a phenomenon and hypotheses testing (Biyman 2004; Parahoo 1997).
The literature review for this study demonstrated that both approaches had been employed in 
previous research in relation to PICC lines with the qualitative approach apparent in studies 
relating to patient aspects (Gabriel 2003; Oakley et al 2000) and the quantitative approach
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common in studies investigating the technical aspects of the lines (Moureau et al 2002; Walshe 
et al 2002; Cardella et al 1992).
Corner (1991), commenting on the qualitative-quantitative debate, argued that the most 
appropriate approach is that which meets the overall aims of the research. This study aimed to 
examine the views and experiences of patients receiving ambulatoiy MdG chemotherapy via a 
PICC line. The research objectives sought to explore, describe and measure certain aspects of 
the experience therefore both approaches were utilised in this study.
3.2.2 Triangulation
The term triangulation can be traced back to navigational, military and surveying contexts 
(Murphy et al 1998) whereby it was used to pinpoint an exact location by using more than one 
reference point, rather like the co-ordinates of a map. Murphy et al (1998) cite Campbell and 
Fiske (1959) as being among the first to introduce the concept into social research although it is 
noted to refer only to the use of more than one method to test an existing hypothesis.
Denzin (1970) extended the concept of triangulation to include four types; method, data, 
investigator and theoretical. Method triangulation involves the use of different methods to 
address the same phenomenon; data triangulation uses different data sources; different 
investigators are used in the same study with investigator triangulation and theoretical 
triangulation involves different theoretical models utilised in the same study. It has been argued 
that triangulation is increasing in popularity owing to the more moderate views of researchers in 
general, and the recognition that the utilization of triangulation can increase the researcher’s 
likelihood of meeting the aims of the research (Bryman 2004; Foss and Ellefson 2002 and Coyle 
and Williams 2000).
Debate regarding the strengths and limitations of triangulation exists throughout the literature. 
Begley (1996) argued that the research methods employed should depend on the research aims 
but when used appropriately the main advantage of triangulation was to confirm or complete the 
data. Parahoo (1997) states that although combining different methods in the same study can 
result in conflicting data, it is the responsibility of the researcher to deal with this and develop 
understanding of what exactly is going on. Shili (1998) suggested that the qualitative approach 
could be seen as discoveiy whilst a quantitative aspect could provide verification of the findings 
but warned against a mixed approach being seen as “inherently good”. Murphy et al (1998) 
discuss in detail the ways in which triangulation can enhance the validity of research but state 
that the strongest argument for triangulation is as a means increasing the comprehensiveness of 
the study. The argument is that triangulation is more likely to demonstrate variations in the
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phenomena under study that can be more fully explored and thus add to the truth-value of the 
research. Some researchers however remain committed to the belief that the triangulation is 
fundamentally wrong because qualitative and quantitative approaches are epistemologically and 
ontologically incompatible, as discussed in Bryman (2004) although this rigidity is not apparent 
in the conventional nursing literature.
One of the most widely accepted uses of triangulation is to develop quantitative measurement 
tools from data obtained from qualitative interviews (Bryman 2004; Polit et al 2001; Parahoo
1997), a process known as across methods or between methods triangulation (Begley 1996). 
Oppenheim (1992) whilst not actually using the term triangulation describes the process of 
carrying out in-depth intei-views to generate data for later questionnaire design. This type of 
design can be seen in the nursing literature; for example Meredith and Wood’s (1996) 
frequently cited study into patient satisfaction with surgical services.
Whilst triangulation cannot be considered a panacea for the difficulties encountered in nursing 
research, when used appropriately and provided the researcher continually reflects on the 
processes involved, it can improve the quality and robustness of the research (Biyman 2004; 
Polit et al 2001; Parahoo 1997). In this study, method triangulation was used to increase study 
robustness and involved the use of both qualitative semi-structured interviews and quantitative 
questioimaires. This approach was appropriate because the researcher aimed to both qualify and 
quantify aspects of the patient-impact of PICC lines. It was also intended that the results would 
be transferable to the wider MdG PICC line patient population in order that nurses involved in 
PICC-line services would be better placed to support patients during the experience of living 
with a PICC line whilst undergoing ambulatory MdG chemotherapy.
The literature review demonstrated that no pre-existing evidence regarding the impact of PICC 
lines on patients undergoing ambulatoiy MdG chemotherapy existed. To meet the study aims 
and objectives it was thus necessaiy to explore patients’ views regarding the PICC-line 
experience through the qualitative approach but also to quantify which aspects of living with a 
PICC line caused patients the most difficulty through quantitative methods. Thus the qualitative 
data collected in Phase 1 of the study were used to develop the questionnaire for use in Phase 2.
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3.3 Justification of qualitative methods chosen
3.3.1 Introduction
Different methods of qualitative research exist including interviews, focus groups, observational 
techniques and diary keeping (Bryman 2004). In this study focus groups were rejected owing to 
the limited time and resources available and researcher inexperience. Observational studies 
were inappropriate since it would not have been possible to observe patients going about their 
daily lives. Diary keeping was rejected on the grounds that it could have been too demanding of 
this group of patients. The method chosen for Phase 1 of the study was the semi-structured 
interview. This was because the aim was to collect focused qualitative data which would help 
inform questionnaire development.
3.3.2 Interviews
The interview is the most common method of data collection used in qualitative research 
(Biyman 2004; Holloway and Wheeler 2002), Parahoo (1997, p 282) describes an interview as 
“a verbal interaction between one or more researcher and one or more participant for the 
purpose of collecting valid and reliable data to answer particulai’ research questions”.
The main difference between interviews in qualitative and quantitative research is the level of 
structure applied. Quantitative interviews are highly structured to collect predetermined 
responses that can be coded easily whereas qualitative interviews are loosely structured 
(although to vaiying degrees) and allow the researcher flexibility in data collection (Bryman 
2004; Holloway and Wheeler 2002; Clifford 1997).
Biyman (2004) states that semi-structured interviews are applicable when the researcher has 
identified specific areas of interest in relation to the subject matter. Semi-structured interviews 
were thus appropriate for this study since the aim was to collect qualitative data in relation to 
the patient-impact of a PICC line.
Semi-structured interviews have a focus in terms of the types of data to be collected but allow 
the researcher flexibility in terms of the wording and sequencing of questions (Holloway and 
Wheeler 2002; Clifford 1997) and allow the inteiviewer to seek clarification of findings at the 
time (Parahoo 1997). An ‘interview guide’ which contains questions pertinent to the areas of 
interest is used (Bryman 2004; Holloway and Wheeler 2002; Polit et al 2001) and allows the 
researcher to capture the world through the eyes of the participants but also ensures that the data 
collected are comparable for the purposes of seeking patterns (Parahoo 1997) and generating 
ideas (Biyman 2004).
42
Strengths of semi-structured interviews include the high response rates obtained (Polit et al 
2001; Parahoo 1997); that they are very participant orientated (Clifford 1997); that they allow 
clarification of responses and are good for new areas of study (Bryman 2004). Limitations 
include potential interviewer bias and the propensity of collecting useless data (Parahoo 1997). 
Furthermore they are veiy labour intensive (Pontin 2000), and arguably are unable to truly 
capture the participants’ real world (Biyman 2004).
3.3.3 The role of the researcher in qualitative research
The qualitative approach dictates that the researcher is viewed as having influence over all 
aspects of the research process (Parahoo 1997) but it remains important that qualitative 
researchers aim to minimise error (Pellatt 2003; Murphy et al 1998). The use of reftexivity is 
one way in which qualitative researchers have attempted to answer their critics with regard to 
the issue of subjectivity (Bryman 2004).
Many definitions of reflexivity exist (Carolan 2003; Pellatt 2003) but there is consensus that it is 
a process whereby the researcher continually reflects upon the ways in which he or she may 
have influenced the research process (Parahoo 1997). This may be in terms of the approach 
taken, study design employed, analysis of data or in the actual interaction of the researcher with 
the research participants (Biyman 2004; Murphy et al 1998).
The researcher must thus continually reflect upon the impact of his/her thoughts, assumptions 
and attitudes as well as actual presence are having on the research process and present evidence 
of decision-making processes (Holloway and Wheeler 2002). Provided a full explanation is 
given through a reflexive account, the researcher’s existing knowledge and experiences may add 
value to the study by providing thoughtful insight into the findings and by further developing 
theory (Hand 2003; Porter 2000). The researcher employed reflexivity throughout the study.
3.3.4 Qualitative data analysis
Content analysis has been used in both qualitative and quantitative research (Bryman 2004; 
Cavanagh 1997) and is described by Polit et al (2001) as a process whereby qualitative data are 
organized according to emerging themes and concepts which can then be quantitatively 
measured. This involves studying texts, analysing the words and grouping them into a smaller 
number of content related categories (Cavanagh 1997). Fuller explanation of the steps taken is 
provided by several writers (Polit et al 2001; Cavanagh 1997; Burnard 1991) namely immersion 
in the data, consideration of ‘a priori’ information, category definition, initial coding, revised 
coding and data analysis. It is suggested that using expert peer review and/or looking for
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consistency between more than one coder makes the process more reliable (Polit et al 2001; 
Cavanagh 1997).
Manifest content analysis refers to the process of discovering ‘what is said’ as opposed to ‘why 
it is said’ (Polit et al 2001) in keeping with the original work by Berelson (Cavanagh 1997). 
Thus manifest content analysis was employed for the analysis of the qualitative data collected in 
Phase 1 of this study since the researcher was looking for common themes rather than 
attempting to interpret the meaning of what was said, a process more commonly associated with 
particular research traditions such as phenomenology and grounded theory (Polit et al 2001).
3.4 Justification of quantitative methods chosen
3.4.1 Introduction
Three main quantitative research designs were identified in the literature: descriptive, 
correlational and experimental (Polit et al 2001; Carter 2000; Parahoo 1997). hi this study there 
was not enough pre-existing information regarding the impact of a PICC line on the patient 
receiving MdG chemotherapy to allow the researcher to isolate any specific variables for 
investigation and therefore experimental and correlational designs were unsuitable.
A descriptive design was the most appropriate to address the aims of the study. Structured 
interviews, sti'uctured observations and questionnaires were considered. Structured interviews 
were rejected on the basis of limited time and resources. Structured observations were rejected 
on the grounds that it would not have been possible to observe patients going about their daily 
lives. As the researcher knew in advance the type of information she was seeking given the 
literature review and interview data, a questionnaire was most appropriate.
3.4.2 Questionnaires
Questionnaires are the most widely used data collection instrument (Bryman 2004; Polit, Beck 
and Hungler 2002; Parahoo 1997; Oppenheim 1992). Parahoo (1997, p247) defines a 
questionnaire as “a method that seeks written or verbal responses from people to a written or 
verbal set of questions or statements”. Questionnaires can be administered by a researcher or 
completed by participants themselves and vary in terms of their structure, obtrusiveness, 
objectivity and quantifiability (Polit et al 2001). They can be used to describe, evaluate and 
measure aspects of the phenomenon under investigation (Parahoo 1997).
The self-report questionnaire is the most commonly used in health and social research (Bryman 
2004). Structured self-report questionnaires are appropriate when the researcher knows in
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advance the type of information they require to address the study objectives (Polit et al 2001). 
It can be completed in the absence of the researcher and contains a number of pre-coded 
questions or statements that respondents reply to (Polit et al 2001; Oppenheim 1992).
Strengths of questionnaires include the relative ease of distribution and data analysis 
(Oppenheim 1992); the high level of relevant data obtained about different aspects of the 
phenomenon under study (Murphy-Black 2000; Parahoo 1997); the convenience afforded to 
participants (Biyman 2004); and the reduction or absence or interviewer bias (Bryman 2004). 
Limitations include potential low response rates (Oppenheim 1992); response biases (Polit et al 
2001); the inability to seek clarification of responses (Bryman 2004) and the superficial view of 
phenomenon obtained (Bryman 2004). Despite the limitations, Parahoo (1997) states that when 
used in descriptive studies, questionnaires can provide data that expand and improve 
understanding of the phenomenon, aid further conceptualisation and lead hypothesis 
development.
Questionnaires can be designed to collect data on the experiences, attitudes and opinions of 
patients (Duxbuiy and Senior 2003; Polit et al 2001; Oppenheim 1992) and are commonly used 
by nurse researchers (Priest, McColl, Lois, and Bond 1995). Oppenheim (1992) distinguishes 
between factual data such as age, gender and eye colour for which a precise answer exists and 
non-factual data such as attitudes, beliefs and views which are more likely to be multi-faceted 
and thus may be more difficult to assess. Polit et al (2001, p271) refer to “composite scales” 
which allow the researcher to explore, describe and measure such multi-faceted concepts. 
These scales comprise a number of statements or items that express a viewpoint on a particular 
subject. Respondents are asked to rate the statement in some way allowing the researcher to 
categorize respondents according to strength of view or opinion held (Polit et al 2001; 
Oppenheim 1992). The main advantage of using a scale to assess experiences or viewpoints is 
that they can explore different aspects of the opinion or viewpoint which could not be disclosed 
by responding to a single question (Adams 1998). Since this study was concerned with 
patients’ views regarding the impact of a PICC line, it was necessaiy for the questionnaire to 
contain a composite scale.
The most common types of scaling technique are the Thurstonne, Guttman, semantic- 
differential and the Likert scale (Edehnann 2000). All scales have their strengths and 
limitations and the scale chosen should best suit the aims and resources of the study (Edelmann 
2000; Oppenheim 1992). The Likert-type scale was chosen as the most appropriate method of 
assessing patients’ views as it is useful in descriptive studies (Oppenheim 1992) and is regarded
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as being less time-consuming and more straightforward in terms of development and 
completion than other rating scales (Polit et al 2001; Edelmann 2000).
3.4.3 Likert Scales
The Likert scale is a multiple-indicator or item measure of opinion held towards an area of 
interest (Biyman 2004; Oppenheim 1992). The items included must be statements rather than 
questions and must all relate to the same are of interest (Bryman 2004). Furthermore the scale 
must exhibit homogeneity, that is, all the items must be internally cohesive (Oppenheim 1992).
Participants are asked to indicate their level of agreement or disagreement to a number of 
statements which are then collated to provide an indication of the strength of opinion held (Polit 
et al 2001). Debate exists as to the optimal number of positions offered on the scale and also 
the usefulness of a neutral position (Oppenheim 1992; Edelman 2000) although ultimately the 
basic aim of the scale remains the same (Adams 1998). The most commonly used Likert-type 
scales consist of five categories of response usually ranging from strongly agree to strongly 
disagree (Jamieson 2004; Edelmann 2000; Oppenheim 1992). It is suggested that the inclusion 
or exclusion of a neutral point be decided on the basis of whether a neutral point is sensible and 
acceptable (Priest et al 1995; Oppenheim 1992). Likert-type scales also allow for the inclusion 
of less obvious items which the researcher believes may be linked to opinions and can help 
develop underlying theoiy regarding the phenomenon under study (Oppenheim 1992).
The main criticism of Likert-type scales is that they are technically irreproducible 
(Oppenheim1992). Because the structure is such that the total score for any participant can be 
gained in a number of ways, identical scores may be obtained for multiple participants with 
different underlying meanings (Edelmann 2000). As with other composite scales, Likert-type 
scales can also be affected by response set biases, namely social desirability bias, extreme 
response bias and acquiescence response bias (Polit et al 2001). The responses may therefore 
reflect underlying personality traits of the participants rather than the actual attitude or opinion 
held.
A further limitation of Likert-type scales is that they do not allow the researcher to determine 
when an opinion towards an item changes from mildly positive to mildly negative and the 
neutral point, if included can be difficult to interpret (Oppenheim 1992). However, provided all 
limitations are taken into account during data analysis, Likert-type scales have been shown to 
perform well in social and health research and can also produce ideas for future research 
(Oppenheim 1992).
46
3.4.4 Quantitative data analysis
Quantitative data are numerical (Biyman 2004; Polit et al 2001) and analysis involves 
organising data to be presented in a meaningful way (Parahoo 1997). Data analysis in 
quantitative research is dependent upon the types of variable under investigation (Biyman 
2004). A variable is any item or observation that varies from individual to individual or from 
time to time (Crichton 2001). In this study, the variables were the responses to the 
questionnaire statements. The data collected were nominal and ordinal.
Nominal
This is the lowest level of measurement (Polit et al 2001; Parahoo 1997; Heiman 1996). 
Nominal data are categorical and are more a method of identification than an actual measure of 
amount (Heiman 1996). Thus nominal scales assign respondents into ordered categories which 
have no hierarchical ranking (Belcher 2001). For example, blue eyes are not greater or lesser 
than green eyes. The demographic data collected in this study were thus nominal.
Ordinal
Ordinal scales are similar to nominal scales but constitute a higher level of measurement as the 
values can be ordered or ranked (Belcher 2001). However the value is a relative amount rather 
than a true measurement m the mathematical sense (Polit et al 2001; Heiman1996). This is 
because the value attached to the variable is used only to reflect increasing or decreasing value 
and there is no equal unit of measurement between the scores (Heiman 1996). For example, the 
difference between a mild, moderate and severe pain score cannot be measured in any way 
however severe pain is worse than mild pain. Likert-type scales thus collect ordinal data which 
is ranked according to how much participants agree or disagree with the given item statements 
(Biyman 2004; Polit et al 2001; Belcher 2001). The data generated from the Likert-type scale 
used in the questionnaire in this study were therefore ordinal.
A further consideration in quantitative data analysis is whether the variables are measured on a 
continuous or discrete seale; that is to say, whether or not the measurements can sensibly 
include a decimal point (Heiman 1996). Nominal and ordinal data are discrete (Belcher 2001; 
Heiman 1996) thus the data collected in this study were discrete. The presence of discrete or 
continuous variables and the level of measurement involved determine which statistical 
procedures may be applied to the data (Belcher 2001; Crichton 2001; Heiman 1996). The 
resulting analysis produces either descriptive or inferential statistics (Crichton 2001; Polit et al 
2001; Heiman 1996).
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Descriptive statistics are used to organise and describe data (Polit et al 2001) in order that 
important characteristics of the data can be easily displayed (Heiman 1996). Descriptive 
statistics provide a summaiy of the data for a particular variable using tables and graphical 
representations such as bar charts and (Crichton 2001). However, it is important to note that 
descriptive statistics only describe the characteristics of the sample used in the study (Polit et al 
2001; Heiman 1996) and if the researcher wishes to generalise from the sample to the 
population, inferential statistics are necessaiy (Polit et al 2001; Crichton 2001; Heiman 1996).
Inferential statistics use certain mathematical techniques based on ideas of probability to make 
inferences about the population represented by the sample, from the sample data obtained (Polit 
et al 2002; Heiman 1996). Hypothesis testing and estimation through confidence intervals are 
the most commonly used inferential statistics in health-related research (Crichton 2001). It is 
strongly argued that confidence intervals are more useful than hypothesis testing as they provide 
not only a measure of statistical significance (or not) but also provide information on the size of 
the obsewed effect (Crichton 2001; Davies 2001). This means that researchers can tell whether 
the effect is statistically significant and also judge whether any effect is clinically relevant 
(Crichton 2001; Davies 2001).
The confidence interval provides a range of values that the population mean or proportion is 
likely to lie within (Crichton 2001). Thus it is an estimate of the true but unknown effect size 
with an upper and lower limit on the probable size of the effect (Davies 2001). A proportion 
usually between 90 and 99% will also be specified known as the confidence level with the upper 
and lower limits known as the confidence limits (Davies 2001). The 95% confidence level is 
most commonly utilised (Crichton 2001; Davies 2001) which means that the true value of the 
variable of interest will lie within the confidence limits 95% of the times that the method is 
used.
Statistical significance is assessed from a confidence interval depending on whether or not the 
confidence interval contains the value reflecting ‘no effect’ (Davies 2001). Thus if a confidence 
interval contains the value zero, then the result is not statistically significant. The confidence 
limits also provide information on the width of the confidence interval (Crichton 2001). The 
wider the confidence inteiwal, the greater the margin of error and hence the less precise the 
information about the size of the effect (Crichton 2001). A narrower confidence interval 
suggests either small variability of the variable under investigation or a large sample size and 
therefore a more precise estimate of the true effect (Davies 2001).
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However statistical significance does not infer clinical significance therefore one must take care 
in the interpretation of confidence intervals (Crichton 2001; Davies 2001). Davies (2001) 
further states that the size of the effect must be considered in light of the significance. For 
example, a clinical trial may show that a new drug lowers blood pressure more than the existing 
drug and the difference is statistically significant. However, the effect may be so small that 
changing the patient’s medication is not justified as the clinical benefit is negligible.
It is also important to consider the results in light of the overall study design (Davies 2001). No 
statistical test is infallible and the only known results are those which apply to the sample 
(Davies 2001). Thus it is necessary to consider the results with respect to the overall 
trustworthiness of the study (Davies 2001). This involves consideration of the study design, any 
possible biases, the sample used and the interpretation of the results (Davies 2001) therefore 
confidence intervals whilst providing important information do not sit in isolation when 
interpreting and discussing results.
In this study, both descriptive statistics and inferential statistics were used in accordance with 
advice from a statistician. Confidence intervals were used as they provided an estimate of the 
true population proportions that were likely to hold a particular viewpoint and also information 
on the size of the effect observed.
3.5 Literature relating to validity and reliability
Bryman (2004) states the three most common criteria for evaluating research are reliability, 
replicability and validity. Validity and reliability are the two crucial elements of assessing the 
credibility and quality of questionnaires generally and Likert scales specifically (Bryman 2004; 
Polit et al 2001; Carter and Porter 2000; Parahoo 1997; Oppenheim 1992).
3.5.1 Validity
Validity is the extent to which a data collection instrument measures what it intends to measure 
(Carter and Porter 2000; Oppenheim 1992). Different types of validity exist but not all may be 
evident in any given instrument (Eby 1993).
Content validity is concerned with how much the items in the instrument adequately cover the 
area of interest (Gibbon 1998; Parahoo 1997). Researchers use the literature review, expert 
opinion and qualitative data from other sources to assert content validity (Gibbon 1998; 
Oppenheim 1992). Face validity is said to be the weakest form of validity and is simply how 
much a tool looks like it is measuring what it claims to measure (Polit et al 2001).
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Concurrent validity, sometimes referred to as criterion-related validity, is the extent to which a 
measure correlates with a pre-existing accepted measure, or a previously validated tool (Carter 
and Porter 2000). Convergent validity is the degree to which different methods of measuring a 
concept correlate with one another (Bryman 2004). Construct validity examines the relationship 
between the measure and some potential underpinning theory (Carter and Porter 2000). 
External validity is the extent to which the instrument of collection would generate the same 
findings in a setting different to that from which the sample came (Polit et al 2001).
3.5.2Reliability
Reliability refers to the consistency of an instrument and is a measure of how well the 
instrument produces the same or similar results if administered under the same or similar 
conditions (Parahoo 1997). Oppenheim (1992) refers to this in terms of the degree of error of 
the instrument and explains that high reliability assures us it is the instrument that is producing 
the results and not a chance finding.
Difficulties exist in determining the reliability and validity of composite scales such as Likert- 
types scales (Oppenheim 1992). Since attitudes and opinions are indirect indicators of the 
concept under investigation and are unable to be truly confirmed (Biyman 2004), it is not 
always possible to measure them against any pre-existing established criteria. Oppenheim 
(1992) also states that attitudes are complex and context bound and therefore there is no “true” 
answer to the questions posed. For these reasons, Biyman (2004) states that many researchers 
are unable to rigorously apply all the principles of validity and reliability in any given study. 
Furthermore, Oppenheim (1992) states that the purpose of the instrument is the most important 
consideration and researchers must recognise the limitations inherent in them when making 
claims from results.
3.5.3 Validity and reliability in qualitative research
Lincoln and Guba (1985) propose a completely new set of criteria for assessing the quality of 
qualitative research. They rejected the notion of internal and external validity in particular 
because in their view there is no one true reality and therefore there can be no claim to ever 
completely accurately represent someone else’s reality through the research process. Instead, 
Lincoln and Guba (1985) favoured the concept of ‘trustworthiness’ in qualitative research which 
has four main criteria.
Credibility is used in place of internal validity and refers to the level of agreement between the 
researchers’ findings and the participants’ realities. Ways of increasing credibility include 
member checking, peer review, analysis of negative cases and prolonged engagement in the
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field. Dependability is similar to reliability and involves the use of an ‘audit trail’ to ensure that 
the researcher’s processes are logical, traceable and acknowledged. Confirmability is suggested 
in place of objectivity and is the researcher’s way of showing neutrality, which can also involve 
the use of an audit trail which clearly links the findings and interpretations to the original data 
sources. Transferability is in place of generalizability where the researcher uses thick 
description to present the findings in such a way that others can determine if it is relevant to 
their setting. In addition, Lincoln and Guba propose a number of further steps to be taken to 
demonstrate the authenticity of the research in terms of the wider impact although Bryman 
(2004) states that these have not been widely influential in the qualitative research community.
Mays and Pope (2000) however take the viewpoint that the criteria of validity and reliability can 
be used to evaluate qualitative research provided they are modified to meet the aims of the study 
in question. They state that the aim of both qualitative and quantitative researchers should be to 
uncover the “subtle realism” of the world and those in it -  that is to discover reality rather than 
one universal ‘truth’. Thus they propose that it is the validity and relevance o f the research that 
is most important as a means of ensuring its quality. Ways of improving validity by this token 
include triangulation, respondent validation or member checking, providing a clear account of 
the processes of data collection and analysis, demonstrating researcher reflexivity and attention 
to negative cases. In addition, fair dealing which demonstrates that the researcher has included 
a wide range of different perspectives ensures that no potential viewpoint is neglected.
3.5.4 Validity and reliability in this study
In this study the researcher used the criteria of validity and reliability throughout. The reasons 
for this were as follows;
• The research design incorporated both qualitative and quantitative elements and 
therefore it seemed practical to use consistent terminology.
• The debate regarding the use of the criteria remains unresolved and therefore there was 
no one over-riding argument against this stance. Furthermore, several prominent 
writers in the field of research (Bryman 2004; Mays and Pope 2000; Murphy et al 1998) 
proposed the acceptance of the criteria of validity and reliability provided the aims of 
the research were met.
• The means by which the researcher demonstrated quality were method appropriate in 
line with Bryman (2004), Mays and Pope (2000) and Murphy et al (1998).
An explanation of the ways in which validity and reliability were applied to this study is found 
in section 6.5.
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3.6 Ethical issues
3.6.1 Ethics in research
Ethics is a branch of philosophy concerned with morality and what is considered to be right or 
wrong in society (Beauchamp and Childress 1994). Ethics in research became prominent 
following the abuse of human rights under the guise of research including Nazi experimentation 
and led to a number of ethical codes being formulated and adopted by those involved in research 
(British Medical Association (BMA) 2001). The BMA stated the purpose of research in health 
is to contribute to the existing body of knowledge on a given topic by the use of precise and 
robust methods.
However the research process may result in the disclosure of information about individuals that 
is not already known (McHaffie 2000) and therefore the entire research process is subject to a 
number of ethical considerations from the choosing of the research topic through to the 
dissemination of the findings (Paralioo 1997). A number of ethical principles exist which form 
the basis of ethical research namely autonomy, non-maleficence, beneficence and justice 
(Beauchamp and Childress 1994).
3.6.2 Autonomy
The literal meaning of autonomy is ‘self-rule’ and was first used to describe the self-governance 
of the ancient Greek Hellenic city-states (Beauchamp and Childress 1994). The concept of 
autonomy has been widened to include individuals and has various definitions including “self- 
governance”, “freedom of the will” and “being one’s own person” (Beauchamp and Childress 
1994, pi 20). The Royal College of Nursing (RCN) define autonomy as being “the ability of an 
individual to make reasoned decisions about issues that affect them” (RCN 1994, p4). Thus the 
autonomous individual has the capacity to act in a self-determining way although as Beauchamp 
and Childress (1994) point out, capacity to act autonomously is not the same as actually acting 
autonomously, in other words people can fail to act autonomously.
In order to be autonomous, individuals must posses “liberty” (independence from controlling 
influences) and “agency” (capacity for intentional action) (Beauchamp and Childress 1994, 
pl21). The BMA (2001, p37) describe the components of autonomy as being “understanding, 
the absence of mental illness and social opportunity” which compares with Beauchamp and 
Childress’ concepts. Thus it can be seen that whilst respect for autonomy is a guiding ethical 
principle (Beauchamp and Childress 1994), not all individuals have the capacity or the 
opportunity to act autonomously.
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Research has the potential to threaten a person’s autonomy in several ways (BMA 2001);
• The researcher may have power or influence over the research participants
• The research subjects may form part of a vulnerable population and feel obligated to 
take part in the research
• The eligibility criteria of the study may exclude individuals thus denying their chance 
to take part in the research.
Polit et al (2001) state that to respect participants’ autonomy, participation must be voluntary 
and participants made aware of their right to decline participation or withdraw from the study at 
any time without prejudice. The BMA (2001) however caution that simply being invited to take 
part in a study by a health care professional may give the study credibility and vulnerable 
patients may agree to participate to ‘help’ the health care professional which could in turn 
challenge a person’s autonomy. This is echoed by Redsell and Cheater (2001) who state that 
patients recruited into studies by a nurse known to them may consent in order to please the 
nurse.
Beauchamp and Childress (1994) state that autonomous decision making and informed consent 
are inextricably linked in biomedical ethics. The physician is obliged to inform by providing 
full and comprehensive information to the patient and also to insure that the information given 
is able to be understood by the patient (Beauchamp and Childress 1994). Consent involves the 
individual’s free choice to proceed in the matter after being informed (Beauchamp and 
Childress 1994). Thus informed consent requires that the individual receives and understands 
adequate and appropriate information and voluntarily consents to the care, treatment or 
intervention. Beauchamp and Childress (1994) further state that the researcher is thus obligated 
to insure informed consent from potential and actual research participants in order to address the 
principle of respect for autonomy.
In addition, although individuals may make an autonomous decision to take part in research, 
there remains the potential for the research to cause harm for example by exposing them to side 
effects of new drugs or by disclosing intimate personal details in interviews. Therefore it stands 
that autonomy does not exist in isolation but is a component of an ethical framework inclusive 
of the other guiding principles.
53
3.6.3 Non-maleficence and beneficence
Non-maleficence is defined as the moral obligation not to harm whilst beneficence is to do good 
(Beauchamp and Childress 1994). It is further defined that ‘harm’ can be both physical and 
emotional (Bryman 2004).
Some moral philosophers have argued that the obligations of non-maleficence are more rigorous 
than those of beneficence (Beauchamp and Childress 1994). Thus a person is obligated first and 
foremost to do no harm but the obligation to do good is more passive. For example, a person is 
less obligated to jump into a river to save someone from drowning than to act not to throw them 
into the river in the first instance. Beauchamp and Childress dispute this and claim that 
although the concepts of non-maleficence and beneficence are distinct, they are both important 
and should not be ranked in any way hierarchical way.
Non-maleficence and beneficence are important concepts in the research process in part owing 
to the unpredictable element of discoveiy embedded in research (Orb, Eisenhauer and Wynaden 
2001). The BMA (2001) further explain that the quest to produce research-based knowledge to 
do good could result in doing harm to individuals. To find a cure for cancer, one may expose 
research participants to the unwanted side effects of new drugs, a concern even when an 
autonomous decision to take part has been made.
However, it could be argued that it is impossible to eliminate all potential physical and 
emotional harm from the research process therefore the most important issue is that the 
researcher strives to promote non-maleficence and beneficence. Polit et al (2001, p76) 
summarise this well as the “risk/benefit ratio” in research. They provide a framework which 
allows the researcher to consider the potential benefits of the research against the potential harm 
to participants and ensures that the proposed benefits never take precedence over the individual 
risks to participants.
3.6.4 Justice
The principle of justice refers to an individual’s right to be treated fairly and equally (Polit et al 
2001; Orb et al 2001). Beauchamp and Childress (1994) further explain that injustice therefore 
incorporates an act or omission that denies an individual their right to a resource or privilege. 
To act in a just way also insures that people are not exploited or abused (Orb et al 2001).
In terms of the research process, this means that all individuals who may benefit from the 
research should have the opportunity to take part and has implications for the setting of 
eligibility criteria (Polit et al 2001). Non-justifiable exclusion of a particular group of patients 
from a drug trial for example could mean that future similar patients are denied the drug.
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Other ways of acting in a just way in research include being sensitive to participants needs and 
concerns, acting in a respectful manner towards participants, providing the opportunity to 
clarify participants’ concerns and respecting all arrangements agreed with the participant (Polit 
et al 2001).
As well as the above underlying principles of ethical research there exist a number of related 
issues which must be addressed in any research study and which help to insure proper conduct 
in a study (Bryman 2004; Polit et al 2001; RCN 2001).
3.6.5 Confidentiality and anonymity
Research in humans may encroach into aspects of the individual’s personal life therefore 
participants have the right to privacy (Polit et al 2001). The concepts of confidentiality and 
anonymity are used to safeguard privacy.
Confidentiality in research means that the identities of participants or the information they 
provide is not displayed in the public arena without their prior consent (Polit et al 2001). 
Anonymity refers to the process of insuring that the information provided by participants is 
unable to be linked back to them in any way thus the researcher is unable to tell who provided 
which data (Polit et al 2001). For Polit et al (2001) the right to confidentiality is implicit in the 
principle of justice, meaning that participants are treated fairly and the information they provide 
is treated with the same respect.
It follows that while all data can be treated confidentially, not all data can be anonymized. 
Whilst the self-report questionnaire can be anonymized it is not possible to anonymize the data 
in inteiwiews, obseiwations and experiments, hr such circumstances, researchers must treat the 
data confidentially for example by using identification codes in place of participants’ names, to 
insure that no one other than those consented to by participants is able to link the data with the 
participant (Polit et al 2001). Furthermore, the data obtained must be edited to insure that the 
participant is not identifiable from other means such as age, occupation or distinguishing 
features (Redsell and Cheater 2001).
This has implications for researchers in terms of how data is recorded and stored. The 
researcher’s responsibilities with respect to this are laid out in the 1998 Data Protection Act.
3.6.6 Data Protection Act
The Data Protection Act (UK Parliament 1998) was introduced to insure that information about 
individuals was treated fairly and lawfully. The Act gives individuals certain rights regarding 
information held about them and who can access it and covers factual information relating to the
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individual and opinions held by them (UK Parliament 1998). There are eight principles of good 
practice relating to the holding of personal information: the information must be;
• Fairly and lawfully processed
• Processed for limited and specific pui*poses
• Accurate and up to date
• Adequate, relevant and not excessive in relation to the purpose(s) for which they are 
processed
• Not kept longer than necessaiy
• Processed in accordance with the individual’s rights
• Securely held to insure no unauthorised or unlawful processing of personal data and 
against accidental loss or destruction of, or damage to, personal data
• Not transferred to countries outside the European Economic area unless countiy has 
adequate protection for the individual.
Interestingly personal data obtained for research purposes is exempt from certain aspects of the 
Act provided particular guidelines are followed (Redsell and Cheater 2001). An example is that 
personal data obtained from research can be kept indefinitely (UK Parliament 1998). 
Nonetheless it is stated that personal information obtained through research must be treated 
confidentially and must not be processed in such a way as to cause damage or distress to the 
individual concerned (UK Parliament 1998).
The Data Protection Act also makes it a criminal offence to distribute personal information 
about an individual or to allow access to personal information without prior consent from the 
individual. The implications of this are discussed by Redsell and Cheater (2001) who found 
that confusion regarding aspects of the Act exists in the health service and academic 
community. Redsell and Cheater (2001) cite two instances where they believe bias was 
inh'oduced into a study as a result of how the Data Protection Act was interpreted. In one study 
the researcher was not given ethics approval to recruit participants but rather had to recruit 
through a third party known to the participants; in this instance a nurse; as the ethics committee 
deemed that to give the researcher potential participants’ details would contravene the Data 
Protection Act. Thus the researcher had no way of knowing which potential participants were 
approached or whether potential participants were not asked to participate for reasons related to
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the recruiting nurse rather than the study (Redsell and Cheater 2001), In the second study, the 
Data Protection Act was contravened as contact details of staff were provided to researchers 
without the prior consent of the individuals involved (Redsell and Charter 2001). Redsell and 
Cheater conclude by stating that the Data Protection Act has implications on study design and 
execution and that the researcher must insure methodological rigour is not compromised as a 
result.
3.6.7 Deception
Biyman (2004) states that deception can occur in research in a number of ways including 
deceiving participants as to the true aims of the study, not providing participants with enough 
information regarding the study and presenting unsubstantiated findings. Bryman (2004) argues 
that some degree of deception is widespread in research as it may not be possible or desirable to 
fully inform every individual participant of every aspect of the research. However, Polit et ai 
(2001) caution that deception can interfere with a person’s autonomous decision making and 
therefore participants must be fully informed of all relevant and necessaiy information. It could 
also be argued that deception is potentially problematic in qualitative research when the 
researcher is an instrument of data collection and is linked to the concept of reflexivity which is 
discussed in section 3.3.3.
3.6.8 Vulnerable/dependant subjects
The use of vulnerable and/or dependent participants raises the potential for abuse in research 
(BMA 2001). The BMA state that dependant groups such as people with illnesses are often 
chosen as research subjects and indeed most health-related research is conducted using people 
with vaiying illnesses. It is further recognised that almost all research participants are 
vulnerable to some extent by virtue of being recruited into the aiguably uncertain nature of a 
research study (BMA 2001). Certain groups of individuals are recognised as being particularly 
vulnerable including children, the mentally handicapped and unconscious patients whose
capacity to act autonomously is challenged (BMA 2001; Polit et al 2001),
However, it is further apparent that patients recruited into health-related research studies can 
demonstrate more subtle forms of dependency and vulnerability (BMA 2001). Patients being 
treated by a medical team may feel obliged to take part in studies to help or ingratiate
themselves to members of the medical team as discussed in section 3.6.3.
Thus vulnerability and dependency are also linked to the concept of autonomy and it could be 
argued that a person’s liberty, or freedom from controlling influences, is challenged when one is 
under the ongoing care of a medical team.
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3.6.9 Ethical issues raised by this study
In this study, the participants were patients receiving cytotoxic chemotherapy for incurable 
colon cancer and thus were considered as potentially vulnerable and dependant. At the time of 
data collection the researcher was a member of staff of the Oncology unit where the study took 
place although none of the participants were known to her. Nonetheless, it was possible that the 
potential participants may have felt compelled to consent as they recognised her as a staff 
member or because they felt grateful for the treatment they were receiving. It was thus crucial 
that potential participants were aware of their rights to decline participation or withdraw from 
the study at any time without prejudice. Furthermore in order to respect patient autonomy it 
was necessaiy to fully inform participants of the nature of the study, that it was not an essential 
part of their care and that although future patients may benefit from the study results, they 
themselves would not benefit directly from the study.
There was no potential for the study to cause physical harm to participants although it was 
possible that emotionally challenging subject matter might come to light as patients discussed 
the impact of having a PICC line on their lives and those of their families and friends. The 
mixed methods approach taken also meant that information obtained from the semi-structured 
interviews was not anonymous but all information was treated confidentially and in accordance 
with the Data Protection Act (1998). The measures implemented to adhere to ethical research 
guidelines are described in section 4.5.
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CHAPTER FOUR -  MATERIALS AND METHODS
4.1 Study aims
The aim of this study was to examine the views and experiences of patients receiving 
ambulatory MdG chemotherapy via a PICC line. The objectives of the study were:
1. To determine which aspects of living with a PICC line cause patients most difficulty.
2. To explore patients’ views of the PICC line experience.
3. To determine if patients view PICC lines as a benefit or a burden when receiving ambulatory 
MdG chemotherapy.
This chapter outlines the steps taken in conducting the study and describes the study design, 
study sample, ethical considerations, research instruments, data collection procedures and 
methods of data analysis. Sections 4.2, 4.3, 4.4 and 4.5 are applicable to both phases of the 
study. Following these sections, the two phases of the study are described sequentially.
4.2 Overview of study design
This was a multi-method triangulated descriptive study implemented in two phases over two 
years and employing both qualitative and quantitative methods. Phase 1 involved the collection 
of qualitative data through semi-structured interviews from a convenience sample of 10 
participants. The qualitative data were analysed using content analysis from which emerging 
categories and themes were produced. The themes were used to construct a questionnaire for 
use in Phase 2 from which quantitative data were collected from a convenience sample of 62 
participants. Statistical advice was provided and the quantitative data analysed using Minitab.
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Figure 1: Illustration of study design
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4.3 Study site
The study took place in the chemotherapy day unit of a large oncology centre in Scotland. The 
Oncology Centre serves a population of >2.8 million patients from five health board areas, both 
rural and urban. The Centre is a specialist cancer tertiary centre and treats patients with a wide 
variety of cancers as in and out-patients. Owing to the wide geographical area seiwed, many 
patients are required to stay away from home or travel long distances in order to receive 
treatment. In the region of 8,000 new patients attend the Centre yearly and >6,500 courses of 
radiotherapy and >15,000 courses of chemotherapy are administered. The chemotherapy day 
unit on average treats approximately 40 patients per day and approximately 500 PICC lines are 
inserted in patients each year.
4.4 Access
All oncology consultants (n=7) referring patients to the chemotherapy day unit for MdG 
chemotherapy with a PICC line were informed of the study in writing (Appendix I), issued with 
a copy of the research proposal and permission to access their patients was requested. All 
agreed. Access was also requested and granted from the Clinical Nurse Manager of the Centre, 
the Chemotherapy Service Senior Nurse and the Chemotherapy Day Unit Manager (Appendix 
II). Members of the chemotherapy nursing team were informed of the study by holding 
informal briefing sessions and given the opportunity to ask questions or raise concerns. This 
was considered important since the researcher would spend a eonsiderable amount of time in the 
unit and because these nurses would be involved in aspects of participant recruitment (see 
section 4.8). No major concerns were raised and all queries were addressed.
4.5 Ethical considerations and ethics approval
As discussed in section 3.6.10, the ethical issues raised by this study were the 
vulnerable/dependent nature of the participants, the participants’ autonomy, informed consent, 
potential harm to paiticipants and issues of confidentiality and anonymity, all of which are 
interlinked.
4.5.1 Respect for autonomy
Autonomy is defined as “the ability of an individual to make reasoned decisions about issues 
that affect them” (RCN 2004, p4) and can be tlrreatened when research participants are 
vulnerable or when the researcher has power or influence over the study participants (BMA 
2001).
The participants in this study could be considered vulnerable and dependent as they were 
receiving chemotherapy for terminal cancer. The BMA (2001) states that simply being asked to
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participate in a research study can make patients feel obligated and give the study credibility. It 
is therefore essential that potential participants receive adequate information to allow them to 
make an informed decision to participate or not and that they are aware of their rights. In this 
study, this was achieved by providing a patient information sheet (Appendices III and IV) 
containing explicit information to protect patient autonomy namely;
• The aims and objectives of the study
• Why their participation was being sought
• That participation was entirely voluntaiy
• That the participants themselves would not directly benefit from the study
• That the participants could withdraw from the study at any time without prejudicing their 
care
• That the study findings would be made available to others with an interest in the subject.
4.5.2 Informed consent
Informed consent is linked with autonomy (Beauchamp and Childress 1994) and in addition to 
the measures outlined above, participants were also given time to consider participation and to 
have any outstanding questions or queries addressed.
For the Phase 1 interviews, written consent was provided by the participants (Appendix IV) 
stating that they understood the nature, purpose and possible consequences of taking part in the 
study and that they were free to withdraw at any time.
In Phase 2, the front page of the questionnaire had statements with tick boxes beside them for 
participants to indicate that they understood questionnaire completion was for research 
purposes, that they had read and understood the patient information sheet and that they 
understood participation was voluntary and they could withdraw at any time without prejudice.
4.5.3 Potential harm to participants
The principles of beneficence and non-maleficence are applied in research to insure the risks of 
research do not outweigh any potential benefits (Polit et al 2001). There was no potential for 
physical harm in this study. However although unlikely, it was possible that psychological 
harm could occur as a result of discussing sensitive issues in the interviews. It was therefore 
decided that should any participant become emotionally distressed during the interview, the 
researcher would alert the patient’s chemotherapy nurse in order that she could ensure the 
patient’s distress was addressed.
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4.5.4 Confidentiality/anonymity
Ali participants have the right to privacy (Polit et al 2001) and the concepts of confidentiality 
and anonymity are used to safeguard privacy. To insure confidentiality, the participants’ 
identities or the information they provide must not be displayed publicly without their prior 
consent. Anonymity refers to the process of separating the data from the provider so that no- 
one is aware of who provided the data.
The patient information sheet made participants aware that the study findings would be made 
available to others with an interest in the subject but that all information they provided would be 
treated confidentially. This was insured by using identification codes on both the interview 
transcripts and questionnaires so that no-one other than the researcher was able to link the data 
with the participant. Thus the information provided was not anonymous but adequate steps 
were taken to insure eonfidentiality and treat the information in accordance with the Data 
Protection Act (UK Parliament 1998). The data were stored either on a password protected 
computer or in a locked cabinet. Participants’ details were kept separate from their responses at 
all times by use of the identification code and the data were enough to answer the research 
questions but not excessive. The data were held until the study was completed and published 
then destroyed in accordanee with the 1998 Data Protection Act.
4.5.5 Ethics Committee Requirements
For this study, ethics approval was obtained from the Local Research Ethics Committee 
(LREC). The triangulated study design meant that submission for ethics approval was required 
on two occasions.
Submission to LREC was made on December 2003 for ethics approval to undertake the Phase 1 
interviews and on January 2004 to undertake the Phase 2 questionnaires. On both occasions, 
minor adjustments were required to the accompanying Patient Information Sheet and on the 
second submission; the addition of a medical clinician’s name to the application was required. 
Following these minor adjustments formal ethics approval was granted (Appendices VI and 
VII).
4.6 Phase 1 sample and sample size
A convenience sample was used to collect the qualitative data through the semi-struetured 
interviews. Although recognised as the weakest form of sampling (Polit et al 2001), it is often 
used by nurse researchers and in qualitative designs (Polit et al 2001; Parahoo 1997), 
Additionally there was not enough pre-existing information available to determine any potential 
variables which could have been used to specify the requirements of a purposive or quota
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sample which are generally considered to be more robust methods of obtaining a qualitative 
sample (Polit et al 2001; Oppenheim 1992). In this study, tliree participants took part in the 
pilot study and five male and five females took part in the main study interviews. Polit et al 
(2001) state that smaller samples of 10 or less are usually sufficient for qualitative studies.
4.6.1 Inclusion criteria
• PICC line in situ for at least 8 weeks
• > 18 years of age
• attending day unit at study site
• receiving any MdG chemotherapy regimen
• willing and able to give informed consent
4.6.2 Exclusion criteria
• unable to read or write English
4.6.3 Justification for inclusion/exclusion criteria
The period of eight weeks was chosen as this allowed for a reasonable period of time to assess 
day to day living and for patients to have experienced living with the PICC line in situ.
It was decided to sample patients receiving MdG chemotherapy in order to target a more 
homogenous population. As described in section 2.5.4, PICC lines are used for the 
administration of a wide variety of chemotherapy regimens including short bolus 
administration, intermittent infusion and continuous pump. By sampling only MdG PICC-line 
patients, potential sources of bias such as the severity of toxicities which could affect 
participants’ perceptions of daily life were reduced (Meredith and Wood 1996). Furthermore, 
there are less 'badges’ of cancer in this group of patients such as alopecia which could make it 
difficult to distinguish between PICC-line related altered body image perception and that 
induced by other causes (Daniels 1996).
In addition to the inclusion/exclusion criteria, World Health Organisation (WHO) Performance 
Status and toxicity assessment (Appendix VIII) took place prior to participants’ interviews. The 
researcher decided that those with Performance Status > two and those experiencing >Grade 
two toxicities would have their interview postponed or cancelled for two reasons; it would have 
been inappropriate to ask an ill patient to sit through a fairly extensive interview. Secondly, if a 
participant was particularly unwell at the time of intewiew, this could introduce a potential
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source of bias, since it has been recognised that the patients’ condition can be a significant 
variable in assessing responses to particular questions (Meredith and Wood 1996).
4.7 Construction of the Phase 1 semi-structured interview schedule
Justification for the Phase 1 data collection method chosen is provided in section 3.3. The aim 
of the interviews was to provide qualitative data which could be analysed for themes that would 
contribute to the development of the Phase 2 questionnaire.
The interview schedule (Appendix IX) was developed taking into account the specific aims of 
the research and key findings from the literature review. Consideration was given to 
maximising the strengths and reducing the limitations of interviews. The schedule was 
designed in such a way as to avoid the use of leading and/or ambiguous questions (Bryman 
2004). The questions used were open but focussed to allow the participants to give answers in 
their own words but also to ensure they remained focussed on the aims of the study (Parahoo 
1997). Questions were kept short and the use of jargon avoided (Oppenheim 1992). The 
number of questions used was considered carefully to avoid overburdening participants and to 
ensure the intei'views were not too lengthy or tiring (Biyman 2004). The final question allowed 
participants the opportunity to add anything they thought relevant that was not already covered 
(Oppenheim 1992).
The devised interview schedule was subject to piloting following which several minor 
adjustments were required (see 4.9.4).
4.8 Phase 1 Recruitment strategy
The steps taken in recruiting participants for the Phase 1 interviews were as follows:
1. A checklist detailing the study inclusion/exclusion criteria was drawn up.
2. Potential participants were identified from the chemotherapy day unit admissions list by a 
member of the chemotherapy nursing team.
3. The chemotherapy nurse checked eligibility using the patient’s case notes and the checklist 
described above.
4. Potential participants were issued with a patient information sheet (Appendix III by the 
chemotherapy nurse and willingness to paiticipate eonfirmed.
5. The potential participant was identified to the researcher by the chemotherapy nurse.
6. The researcher approached the potential participant, checked eligibility criteria, answered 
any outstanding questions and obtained written consent.
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4.9 Phase 1 pilot study
Pilot studies allow for testing of the researcher as a tool for data collection (Mason 1992); 
testing of the data collection methods (Clifford 1997) and also afford the researcher the 
opportunity to develop and practise their interviewing skills (Holloway and Wheeler 2002; 
Mason 1992).
4.9.1 Pilot study objectives
1. To assess the suitability of the room environment for interviews.
2. To test the quality of recording equipment.
3. To assess the suitability of the recruitment strategy.
4. To allow the testing of interview questions in terms of participants’ understanding and 
sequence of questions.
5. To commence the process o f reflexivity, especially in relation to the researcher’s 
interview style.
6. To familiarise the researcher with the process of data analysis
7. To examine the quality of the data generated in terms of meeting the aims of the study.
4.9.2 Pilot study data collection
The pilot interviews were carried out in the room intended for use in the main study. The 
proposed interview schedule was used. A convenience sample of two participants who met the 
eligibility criteria was involved in the pilot interviews. The steps outlined in section 4.8 above 
were carried out following which the researcher and participant agreed a mutually convenient 
date and time for interview. On the day of interview the participant was given the opportunity 
to discuss any outstanding questions or queries. The researcher then assessed the WHO 
performance status and toxicity assessment prior to conducting the interview. These were 
satisfactoiy and the interviews proceeded. The interviews were audio-taped and then transcribed 
verbatim. Field notes were written up immediately following the interviews and included a 
personal assessment of the researcher’s inteiwiew performance.
4.9.3 Pilot study findings
The main findings of the pilot study with regard to the objectives were as follows;
1. The room was satisfactory for interviews.
2. The recording equipment adequately recorded both researcher and participants’ words 
and there were no problems with the transeribing of tapes.
3. The process of recruiting participants worked well and no problems were identified.
4. Two of the original interview questions needed to be altered as it was clear that both 
participants had difficulty understanding what information was being requested. One
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question was reviewed and effeetively became two separate questions and a further 
question was replnased. The sequencing of the questions appeared satisfactory.
5. The interviews appeared to flow well overall. The researcher had previously undergone 
training in communication and counselling skills, many of which were transferable to 
this type of interview situation; for example, active listening skills, non-verbal 
communication cues and remaining silent when necessary. However, there was a 
degree of anxiety present, which may have been apparent as one participant commented 
that “you look very serious” and the researcher felt that her performance as an 
interviewer could be improved upon. It was also evident that the two initial pilot 
interviews were very unequal in terms of length with interview one lasting seven 
minutes and interview two lasting 25 minutes. It was not clear whether this variation 
was a result of interview technique or participant behaviour, but the short length of the 
first interview was seen as being a concern as further short interviews could potentially 
impact on the amount of useful data gathered.
6. The researcher was able to familiarise herself with the data analysis process.
7. The data generated from the pilot interviews appeared consistent with the aims of the 
research.
The pilot study also yielded further valuable in relation to the use of field notes.
The field notes made after the pilot interviews eonsisted almost entirely of information relating 
to the researcher’s performance. Whilst this was an important objective of the pilot study, the 
lack of observation in relation to other aspects of the intei'views was seen as lacking. It was 
therefore decided to construct a template to be used during further interviews as a means of 
structuring the field notes and making them more systematic and robust. The template 
(Appendix X) would serve to prompt the researcher to write down notes relating to other 
important interview features such as participants’ non-verbal communications, any surprising 
findings/feelings or any other factors the researcher felt might be affecting the intei-view.
Taking all of the above into account, it was decided to carry out a further pilot interview to 
allow the researcher further practice of technique, better estimation of interview time and to 
further test interview questions in light of alterations made. The third pilot interview was 
carried out in accordance with all existing criteria governing the initial two pilot interviews. 
Following the third pilot, it was felt that the extra practice obtained had been valuable and the 
researcher felt confident to move on to the main study with no further alterations necessary.
Patients participating in the pilot intei'views were excluded from the main study.
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4.10 Phase 1 Main study
4.10.1 Recruitment
Data collection for the semi-structured interviews took place between March and May 2004. 
Potential participants were identified from the chemotherapy day unit admissions list by a 
member of the chemotherapy nursing team, eligibility criteria checked and then provided with a 
patient information sheet to read and consider. The chemotherapy nurse then obtained verbal 
consent and alerted the researcher of a potential participant. The researcher then approached the 
patient, confirmed their willingness to participate, ehecked study eligibility and answered any 
outstanding questions. A mutually convenient date and time for interview was then arranged. 
All participants elected to have the interview carried out during their next scheduled 
chemotherapy appointment, hi total, 11 patients (six male) were approached to take part in the 
Phase 1 of the study. One male patient declined (no reason was sought) and one male patient 
was unable to complete the interview. None of the participants were known to the researcher,
4.10.2 Semi-structured interviews process
All interviews took place in a quiet, non-clinical room adjacent to the chemotherapy unit and 
were carried out by the researcher. Immediately prior to each interview, the researcher carried 
out a final assessment of WHO Performance Status and toxicity grading to ensure each 
participant was fit enough to be interviewed. Both were satisfactoiy in all participants allowing 
all interviews to proceed. The interview schedule was adhered to and the researcher paid 
particular attention to applying the skills of good inteiviewing. Care was taken to ensure 
adequate understanding of the questions and time was allowed for the participant to respond. 
The researcher maintained a neutral posture during the interviews and was mindful of body 
language and other non-verbal communications. Gentle encouragement was given when 
needed.
The interviews varied in length from eight minutes to 32 minutes, averaging 19 minutes. As 
with the pilot study, any initial anxiety on the part of the researcher quickly faded and there was 
no difficulty in establishing rapport with the participants. Generally, the participants answered 
the questions without hesitancy.
The interviews progressed without any difficulties with one exception. During this interview, 
the participant began to complain of feeling nauseous approximately half way into the 
interview. The participant at this time stated his willingness to continue. However the 
researcher decided to end the interview as it appeared that the participant’s main concern was in 
“letting down” the researcher. Assurance was given that this was not the case and the
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participant was returned to the unit and his care taken over by the chemotherapy nurse. This 
participant’s responses were omitted from the data analysis for reasons previously outlined in 
section 4.5.3 and also because the data collected were only partially complete. Furthermore, it 
was decided that it would be inappropriate to re-schedule the interview on the grounds that the 
participant may have felt obligated to take part.
The interviews were tape-recorded with participant permission and the researcher completed 
field notes immediately following the interview to avoid disturbing the participant or 
obstructing the flow (Holloway and Wheeler 2002; Polit, Beck and Hungler 2001). The 
researcher used a template to order the field notes and to serve as an aide-me moiré when 
detailing any factors which may have influenced the intei’views as described in section 4.9.4.
The recorded interviews were transcribed verbatim by the researcher and analysed using 
Microsoft Word. It was decided not to carry out a replacement interview for the incomplete 
interview as the data obtained was already voluminous and because of the time constraints of 
the study.
4.10.3 Phase 1 data analysis
Data analysis took place after all interviews had been completed to ensure that the initial 
findings did not influence ongoing interviews. Manifest content analysis was appropriate for 
the analysis of the qualitative data and justification for this is provided in Chapter three, hi 
keeping with the aims of manifest content (see 3.3.4), the researcher focussed on drawing out 
the data which addressed the study aims. This involved studying the texts, analysing the words 
and grouping them into a smaller number of content related categories (Cavanagh 1997).
The following description details the application of manifest content analysis to the qualitative 
data.
1. Immersion in the data was obtained by listening to the audio-tapes and manually 
transcribing verbatim.
2. The field notes were read with the transcripts and notes made on the transcripts reflecting 
the researcher’s thoughts regarding the emerging themes. For example, one participant had 
stated that he “couldn’t wait to get the thing (PICC line) out” but was on his last treatment 
and was referring to the relief of finishing chemotherapy rather than implying that he had 
negative views towards the PICC line. Thus it was important to regard the patients’ words 
in the eontext within which they were intended, with the field notes providing additional 
evidence.
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3. The transcripts were then read again and keywords/significant statements highlighted on the 
transcripts. This was carried out line by line and often reflected the participants’ actual 
words; for example, “it could be worse”. This initial coding generated 88 
keywords/significant statements (Appendix XI).
4. The keywords/significant statements were considered and compared and reorganized into a 
smaller number of broader categories (Appendix XII).
5. The transcripts were read again to ensure the categories were a true reflection of the 
interview content.
6. The categories were considered further and the underlying themes identified. This resulted 
in a final list of four themes (Appendix XIII) which the researcher believed accurately 
described the thematic content of the interviews: impact on daily life, information giving, 
responsibility/coping at home and adaptation/acceptance.
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Figure 2: thematic analysis steps
Transcripts reread and 
accuracy o f  categories 
ensured
Tapes listened to and 
interviews transcribed 
verbatim
R evised coding o f  22 
broader categories
Four themes reflecting 
interview content 
identified
Transcripts considered 
alongside field notes 
and researcher’s 
thoughts
Initial coding o f  88
keywords/significant
statements
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4.11 Phase 2 sample and sample size
It was decided to include all patients who met the eligibility criteria during the timeframe of 
Phase 2 data collection. The researcher was able to determine the approximate number of 
potential participants from activity data of the unit where data collection was being carried out 
and ascertained the number of potential participants would be manageable. Therefore by 
including all eligible patients as potential participants, the sample would be representative of the 
target population providing there were minimal non-responders.
Consecutive eligible participants who presented and met study criteria between January 2005 
and June 2005 were approached to take part in Phase 2 of the study (n=69). There were three 
outright refusals and four non-responders therefore the final sample size was 62.
4.11.1 Inclusion criteria
hiclusion criteria for Phase 2 of the study were the same as those used in Phase 1 (see 4.5.1).
4.11.2 Exclusion criteria
The exclusion criteria for Phase 2 of the study were the same as those used in Phase 1 (see 
4.5.2). In addition, those who participated in Phase 1 were excluded from Phase 2. As 
discussed in section 4.5, the patients recruited in this study had a terminal illness and therefore 
to ask for participation in both phases of the study was seen as being excessive.
4.12 Construction of phase 2 questionnaire
The themes generated from the Phase 1 interviews were used to construct a questionnaire for 
use in Phase 2 to address the aims and objectives of the study. Justification for this approach is 
provided in Chapter 3.
4.12.1 General considerations
The questionnaire was constructed to minimise bias and ensure the study aims were met. 
Furthermore, consideration was given to methods of increasing response rates which also 
increases study robustness (Oppenheim 1992). These include the use of clear instructions, a 
simple layout, consistent headings, easy to read type face, short sentences, and the avoidance of 
jargon (Biyman 2004). A time limit for return of the questionnaire was stated (Biyman 2004; 
Oppenheim 1992) as two weeks. Personal and demographic questions were placed at the 
beginning to ease participants into the questionnaire (Oppenheim 1992). To maximise data 
collection, the questionnaires were coded to allow a recall letter (Appendix XV) to be issued to 
non-responders. As discussed in section 4.5, this information was available only to the 
researcher and was used to only to issue recall letters. The questionnaire included a column
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clearly marked “for office use only” for coding purposes. A final section was also included 
allowing participants the opportunity to add anything of relevance not covered elsewhere, again 
contributing to the validity of the findings (Oppenheim 1992).
4.12.2 Construction of Likert-type scale
Four themes relating to the PICC line experience were generated from the Phase 1 interviews: 
impact on daily life, information giving, responsibility/coping at home and 
adaptation/acceptance. Each theme became the basis for a section of the questioimaire.
Impact on daily life
The aim of this section of the questionnaire was to determine which aspects of living with a 
PICC line caused patients most difficulty. The daily life activities for inclusion in the 
questionnaire were taken from the Phase 1 interview responses and the key literature review 
findings. A list of 13 daily life activities was drawn up and space was also provided for 
participants to add any other daily life activity affected by the PICC line but not covered in the 
list.
The possible responses were “about the same”, “a little more difficult”, “a lot more difficult” 
and “can’t do because of the PICC line”. A “not applicable” response was also provided to 
allow participants to indicate any activities that they did not carry out before the PICC line was 
inserted, for example, looking after children and driving.
Information giving
The aim of this section was to explore patients’ views regarding the information given to them 
during their PICC line experience. A pool of 15 statements (Appendix XVI) reflecting both 
positive and negative opinions regarding information giving in relation to the PICC line 
experience was generated in keeping with Oppenheim (1992). The statements were developed 
by considering the Phase 1 interview responses and the key literature review findings in relation 
to information giving.
Responsibility/coping at home
The aim of this section was to explore patients’ views regarding taking responsibility for their 
PICC line and coping at home with a PICC line. A pool of 17 statements (Appendix XVI) 
reflecting both positive and negative opinions regarding responsibility and coping at home with 
the PICC line was generated in keeping with Oppenheim (1992). The statements were 
developed by considering the Phase 1 interview responses and the key literature review findings 
in relation to how patients cope at home with a PICC line or other CVAD.
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Adaptation/acceptance
The aim of this section was to explore patients’ views regarding adapting to the experience of 
having a PICC line and also to determine if patients perceived a PICC line to be a benefit or a 
burden. A pool of 15 statements (Appendix XVI) reflecting both positive and negative opinions 
regarding adapting to having a PICC line was generated in keeping with Oppenheim (1992). 
The statements were developed by considering the Phase 1 interview responses and the key 
literature review findings in relation to patients’ acceptance of a PICC line or other CVAD.
The process of creating the Likert-type statements generated an item pool of 47 statements for 
consideration in the questionnaire. An expert panel consisting of a Chemotherapy Clinical 
Nurse Specialist, an Oncology Research Nurse, a Cancer Nurse Consultant, a Colorectal 
Clinical Nurse Specialist and an Oncology Practice Development Nurse were provided with the 
item pool, the 88 keywords/significant statements from the initial coding of the Phase 1 
interview transcripts (Appendix XI) and the final resulting themes from the Phase 1 interviews 
(Appendix XIII). The panel was asked to identify items from the pool for inclusion in the 
questionnaire on the basis of ease of understanding and representativeness of the interview 
themes.
The experts’ responses were considered and the pool items accepted or rejected on the strength 
of the level of agreement between the experts. Those with the greatest inter-rater agreement 
were accepted and those with low inter-rater agreement rejected. Statements which the experts 
were uncertain of were reviewed further by the researcher and compared with the literature 
review findings and interview transcripts to determine which statements belonged in the 
questionnaire. The researcher then decided which statements ‘saf best in the questionnaire to 
ensure an approximately equal number of both positive and negative statements (Oppenheim 
1992), and to reflect overall the themes from the interviews. This left the researcher with 35 
items covering the ‘information giving’, ‘responsibility/coping at home’ and 
‘adaptation/acceptance’ sections of the questionnaire.
This study employed a 5-point Likert-type scale with the possible responses of ‘agree’, 
‘strongly agree’, ‘neither agree nor disagree’, ‘disagree’ and ‘strongly disagree’ as it is the most 
commonly used Likert scale and has been shown to aid data analysis (Jamieson 2004; Edelmann 
2000; Oppenheim 1992). A neutral position was valid and acceptable as it may have been that 
some participants were ambivalent regarding certain aspects of the PICC line experience (Priest 
et al 1995; Oppenheim 1992).
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The draft questionnaire was then circulated to the expert panel to comment on general layout, 
ease of understanding, sequencing of sections, ease of completion and content validity. This led 
to the following minor amendments;
• Question 3: the possible responses were Tess than 10 miles’, ‘between 10 and 20 miles’, 
‘between 20 and 30 miles’ and ‘more than 30 miles’. The third possible response was 
changed to ‘between 21 and 30 miles’ to prevent overlap.
• Question 6: the words ‘for this course of chemotherapy’ were added to the sentence ‘How 
many PICC lines have you had in?’ to ensure respondents knew exactly what information 
was being requested.
• Question 7: the words ‘for this course of chemotherapy only’ were added to the sentence 
‘When was your PICC line first put in?’ to ensure respondents were referring only to the 
current chemotherapy treatment with a PICC line.
Following the changes, the final questionnaire (Appendix XIV) was returned to the expert panel 
who agreed no more changes were required. The time constraints of the study meant that the 
questionnaire was not piloted with patients since it had been tested by the expert panel and it 
was unlikely that further testing would add any additional value.
4.13 Phase 2 Recruitment Strategy
The steps taken in recruiting participants for the Phase 2 questionnaires were as follows;
1. A checklist detailing the inclusion/exclusion criteria for Phase 2 of the study was drawn up.
2. Potential participants were identified from the chemotherapy day unit admissions list by a 
member of the chemotherapy nursing team.
3. The potential participant was identified to the researcher by the chemotherapy nurse.
4. The researcher checked eligibility using the patient’s case notes and the checklist described 
above.
5. The researcher approached the potential participant, provided a patient information sheet 
(Appendix IV) and outlined the intent of the study.
6. The researcher returned to the potential participant once the patient information sheet had 
been read and those who agreed to take part were given the questionnaire and reply-paid 
envelope.
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4.14 Phase 2 Main Study
4.14.1 Process
Data collection for the questionnaires took place between January and June 2005. The 
researcher used the chemotherapy appointments list to determine when potential participants 
would be attending the unit.
The steps outlined above in section 4.13 were adhered to. The researcher approached all 
potential participants and outlined briefly the nature and intent of the study. Potential 
participants were informed that any participation was voluntary and their care would not be 
affected in any way should they decline to participate. The majority of potential participants 
appeared interested in the study and many commented on its patient-focussed orientation. Some 
participants signalled their willingness to participate prior to reading the patient information 
sheet however all potential participants were given time alone to read and consider. The 
researcher then returned to the potential participant and addressed any outstanding queries. 
Those who gave verbal agreement to participation were given the questionnaire and the 
researcher demonstrated how it should be completed. A reply-paid envelope was provided and 
it was requested that the questionnaire be returned to the researcher within two weeks.
The majority of participants elected to complete the questionnaire whilst in the day unit, stating 
that it would help pass the time during chemotherapy administration. However 12 participants 
did not complete the questionnaire whilst in attendance at the unit. Of these 12, eight were 
returned within the two weeks. Four were not returned within the two weeks and a recall was 
issued. Despite the recall, these four questionnaires were still not returned and no further action 
was taken.
A further three potential participants declined participation in the study. One participant 
declined stating that he “could not be bothered”. The remaining two participants offered no 
explanation and none were sought by the researcher.
None of the participants were known to the researcher.
4.14.2 Phase 2 data analysis
The Phase 2 data were analysed using both descriptive and inferential statistics and all statistical 
analysis was carried out in conjunction with advice from a statistician.
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It will be recalled that the questionnaire used in Phase 2 of this study had five sections. These 
were demographic data plus ‘impact on daily life’, ‘responsibility/coping at home’, ‘information 
giving’, and ‘adaptation/acceptance’.
The initial frequency data were summarised using basic descriptive statistics to describe the 
characteristics of the sample (see 3.4.4). This showed the commonly held views of respondents 
towards different aspects of the PICC-line experience. More detailed analysis of the data was 
then carried out to explore the areas where there was less consensus among respondents, 
hiferential statistics were used to determine which views were most likely to be held by the 
population represented by the sample in this study.
The Likert-type scale collected data which constituted a single sample ordinal data that was 
analysed using Confidence Interval (Cl) estimation (see 3.4.4). The aim of analysis was to 
describe the patients’ views regarding aspects of the PICC line experience in terms of the 
population proportions for each of the variables (questionnaire statement responses).
On statistical advice the agree/strongly agree and the disagree/strongly disagree responses were 
treated as paired samples and the differences between the CIs were calculated. This was to 
determine if there was a significant difference in the population proportions who agree/strongly 
agree or disagreed/strongly disagreed with each statement. The interval estimates of the 
difference in population proportions showed the following;
• questionnaire statements for which there was no significant difference between those 
who agreed and those who disagree with the statement
• questionnaire statements for which a significantly larger population proportion agreed 
than disagreed with the statement
• questionnaire statements for which a significantly larger population proportion 
disagreed than agi'eed with the statement.
This meant that it was possible to determine the views which were representative of the MdG 
population towards aspects of the PICC-line experience and also to determine the views for 
which there was less consensus.
The ‘impact on daily life’ section of the questionnaire also collected data which constituted a 
single sample ordinal data that was subject to analysis using Confidence Interval (Cl) 
estimation. The aim of analysis was to describe patients’ views regarding which aspects of 
daily life were most affected by the PICC line terms of the population proportions for each of
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the variables (daily life activities). To aid analysis and on the advice of a statistician, interval 
estimates for the population proportion reporting that the level of difficulty was “about the 
same” or “a little more difficult” were grouped together as it was assumed that the resulting 
impact on daily life would be comparable. This allowed each variable to be considered 
independently in terms of how likely it was to be representative of the views of the population 
in this study and identified the daily life activities most disrupted by PICC-line insertion.
Space was provided at the end of the questionnaire for respondents to add any additional 
comments about their PICC line experience. These comments were listed and the thematic 
content noted.
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CHAPTER FIVE -  STUDY FINDINGS
5.1 Phase 1 findings
This two-phase study used data obtained from interviews in Phase 1 to develop a questionnaire 
for use in Phase 2. This section presents the findings from Phase 1. Manifest content analysis 
was used to analyse the qualitative data (see section 4.10.3) and the themes developed from the 
interview transcripts are listed in Table 1 below.
Table 1: Phase 1 interview themes
Theme Initial coding of interview data
Impact on daily life Need to buy new clothes/alter clothes. Unable to engage in hobbies. 
Difficulty washing, sleeping, dressing, housework, washing hair, showering, 
bathing, driving, working, looking after children. Feel unclean. Life not 
normal. Holidays affected.
Information giving Did not know what a PICC line was. More practical advice needed. Too 
much information. Unprepared for insertion. Insertion unpleasant/okay. 
Some information scary. Doctors/nurses need to tell patient everything. Too 
much negative/technical information. Unsure what to expect.
Responsibility/coping 
at home
Staying out of hospital a bonus. Fear being away from expert help. Other 
health care professionals unsure. Family affected/not affected. Fear of 
chemotherapy spill, PICC line fault/damage, line being pulled, being in 
crowds. Too much responsibility on patient/family. Not relaxed at home. 
Well supported by staff at the unit.
Adaptation/acceptance You get used to it. It could be worse. Just get on with it. PICC line 
becomes a part of you. Need more help at the beginning. PICC line always 
on your mind. Don’t mind/do mind others seeing. Good things more than 
bad. PICC line made treatment easier to get. No cannulations. Gets easier 
with time. Would recommend to other patients.
The interview responc ents were allocated a letter code to ensure confidentiality.
5.1.1 Response rate
A total of 11 patients who met eligibility criteria (see 4.6) were approached to take part in Phase 
1 of the study. One patient declined and one was unable to complete the interview (see 4.10.2). 
Thus nine participants (82% response rate) completed the semi-structured interviews. More 
than half (n=7) stated they were happy to cany out the interview as it would “help others” and 
because it would give them something to do whilst waiting for their chemotherapy to begin. 
Five of the participants were female.
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5.1.2 Demographic data
The participants’ ages ranged from 42 to 76 years of age. The mean length of time the 
participants had a PICC line in situ was 13 weeks (Range: 9 - 2 3  weeks). For the majority of 
participants (n=7), this was their first experience of having a PICC line. The mean distance 
travelled by participants to receive treatment was 19 miles (Range: two -  66 miles). No other 
demographic data were obtained.
5.1.3 Existing PICC line knowledge
At the start of each interview, participants were asked if they had known what a PICC line was 
prior to requiring one and how they felt about having a PICC line inserted. Most participants 
had no understanding of what a PICC line was and there was unease and uncertainty about the 
need for a PICC line. The two participants who knew what a PICC line was, were a nurse who 
had previously seen PICC lines used in sick children and a patient who had seen PICC lines in 
other patients during a previous course of chemotherapy.
All participants voiced apprehension at requiring a PICC line with a few further stating that they 
had felt “scared”. There was a perception that a PICC line meant that their chemotherapy 
treatment was going to be more severe or that their cancer was worse than expected. As one 
participant said “I was very shocked in the beginning, once it was explained to me what it
(PICC line) was it seemed very serious... they tell you that the line will be going straight into
your heart and I  was really, well not scared as such but it did seem like a bid deal and I  
thought, my god, this is serious ”. Participant (P) 1
Another reported ‘I  didn ’t know if it meant the chemo(therapy) was worse or the tumour was 
worse...maybe I  was thinking it was more serious this time and that’s why I  needed this thing 
(PICC line) because it was more serious this time, quite scary ”. P2
5.1.4 Theme 1; Impact on daily life
Participants were asked to consider how the PICC line had affected their day to day lives. 
Seven stated that they found dressing more difficult as a result of the PICC line being in situ. 
Several had purchased new, looser clothes to accommodate the PICC line whilst others had 
adapted existing garments. Some of the difficulties with dressing were only apparent when the 
PICC line was attached to the chemotherapy pump; for example one participant who only wore 
dresses found it necessary to purchase skirts and tops since the tubing for the pump had to be 
threaded out from the body at waist level which was not possible when wearing a dress.
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In addition to dressing, the PICC line affected other aspects of daily life such as sleeping and 
washing. Four participants stated that they had difficulty sleeping with a PICC line including 
P8 who said “m the beginning, I  hardly slept a wink....I’ve got used to sleeping but i t ’s still not 
perfect...it’s subconscious...in your mind that you can’t move around the same”. Another 
participant reported an almost complete lack of sleep since the PICC line had been placed. This 
was attiibuted both to the fear of a cancer relapse and associated treatment and to the presence 
of the PICC line.
The majority also reported difficulties with washing, especially bathing and showering owing to 
a fear of soaking the PICC line dressing or contaminating the PICC line with bathwater. This 
left some with a feeling of being unclean as they felt unable to have a “proper” wash such as P2 
who reported “having a bath, that was the worst bit....you’ve got to hang your arm over the 
side and you can’t get a good wash with just one hand”, hiterestingly while three participants 
stated that nursing staff had informed them it was ‘alrighf if the PICC line got a little wet as 
opposed to completely saturated, nonetheless they still wanted to keep the PICC line completely 
dry for reasons they were not able to explain fully. Another who suffered from veiy diy skin 
was unable to use emollients in the bath or adequately apply cream afterwards and as a result 
complained of diy, itchy skin. Several commented that hair washing was particularly difficult 
since in effect it required use of both arms or help from a family member.
Four participants stated that they were unable to continue with hobbies or leisure activities as a 
result of the PICC line; for example golf, swimming, gardening and hill walking. It was 
reported by one that hill walking meant being too far from medical help if a problem with the 
PICC line arose. Of the six participants who were able to drive prior to PICC line insertion, all 
but one continued to drive although this participant’s perception was that this was because of a 
general lack of confidence rather than any physical impairment.
Other reported changes in daily life included not wanting to have children too close in case of 
contamination or in case a child pulled/damaged the PICC line, general difficulties with 
housework, cooking and shopping and changes to holiday plans.
5.1.5 Theme 2: Information giving in relation to the PICC line
Participants were asked to comment generally on the experience of having a PICC line. In 
response a number of negative comments were made surrounding the information given in 
relation to a PICC line. For example, eight reported that there was too much information or that 
the information was overwhelming. Six stated further that the information was too technical or 
frightening and queried the need to be given such detail. There appeared to be acceptance of the
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need for health care professionals to give all necessary information but still the participants were 
often put off by it. As one said, “I  know the doctors and nurses need to tell you all the things 
that can go wrong so that they can say, you know that you hiew what you should be doing or in
case you don’t want to go ahead with it or th a t  but maybe it’s just me, but I  think nowadays
they just tell you too much...I don’t want to know about all the bad things, about everything that 
might go wrong... it’s too negative ”. P3
Six thought health care professionals gave patients too much information because of a need to 
tell patients eveiything in today’s health care climate or as one respondent put it “Nowadays 
they (health care professionals) tell you everything just because they have to - so that nobody 
can come back and sue them for not telling them everything”. P4
Comments were also made regarding the insertion procedure. Two felt unprepared for insertion 
and found it unpleasant and uncomfortable although relatively painless. Two others found 
insertion painless and more straightforward than they had imagined because they felt the 
information given prior to insertion was quite frightening and perhaps too detailed; “I ’m glad 
they didn’t send the information out to the house because when they explained the procedure to 
me -  that they’d put 50 cm o f cabling up the inside o f my arm and across my shoulder -  I  
thought “you can’t do that without an anaesthetic” and basically they just said to me ....they 
put the cream on the inside o f both my elbows and said to go and sit there for half an hour until 
it takes effect and read this leaflet — I ’m glad I  was basically trapped by that point because it 
looked so alarming... so I  think it’s a good idea that you don't know beforehand or else you 
might not come in for it”. P6
Most participants felt that the shock of being informed of the recurrence of their cancer and 
need for more treatment added to the overall shock of being informed that a PICC line was 
needed. Generally this was a veiy anxious time for them and they struggled to take in and make 
sense of all that was happening around them: “They gave me a very detailed explanation - 1 
know they need to do that so that everyone gets the same information but even though I  knew 
what it was I  was still very frightened. I  surprised myself at that because I  thought I  was pretty 
much in control until then -  maybe it was just hitting home -  all that was happening -  I ’ve 
spoken to other patients and they nearly all say the same, you know that they found it scary”. 
P9
Seven participants also stated they had a need for specific information such as practical advice 
about dressing and washing that had not been given or not taken in owing to the volume 
information given at the same time. In addition, three of this seven said they did not want to
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know about the technical aspects of the PICC line or when the PICC line dressing was to be 
changed or blood samples taken. There was a perception that the management of the PICC lines 
should be the sole remit of the health care professionals and should not be put on to the patient.
As P4 said; " / don’t need to know about...is it flushing you call it? ....flushing the line and
blood tests and stuff....you’re the professionals, you take care o f that.....just tell me what I  can 
and can’t do and that’s all I  need to know ”.
5.1.6 Theme 3: Responsibility/coping at home
The majority of participants stated that they were grateful to be receiving their chemotherapy at 
home although one reported initial disappointment that hospital admission was not required. 
This participant had enjoyed support from other patients during previous hospital admissions 
but now felt that ambulatoiy chemotherapy was preferable to being in hospital.
However, despite the positive comments, a number of concerns regarding coping with a PICC 
line at home were raised.
All participants feared either damaging the PICC line or pulling it out although this fear reduced 
over time. Other common fears were of the chemotherapy spilling (n=5), fear of general PICC 
line complications (n=4) and fear of being in crowded places (n=3). Furthermore, although 
participants were happy they did not require hospital admission to receive chemotherapy, six 
feared being away from the hospital and professional help and some (n=3) had experienced 
problems when non-specialist staff were required to deal with the PICC line. This was 
particularly evident in participants who lived some distance from the specialist centre. District 
Nurses for example on some occasions had never cared for a PICC line before and resorted to 
asking the participant questions about care. There had also been times when staff in general 
hospitals were unsure as to what to do. “/  got admitted back into (name o f local hospital) one 
night and they didn’t have a clue about it (the PICC line). It was like an alien had landed on 
the ward that night and they had to send out to somewhere else to get a nurse that knew what 
she was doing....I thought that can’t be right -  pretty bad you know and maybe I  should have
just come back here (specialist centre) I  could have come to all sorts o f trouble and there
they are asking me... ’’when was it last flushed?” and if  it had moved and stuff...I didn’t know 
and just gave them the book (PICC line diary) but they said it wasn ’t filled in right and I  fe lt as 
i f  they were saying it was my fault but they were the hopeless ones ”. P8
A number of the negative comments raised related to the amount of involvement participants 
and their informal carers/family members were expected to have in PICC line care.
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Two participants voiced strong concerns over their partners’ expected role in helping with the 
PICC line at home. Both stated that it was inappropriate that their wives had been expected to 
deal with PICC-line problems. This was summed up well by P4 who said “Things that the 
nurse also said about responsibilities for your partner ...I wasn’t too happy about them asking 
her to get involved i f  there’s problems with the line and I  said “well wait a wee minute here, I  
am not putting that sort o f responsibility on to my wife”. How in the middle o f the night is she 
going to know i f  there's a problem? I ’m not having that responsibility at all on my family -  is 
it going to turn into septicaemia or phlebitis or thrombosis because that’s the actual words they 
used....frightening names and I  said I  didn’t want my wife having anything to do with that at 
all”.
Participants’ views were mixed regarding how their friends/families felt about the PICC line. A 
few believed their families held negative views towards the PICC line while others felt that their 
families had reacted positively and were keen to find out more. Generally participants tended to 
go along with what they perceived their families’/friends’ feelings to be: the PICC line was
kept hidden and not discussed with those less accepting whereas participants reported open 
discussion with family members and friends who wished to do so.
5.1.7 Theme 4: Adaptation/acceptance
Participants were asked to comment on their overall PICC line experiences and anything they 
thought it would be useful for other PICC-line patients to know. Most of the comments centred 
on ways of coping with daily life as a result of changes to sleeping, dressing and so forth. 
Participants also thought it important that other patients knew living with a PICC line got easier 
as time went on and any initial difficulties were usually resolved as reported by P2: “Everything 
was difficult to begin with -  washing, dressing, sleeping....I mean they tell you it’s ok to do this
and not to do that but it takes tune you get used to it (PICC line) eventually, you just need to
but to begin with it was like....put your arm in here and there and everything was a bit o f a mess 
but I ’ve got used to it now... I  mean I  still look forward to getting it out but it’s not too bad 
now ”.
Despite general agreement that participants adapted to having a PICC line, all expressed 
positive and negative views about the general experience. On the positive side, the main 
perceived advantages of having a PICC line were: home chemotherapy gave participants a 
feeling of control over their life, greater independence and reduced the need for venous 
cannulation to receive chemotherapy. There was a general consensus that the PICC line was a 
good thing as it meant chemotherapy treatment was being given and two participants further 
perceived that the chemotherapy would be more effective if given this way because, “This thing
84
(PICC line) means the chemo(therapy) is going straight into my system...this is the quickest way 
o f getting it (chemotherapy) so it will get to the tumour quicker ”. P7
Although some participants experienced difficulty when non-specialist staff were dealing with 
the PICC line (see section 5.6), most participants felt well supported by their District Nurse/GP 
and commented that the PICC line gave them freedom. This was especially important for some 
who perceived that their life span was now limited such as PIO who said, “I  know I ’m dying...I
hope I ’ll get years but the doctors say it’s more likely months but this line (PICC line) has
meant that I ’ve not needed to be cm>ay from the house overnight, you know, leaving my own bed,
and that’s been great when you’re in hospital everything works round that but i f  you’re at
home, i t ’s more like normal for the fam ily”.
However a number of negative comments were also made regarding adapting to having a PICC 
line in situ. Four participants reported feeling self-conscious as the PICC line signalled to 
outside observers that something was amiss. This was perceived to be more of a problem when 
the chemotherapy pump was attached to the PICC line as explained by P4: “I f  I ’ve got the pump 
fitted then I ’m very conscious o f it -  i t ’s a lump sitting there... and when you ’ve got cancer and 
somebody happens to see you from a distance and says “oh I  saw X  (patient’s name) there and 
he’s got an awful big lump, do you think that’s anything to do with his cancer”...so I ’m not 
going to get a placard saying “by the way I ’ve got a PICC line in and this lump you see is a 
pump ” but it’s just during the course o f it you ’re self conscious ”.
5.2 Key messages from Phase 1
The interviews revealed that participants held both positive and negative views towards aspects 
of the PICC line experience. The main advantages reported were not requiring hospital 
admission, the reduced need for venepuncture and cannulation and the ease of chemotherapy 
administration. Nonetheless life changed when having ambulatoiy chemotherapy with a PICC 
line and daily activities such as washing, dressing, sleeping and engaging in hobbies were 
affected to various extent. Most participants adapted well to the experience however a number 
of concerns were evident. These related in the main to the chemotherapy spilling, the PICC line 
malfunctioning and the PICC line alerting outsiders to the participant’s predicament. 
Furthermore, participants expressed unease over their and their partner’s expected level of 
involvement in PICC-line care.
Information giving to ambulatoiy chemotherapy patients with a PICC line appeared to be the 
area of greatest challenge. The interviews showed that although participants felt well supported 
by staff, they struggled with the volume and nature of the information given to them. The
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infonnation was described as unhelpful, excessive and at times, frightening. Despite this, the 
advantages of having a PICC line outweighed the disadvantages for most participants and the 
general consensus was of adaptation and acceptance.
The Phase 1 themes guided development of the questionnaire (see 4.12) used in Phase 2, the 
results of which follow.
5.3 Phase 2 results
5.3.1 Introduction
As previously noted, the semi-structured interviews carried out in Phase 1 of the study 
generated themes and categories which aided development of a questionnaire used in Phase 2. 
The Phase 2 results are presented in accordance with theses as follows;
• demographic information and response rate
• impact on daily life
• patients’ views of the PICC-line experience
• chapter summary.
Data are presented initially in summary form followed by more detailed analysis of specific 
aspects of the data. Data were analysed using confidence intei-val estimation to determine 
which questionnaire results were likely to be representative of the population represented by the 
sample in this study (see 3.4.4). This analysis showed which views regarding aspects of living 
with a PICC line were most likely to be held by MdG PICC-line patients and thus allowed the 
study aims to be met.
5.3.2 Response rate
A total of 69 respondents who met eligibility criteria (see 4.11) were approached to take part in 
Phase 2 of the study. There were three outright refusals: one declined on the grounds of 
tiredness while two others offered no explanation and none was sought. Four potential 
respondents verbally agreed to take part in the study but failed to return the questionnaire. One 
recall was issued but the questionnaires remained outstanding. Thus 62 respondents completed 
the questionnaire, giving a response rate of 90%. The questionnaires were fully completed by 
most respondents with only four pieces of missing data. All respondents correctly completed 
the front page of the questionnaire thus fulfilling the requirements for consent. Additional 
comments were provided by 13 respondents in the appropriate section.
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5.3.3 Demographic data
Just over half of respondents were male and the majority of respondents were aged between 60 
and 79 years. Most lived within 20 miles of the unit and found the unit easy to get to. The 
biggest majority did not know what a PICC line was prior to insertion and most had required 
only one PICC line. The average length of time with a PICC line in situ on completion of the 
questionnaire was 11 weeks.
Table 2: Summary of demographic data
Sex Male: 54.8% (n=34) 
Female: 45.2% (n=28)
Age 18-59 years: 32.3% (n=20) 
60 - 79 years: 62.9% (n=39) 
80 + years: 4.8% (n=3)
Distance travelled from home to chemotherapy day unit < 20 miles: 54.8% (n=34) 
> 20 miles: 45.2% (n=28)
Easy or difficult to get from home to chemotherapy day unit Easy: 72.6% (n=^ 45) 
Difficult: 27.4% (n=17)
Knew what a PICC line was prior to insertion Yes: 8.1%(n==5) 
No: 79% (n=49) 
Can’t remember: 12.9% (n=8)
How many PICC lines required for this course of freatment 1: 75.8% (n-47) 
2: 22.6% (n=14) 
3 or more: 1.6% (n=l)
Length of time PICC line in situ on completion of questionnaire Mean: 11 weeks 
Range: 8 -1 7  weeks
5.3.4 Impact on daily life
To determine which aspects of living with a PICC line caused patients most difficulty, 
respondents were asked to state the level of difficulty (see 4.12.2) they experienced with a PICC 
line in situ for a number of daily life activities (DLAs). On statistical advice the responses for 
‘about the same’ and ‘a little more difficult’ were grouped together for analysis as it was 
assumed the resulting impact on daily life would be comparable. Respondents were also asked 
to indicate activities that were ‘not applicable’ to them, i.e. those they did not do prior to PICC- 
line insertion; for example, not eveiyone looks after children or drives a car. Space was 
provided for respondents to list any additional activities they were experiencing difficulty with 
which five respondents added to.
87
Table 3 below summarises respondents’ reported level of difficulty for each DLA and is ranked 
for ‘greatest reported difficulty’. The majority of respondents did not experience undue 
difficulty with most DLAs with the PICC line in situ. Only hair washing (n=35, 57.4%) and 
showering (n=25, 56.8%) were perceived to be ‘a lot more difficult’ by a majority of 
respondents although a sizeable minority (n=26, 44.1%) found bathing a lot more difficult. 
Shopping and dressing appeared to be minimally disrupted.
Table 3: Degree of difficulty carrying out DLA with PICC line in situ
Daily life activity About the same/a 
little more difficult
11 = 62 (%)
A lot more 
difficult
n = 62 (%)
Can’t do 
because of the 
PICC line 
n = 62 (%)
Not applicable 
n = 62 (%)
Washing hair 26 (42.6) 35 (57.4) 0 1 (1.6%)
Showering 13 (29.6) 25 (56.8) 6(13.6) 18(29.0%)
Bathing 32 (54.2) 26(44.1) 1 (1.7) 3 (4.8%)
Sleeping 45 (72.6) 17 (27.4) 0 0
Shopping 53 (85.5) 9 (14.5) 0 0
Dressing 54(87.1) 8(12.9) 0 0
Hobbies 37 (84.1) 5(11.4) 2 (4.5) 18(29.0%)
Driving 33 (80.4) 4 (9.8) 4 (9.8) 21 (33.9%)
Washing myself 56 (90.3) 6 (9.7) 0 0
Cooking* 50 (92.6) 4 (7.4) 0 7(11.3%)
Housework 54 (93.1) 4 (6.9) 0 4 (6.5%)
Childcare* 24 (96.1) 1 (4.0) 0 36 (58.1%)
Relaxing 58 (96.7) 2(T3) 0 2 (3.2%)
* missing data = 1
Further analysis was carried out to determine the statistical significance of the results. 
Confidence intervals (CIs) for the population proportions reporting a ‘lot of difficulty’ were 
calculated to identify whieh DLAs the population in this study experienced most difficulty with.
As can be seen from the CIs in Table 4 below, a majority of patients in this study were likely to 
find showering, washing hair and bathing a lot more difficult with the PICC line in situ. While 
cooking, housework and relaxing were still statistically significant, fewer numbers were 
affected. In addition, although a minority of respondents reported a lot of difficulty sleeping, 
the CIs showed that as many as 40% of the population in this study experienced a lot of 
difficulty sleeping.
Table 4; Daily life activity reported as a lot more difficult
Daily life activity Number performing 
activity pre-PICC line 
insertion
n = 62
Number reporting ‘a lot 
more difficulty’ post- 
PICC line insertion 
n = 62
95% confidence 
interval
n = 62
Showering 44 25 (41%, 72%)
Washing hair 61 35 (44%, 70%)
Bathing 59 26 (30%, 58%)
Sleeping 62 17 (16%, 40%)
Shopping 62 9 (7%, 26%)
Dressing 62 8 (5%, 24%)
Hobbies 44 5 (4%, 24%)
Driving 41 4 (3%, 23%)
Washing myself 62 6 (4%, 20%)
Childcare 25 1 (0.1%, 20%)
Cooking 54 4 (2%, 18%)
Housework 58 4 (2%, 17%)
Relaxing 60 2 (0.4%, 11%)
It was not useful to perfoiin CIs for those reporting the DLA as unable to be done with a PICC 
line in situ as the raw data numbers were too small (see Table 3) for meaningful statistical 
analysis.
Overall, these findings suggest that while PICC-line patients experienced a degree of difficulty 
with all DLAs, only a few DLAs were a lot more difficult for the majority of patients in this 
study. There was little evidence to suggest that the DLAs were unable to be carried with a 
PICC line in situ, except in veiy few instances. However, a large number of PICC-line patients 
in this study experienced a lot of difficulty keeping clean thi’ough either bathing or showering 
and hair washing. Furthermore, whilst most respondents reported only minimal disruption to 
sleeping, the Cl demonstrated that as many as four in 10 MdG PICC-line patients in this study 
experienced a lot of difficulty sleeping with a PICC line in situ.
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5.4 Patients’ views on the PICC line experience
Patients’ views were sought towards aspects of the PICC line experience based on the thematic 
analysis of the Phase 1 interview findings. Possible responses were agree (A), strongly agree 
(SA), neither agree nor disagree (N), Disagree (D) or strongly disagree (SD). On statistical 
advice, the sample data responses for ‘agree’ and ‘strongly agree’ were grouped and the 
responses for ‘disagree’ and ‘strongly disagree’ were grouped.
5.4.1 Responsibility/coping at home
Table 5 below summarises the responses to the responsibility/coping at home statements. The 
majority of respondents felt well supported during the experience (n~59, 95%) and were happy 
to take responsibility for their PICC line (n=39, 64%). Similarly most respondents felt that the 
PICC line had made their chemotherapy easier to get (n=46, 74%), gave them independence 
(n=45, 73%) and felt relaxed at home with their PICC line (n=45, 73%).
Table 5: Patients’ views on responsibility/coping at home with the PICC line
Statement Agree/
strongly
agree
Neither 
agree nor 
disagree
Disagree/
strongly
disagree
11=62 (%) n=62(%) n=62 (%)
There is plenty of help and support for people with PICC lines 59 (95%) 1 (2%) 2 (3%)
I worry about the chemotherapy spilling 48 (77%) 0 14 (23%)
The PICC line has made my chemotherapy easier to get 46 (74%) 13 (21%) 3 (5%)
Having a PICC line gives me independence 45 (73%) 9 (14%) 8 (13%)
I am relaxed when I am at home with my PICC line 45 (73%) 6 (9%) 11 (18%)
I wony that things could go wrong with my PICC line 42 (68%) 0 20 (32%)
I am happy to take responsibility for my PICC line * 39 (64%) 11 (18%) 11 (18%)
My family/friends worry about my PICC line * 39 (64%) 4 (6%) 18 (30%)
I worry that the PICC line will fall out 38(61%) 2 (3%) 22 (36%)
PICC lines give me extra worries when getting chemotherapy 18 (29%) 5 (8%) 39 (63%)
My life is restricted because of the PICC line 12 (20%) 9 (14%) 41 (66%)
I would have preferred to get my chemotherapy in hospital 4 (6%) 6 (10%) 52 (84%)
*missing data =1
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A number of worries regarding coping with a PICC line at home were also evident. These 
related to the chemotherapy spilling (n=48, 77%), things going wrong with the PICC line (n=42, 
68%) and the PICC line falling out (n=38, 61%). The majority of respondents (n=39, 64%) also 
felt that their families/friends worried about their PICC line.
Thus the summaiy data showed clear majority views and a range of issues where there was less 
consensus. The data were explored in more depth using Cl estimation to determine which 
views were most likely to be held by the population represented by the sample. The differences 
between the CIs for agree/strongly agree and disagree/strongly disagree were calculated to show 
the areas of statistical significance.
As can be seen in Table 6, statistically significant differences were found between the 
agree/strongly agree and disagree/strongly disagree responses for all statements. However the 
size of the effect and thus the clinical relevance of the findings varied.
Table 6: Cl analysis of differences between patients’ views on responsibility/coping at home with a 
PICC line
Statement A/SA D/SD 95% Cl
There is plenty of help and support for people with PICC 
lines
59 2 (83%, 100%)
I worry about the chemotherapy spilling 48 14 (33%, 76%)
The PICC line has made my chemotherapy easier to get 46 3 (55%, 83%)
Having a PICC line gives me independence 45 8 (42%, 78%)
1 am relaxed when I am at home with my PICC line 45 11 (35%, 74%)
I worry that things could go wrong with my PICC line 42 20 (11%, 59%)
1 am happy to take responsibility for my PICC line * 39 11 (26%, 66%)
My family/friends worry about my PICC line * 39 18 (11%, 58%)
I worry that the PICC line will fall out 38 22 (1%, 50%)
PICC lines give me extra worries when getting 
chemotherapy
18 39 (-56%,-11%)
My life is restricted because of the PICC line 12 41 (-67%, -26%)
1 would have prefened to get my chemotherapy in 
hospital
4 52 (-91%, -63%)
95% confidence intervals for population proportion A/SA minus population
responsibility/coping at home statements.
n=62
*missing data = 1
proportion D/SD for
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In keeping with the summary data, the statement relating to help and support for PICC-line 
patients had the largest majority favour (between 83% and 100%). This provides strong 
evidence that the population represented by the sample data were much more likely to feel well 
supported during the PICC-line experience than not. Furthermore, a significantly larger 
population proportion was likely to be happy to take responsibility for their PICC line (Cl 26%, 
66%).
Despite this, analysis showed discrepancies among views on the statements relating to worries 
when at home with a PICC line. A significantly larger population proportion was likely to 
disagree/strongly disagree (Cl 11%, 56%) that a PICC line presented extra worries when 
receiving chemotherapy. Contradicting this, there was also evidence that a significantly larger 
population proportion agreed/strongly agreed that they worried about the chemotherapy spilling 
(Cl 33%, 76%), something going wrong with the PICC line (Cl 11%, 59%) and the PICC line 
falling out (Cl 1%, 50%), although the size of the effect and thus the clinical relevance is 
potentially small for some.
A further two statements showed a significantly larger population proportion 
disagreeing/strongly disagreeing than agreeing/strongly agreeing. There is strong evidence that 
the majority of the population in this study were unlikely to view the PICC line as a restriction 
(Cl -67%, -26%) or prefer to have chemotherapy in hospital (Cl -91%, -63%) and again suggests a 
favourable opinion towards coping at home with a PICC line.
Overall, statistical analysis of these results showed that in the main, patients’ views towards 
coping with a PICC line at home were generally positive although a number of worries existed. 
The main concern was the chemotherapy spilling. The strongest views held suggested a high 
level of help and support for PICC-line patients and that patients did not want to receive their 
chemotherapy in hospital.
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5.4.2 Information giving
Table 7 summarises the responses to the information statements and demonstrates that 
respondents’ views were inconsistent. Although the majority had a high information need 
(n=47, 76%) and felt this need had been adequately met (n=45, 72%), respondents also felt 
unable to remember the information given (n=47, 76%) and some felt some of the information 
was ‘scary’ (n=43, 69%). A small majority also believed that too much information was 
detrimental (n=33, 53%) and preferred not to be told about what might go wrong (n=34, 55%). 
Similarly, respondents were divided on whether doctors and nurses gave information because 
they had to and whether patients should be told eveiything about their PICC lines. It also 
appears that respondents were unprepared for the PICC line insertion and that most were 
uncertain or felt they had not been given the choice to have a PICC line.
Table 7; Patients* views on information giving
Statement Agree/
strongly
agree
n=62(%)
Neither 
agree nor 
disagree 
11=62 (%)
Disagree/ 
strongly 
disagree 
n=62 (%)
I like to know as much as possible about what is 
happening to me
47 (76%) 4 (6%) 11 (18%)
It is impossible to remember all the information you are 
given
47 (76%) 1 (2%) 14 (22%)
I had all the information I needed to cope with my PICC 
line at home
45 (72%) 3 (5%) 14 (23%)
Some of the information I was given about my PICC line 
was quite scary
43 (69%) 2 (3%) 17 (28%)
The information I was given about my PICC line was just 
right
42 (68%) 12 (19%) 8 (13%)
I do not like to be told too much about things that could 
go wrong
34 (55%) 12 (19%) 16 (26%)
Too much information is a bad thing 33 (53%) 10(16%) 19 (31%)
Doctors and nurses tell you things just because they feel 
they have to
28 (45%) 5 (8%) 29 (47%)
Patients should be told absolutely everything about their 
PICC line
26 (42%) 8 (13%) 28 (45%)
I knew what to expect when the PICC line was put in 22 (36%) 8 (13%) 32 (51%)
I was given the choice to have a PICC line or not 18(29%) 18(29%) 26 (42%)
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Since respondents’ views towards some of the statements were less clear in terms of level of 
agreement, further analysis determined where there was a statistically significant difference 
between respondents’ views. The differences between the CIs for agree/strongly agree and 
disagree/strongly disagree were again calculated to identify the opinions most likely to be 
representative of the population in this study.
As can be seen in Table 8, a statistically significant difference was not found between the 
agree/strongly agree and disagree/strongly disagree responses for all statements. Statistically 
significant results are presented in bold.
Table 8; 95% confidence intervals for population proportion A/SA minus population proportion 
D/SD for information statements, 
n = 62
Statement A/SA D/SD 95% Cl
1 like to know as much as possible about what is 
happening to me
47 11 (38%, 77%)
It is impossible to remember all the information you 
are given
47 14 (32%, 74%)
I had all the information I needed to cope with my 
PICC line at home
45 14 (29%, 71%)
Some of the information I was given about my 
PICC line was quite scary
43 17 (19%, 64%)
The information I was given about my PICC line 
was just right
42 8 (37%, 73%)
I do not like to be told too much about things that 
could go wrong
34 16 (7%, 50%)
Too much information is a bad thing 33 19 (0.03%, 45%)
Doctors and nurses tell you things just because they 
feel they have to
28 29 (-26%, 2%)
Patients should be told absolutely everything about 
their PICC line
26 28 (-27%, 2%)
I knew what to expect when the PICC line was put 
m
22 32 (-39%, 7%)
I was given the choice to have a PICC line or not 18 26 (-34%, 8%)
95% confidence intervals for population proportion A/SA minus population proportion D/SD for 
information statements.
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The analysis showed that in keeping with the initial frequency data, a significant majority of 
MdG PICC-line patients in this study wanted as much information as possible about their 
situation (Cl 38%, 77%) and received optimal information (Cl 37%, 73%) but nonetheless had 
difficulty remembering the information (Cl 32%, 74%) and found some of the information 
‘scary’ (Cl 19%, 64%). The evidence regarding whether patients wanted to be told about what 
might go wrong and whether too much information was detrimental was less conclusive.
Although the results were statistically significant, the wide CIs show that there is less certainty 
about these findings and in addition the size of the effect may be very small.
The statements which this population were as likely to agree as disagree with showed the areas 
where opinion was split. No significant difference was found between those agreeing and those 
disagreeing with the statement ‘doctors and nurses tell you things just because they feel they 
have to’ and ‘patients should be told absolutely eveiyThing about their PICC line’. Furthermore, 
there was no statistical difference between those who felt they had been given a choice to have a 
PICC line and those who did not, or between those who knew what to expect when a PICC line 
was put in and those who did not.
î;
Overall, statistical analysis of the results from this section of the questionnaire revealed 
patients’ views towards the information given during the PICC-line experience were complex 
and at times contradictory. Whilst patients’ views were generally favourable regarding the 
information given, a challenge for health care professionals in providing the optimal level and 
type of information was evident.
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5.4.3 Adaptation/acceptance
Table 9 summarises the responses to the adaptation/acceptance statements and demonstrates that 
respondents’ views were generally favourable. The majority of respondents felt that the 
advantages of a PICC line outweighed the disadvantages and would recommend a PICC line to 
other patients. Furthermore, although more help was needed at the beginning of the PICC-line 
experience, living with a PICC line got easier as time went on. However, a sizeable minority of 
respondents felt that having a PICC line was a frightening experience (n=17, 28%) and that they 
would never get used to having a PICC line (n=14, 23%).
Table 9: Patients’ views on adaptation/acceptance with the PICC line
Statement Agree/ 
strongly 
agree 
n=62 (%)
Neither 
agree nor 
disagree 
n=62 (%)
Disagree/ 
strongly 
disagree 
n=62 (%)
Having a PICC line gets easier the longer you have it 52 (84%) 3 (5%) 7(11%)
The good things about a PICC line are more than the bad * 50 (82%) 11 (18%) 0
I would recommend a PICC line to other patients ** 49 (82%) 11 (18%) 0
Patients with PICC lines need more help at the beginning 44 (71%) 11 (18%) 7(11%)
I will do whatever it takes to get my chemotherapy 43 (70%) 4 (6%) 15 (24%)
I am frightened of needles 40 (64%) 1 (2%) 21 (34%)
I am happy to show my PICC line to anyone 30 (48%) 5 (8%) 27 (44%)
It is best to avoid crowds if you have a PICC line 29 (47%) 12 (19%) 21 (34%)
It bothers me if strangers see my PICC line 23 (37%) 5 (8%) 34 (55%)
Having a PICC line in is a frightening experience 17 (28%) 7(11%) 38 (61%)
Having a PICC line is not the sort of thing you ever get 
used to
14 (23%) 5 (8%) 43 (69%)
Having a PICC line is more trouble than it is worth* 2(3%) 10 (17%) 49 (80%)
* missing data =1, ** missing data =2
A sizeable minority (n=ll, 18%) were uncertain as to whether the benefits of a PICC line 
outweighed the drawbacks and whether they would recommend a PICC line to another patient 
suggesting a level of difficulty in adapting to the experience. Furthermore, a total of 66% of 
respondents (n=33) were either uncertain or thought it best to avoid crowds with a PICC line in 
situ, again suggesting that respondents were unsure about certain aspects of life with a PICC 
line.
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Respondents’ views were mixed regarding whether they were comfortable with other people 
seeing the PICC line. Although 30 (48%) respondents were happy to show their PICC line to 
anyone, 23 (37%) were bothered by strangers seeing the PICC line and a small number were 
uncertain suggesting that some respondents had body-image issues with the PICC line in situ.
Unsurprisingly, the majority of respondents had a fear of needles (n=40, 64%) but it was also 
evident that most respondents (n=43, 70%) would do whatever it took to get their chemotherapy 
which suggests a degree of compliance brought on by the faith in chemotherapy treatment.
Again further analysis was carried out to determine where there was a statistically significant 
difference between the respondents’ views by calculating the differences between the CIs for 
agree/strongly agree and disagree/strongly disagree. As can be seen in Table 10, a statistically 
significant difference between responses was not found for all statements suggesting there were 
areas where the frequency data did not reflect the populations’ views in this study. Statistically 
significant results are presented in bold.
Table 10: 95% confidence intervals for population proportion A/SA minus population proportion 
D/SD for adaptation/acceptance statements. 
n = 62
Statement A/SA D/SD 95% Cl
Having a PICC line gets easier the longer you have it 52 7 (56%, 89%)
The good things about a PICC line ai e more than the bad* 50 0 (72%, 92%)
I would recommend a PICC line to other patients ** 49 0 (72%, 92%)
Patients with PICC lines need more help at the beginning 44 7 (42%, 77%)
I will do whatever it takes to get my chemotherapy 43 15 (23%, 67%)
I am frightened of needles 40 21 (6%, 54%)
I am happy to show my PICC line to anyone 30 27 (-19%, 29%)
It is best to avoid crowds if you have a PICC line 29 21 (-9%, 35%)
It bothers me if strangers see my PICC line 23 34 (-42%, 6%)
Having a PICC line in is a frightening experience 17 38 (-56%, -11%)
Having a PICC line is not the sort of thing you ever get used 
to
14 43 (-68%, -25%)
Having a PICC line is more trouble than it is worth* 2 49 (-90%, -65%)
*missing data = 1 
** missing data = 2
95% confidence intervals for population proportion A/SA minus population proportion D/SD for 
adaptation/acceptance statements.
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In keeping with the initial summary data, this analysis provides strong evidence that a 
significant majority of this population saw the PICC line as a benefit and adapted positively to 
the PICC-line experience.
The summary data showed that almost one third of respondents found the PICC-line experience 
frightening. When explored in more depth, analysis showed that patients were more likely to 
disagree than agree that they found the experience frightening. However, the Cl was wide (Cl - 
56%, -11%) which suggests greater variability in responses and a less precise estimation of the 
size of the effect, meaning less certainty in predicting patients’ views. Similarly, while most 
patients were likely to disagree that they would never get used to having a PICC line (Cl -68%, 
-25%) again the Cl is wide. These results suggest that only a minority of MdG PICC-line 
patients in this study found the experience frightening and struggled to adapt to life with a PICC 
line.
No significant difference in the population proportions agreeing and disagreeing were found for 
three of the statements. This means this population were as likely to agree as disagree with the 
statements and shows where there is uncertainty regarding patients’ views towards that aspect of 
the experience. No significant difference was found between those agreeing and those 
disagreeing that they were troubled by others seeing their PICC line suggestive of a negative 
impact on body image for some patients. Furthermore, opinion was split as to whether it was 
best to avoid crowds with a PICC line in situ suggestive of uncertainty about this aspect of the 
experience and a need to provide clearer information regarding this.
Overall, statistical analysis of the results from this section of the questionnaire revealed that 
patients held generally favourable views towards adapting to a PICC line being in situ and 
showed a high degree of acceptance of the situation. Patients viewed the benefits of PICC lines 
to outweigh the drawbacks and would recommend a PICC line to other patients which again 
suggests a positive adaptation to the experience. However, a small number of patients may not 
adapt so easily to what can be a ffightening situation which suggests that additional help and 
support is required for some.
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5.4.4 Additional comments
Space was provided at the end of the questionnaire for respondents to add any additional 
comments about their PICC-line experience. Additional comments were provided by 13 
respondents.
A number of the comments were not directly related to the PICC line experience for example; 
complaints about car parking and hospital facilities. Comments made relevant to the study were 
summarised as benefits and drawbacks.
Patients’ reported benefits of having a PICC line were;
• receiving home chemotherapy as opposed to being in hospital
• the reduced need for venepuncture and cannulation with a PICC line in situ
• the ease of chemotherapy administration
• the excellent care received.
Patients’ reported drawbacks associated with the PICC line were;
• attachment of the chemotherapy pump to the PICC line exacerbated difficulties with DLAs
• restricted intimacy with partner for fear of damaging the PICC line
• visibility of PICC line, especially in the summer months
• non-specialist staff unfamiliarity with PICC lines.
These comments echoed some of the findings from both the inteiviews and the questiomiaires 
but did not add any new themes to the study findings.
5.5 Chapter key messages
This study’s results show that overall, patients largely viewed PICC lines as a benefit rather 
than a burden when receiving MdG ambulatory chemotherapy. The key findings were;
• most patients experieneed only minimal disruption to daily life activities with a PICC line in 
situ
• patients’ views towards the PICC-line experience were largely favourable and a number of 
benefits associated with having a PICC line were reported
• a number of coneems regarding eoping at home with a PICC line were evident however 
patients generally adapted well to the experience
• patients’ views towards the information received during the PICC-line experience were 
complex and at times ineongruent
• patients would not prefer to have their chemotherapy in hospital.
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CHAPTER SIX - DISCUSSION
6.1 Introduction
This study was conducted to explore the impact of a PICC line on patients receiving ambulatory 
chemotherapy in response to the author’s observations that patients were not being adequately 
prepared for the experience of ambulatoiy chemotherapy. The research objectives were 
developed to determine which aspects of living with a PICC line caused patients the most 
difficulty and what the important issues were for patients. By discovering this, nurses would be 
better placed to prepare patients for the experience of living with a PICC line whilst receiving 
ambulatoiy chemotherapy and to pro-actively manage each care episode.
The study results and the extent to which the study aims were met are discussed in this chapter. 
The limitations of the study are also presented. The main aim of the study was to explore the 
views of patients receiving MdG cytotoxic chemotherapy via a PICC line in order to contribute 
to the current understanding and research on the subject matter. The objectives of the study 
were:
1. To determine which aspects of living with a PICC line caused patients most difficulty.
2. To explore patients’ views towards the PICC-line experience.
3. To determine if patients view PICC lines as a benefit or a burden when receiving cytotoxic 
chemotherapy.
6.2 Aspects of living with a PICC line that cause patients the most difficulty
This study’s results demonstrated that having a PICC line in situ affected the daily lives of 
participants in a number of ways in keeping with Dobson (2001), Cole (1999), Daniels (1996) 
and Thompson et al (1989) who also reported that the presence of a CVAD had the potential to 
impact on patients’ lives in multiple ways.
Although the interview findings revealed that most patients experienced difficulty with 
dressing, sleeping, bathing, showering and partaking in hobbies as a result having a PICC line, 
when impact on daily life was assessed by the questionnaire, it was found that only minimal 
difficulty with most DLAs was reported by the majority of patients. This is in keeping with 
Gabriel (2003; 2000) and (Borst et al 1992) who found that lifestyle was relatively unaffected 
by the PICC line but minor disruption was reported by some patients.
The aspects of daily life that patients experienced most difficulty with were showering, hair 
washing, bathing and sleeping. This compares favourably with the findings of Oakley et al 
(2000) who reported that patients experienced most difficulty with bathing and sleeping but that
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these difficulties diminished with time. In this study, generally baths were easier than showers 
with a PICC line in situ since the affected arm could be kept away from the water. Nonetheless, 
keeping clean by showering, bathing and hair washing proved difficult for most patients. These 
findings are important since keeping clean and sleeping are arguably among the most vital of 
DLAs and disruption of them could lead to additional physical and emotional upset. Oakley et 
al (2000) also reported difficulty dressing in half of their study patients however this finding 
was not upheld in this study. It may be that since the patients in this study had the PICC line in 
situ for a longer period of time, that is a mean of 11 weeks at time of questionnaire completion 
compared with four weeks in Oakley et al’s study, that any initial difficulties with dressing had 
been resolved.
Despite this, it is a concern that a range of difficulties were experienced by participants at the 
start of the PICC line journey when they were still struggling to come to terms with a potentially 
fatal relapse of cancer and the commencement of a new chemotherapy regimen. For example, 
the necessity to purchase new or modify existing clothing to accommodate the PICC line was a 
potential stressor that the patients could have done without at such a difficult time. Similarly it 
is essential that patients who may already be fatigued because of their advanced disease or as a 
result of their chemotherapy get adequate rest and sleep at night. The number of patients who 
experienced difficulty sleeping with a PICC line in situ was a concern and perhaps more 
practical infomiation relating to sleeping positions with a PICC line is needed.
Interestingly in this study, the participants’ actions did not always mirror the advice they had 
been given. Interview participants often stated that although they had been advised that a 
certain activity was allowed, they nonetheless opted not to carry out that activity. An example 
of this is the advice given re bathing and showering: participants acknowledged being told that 
it was “alright” if the PICC line and dressing got wet but to avoid completely soaking the PICC 
line yet they still preferred to avoid the PICC line getting wet at all, in one case by not bathing 
or showering for the full duration of the PICC line being in situ. These fears of soaking the 
PICC line may part explain the difficulties with bathing, showering and hair washing reported 
by questionnaire respondents.
Similarly, participants reported they were advised that hobbies such as golf and bowls were safe 
to do but nonetheless they decided not to engage with whilst the PICC line was in situ. Four 
interview participants stated that they did not feel able to partake in certain hobbies with a PICC 
line as they feared damaging it or themselves in some way The questionnaire results also 
revealed that a small number of patients felt unable to engage in hobbies (n=2) or drive (n=4) as 
a result of the PICC line being in situ. The only activity which is medically contra-indicated
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with a PICC line in situ is swimming (Philpot and Griffiths 2003). Therefore it would appear 
that in some instances the participants remembered the advice given but chose to disregard it 
and therefore the impact on daily life was arguably more than it would otherwise have been. 
This incongruence between advice received and behaviour exhibited also suggests that some 
difficulties experienced in the day to day lives of PICC-line patients related to the information 
given and is further explored in the next section.
6.3 Patients’ views towards the PICC line experience
6.3.1 Information giving
This study’s results suggest that participants found it difficult to cope with the amount of 
information given to them around the time of PICC line insertion and that some of the 
information given was frightening and/or unhelpful. This is not surprising when one considers 
the amount and type of information that these patients require to be given around this time and 
which includes; details of the recurrence of cancer, prognostic outlook, schedule of 
appointments, chemotherapy regimen and side effect management, and PICC-line information.
A key finding from the literature review was that although patients may express a wish to 
receive as much information as possible regarding their treatment/care (Knowles et al 1999; 
Graydon et al 1997; Meredith et al 1996), they nonetheless struggle to cope with the volume of 
information given (McCaughan and Thompson 2000). This study also found that although 
patients wanted and received information, most found the information given overwhelming and 
impossible to remember. The interviews revealed there was a perception among some patients 
that health care professionals give information because of a need to tell patients everything in 
today’s health care climate to avoid litigation, which suggests that patients could not see value 
in some of the information that was being given. Analysis of the questionnaire results showed 
that opinion on this was split and therefore no firm conclusions can be drawn from this study. 
However it remains evident that a number of patients with PICC lines felt information was 
being mass produced rather than individually tailored to their needs.
Furthermore, although patients reported a high information need, most also wished to avoid 
excessive information about what might go wrong. This suggests that the type of information 
supplied to patients is not necessarily in keeping with that which is required and supports the 
earlier findings of Skalla et al (2004), Elf and Wikblad (2001), McCaughan and Thompson 
(2000), Sitzia and Wood (1998b) and Ferns 1er (1986). These findings when considered in light 
of the difficulties reported in coping with DLAs with a PICC line in situ (see 6.2) further
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suggest that patients need more information about the practicalities of living with à PICC such 
as advice on dressing, sleeping, washing and so forth and less on the potential problems 
associated with PICC lines. %
Many of the difficulties experienced by participants in this study appear to have been
?heightened by the complex nature of the information giving around the time of PICC line 
placement. The dichotomy is that whilst much information must be given to patients to prepare 
them for and enable them to cope with a PICC line, the volume of the information and the 
gravity of the situation means that they are often unable to comprehend or remember all the 
information. The literature on information giving to chemotherapy patients showed that patients [
may fail to retain information in stressful situations (McCaughan and Thompson 2000; Knowles 
et al 1999) and that oveiwhelming patients with information can add to feelings of fear, 
confusion and anxiety (McCaughan and Thompson 2000). Paradoxically, the provision of 
infoimation can also reduce anxiety and distress (Sitzia and Wood 1998a) if it is timely and 
appropriate.
Participants in Phase 1 of this study commented that they were given a great deal of detail 
regarding the actual intricacies of the insertion procedure yet almost half felt unprepared when it 
happened. This was in keeping with the questionnaire results which showed there was no 
significant difference between the number of patients who knew what to expect when the PICC 
line was put in and those who did not and compares with the findings of Goossens et al (2001),
Daniels et al (1996) and Borst et al (1992) who found that patients felt unprepared for the 
insertion experience despite the information given pre-insertion.
The questionnaire results also showed that a considerable number of patients in this study did 
not feel they had been given the choice to have a PICC line or not. This is a concern since 
patients are required to provide written consent prior to PICC-line insertion yet no evidence was 
found to suggest that patients generally felt prepared for the event and it may be that patients 
felt they had no option but to accept a PICC line. Cole (1999) and Gabriel (2003) stated that 
perceived choice in device selection/method of administration can have a positive impact on 
how readily patients accept a PICC line or other CVAD. However in this study the lack of 
perceived choice in having a PICC line did not appear to influence acceptance of the device. 
Nonetheless AETMIS (2004) and Rowe et al (2002) stressed the importance of patient choice in 
decision making regarding chemotherapy administration in the ambulatory setting to avoid 
those less able or reluctant for home treatment being coerced into accepting. It may be 
however, that the growing demand for chemotherapy (Twelves 2001) and the associated
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increase in out-patieiit/ambulatoi'y chemotherapy (Young and Kerr 2001; Sitzia and Wood 
1998a) dictates that PICC lines become standard and patient choice is diluted as a result.
The implications of this for practice are fairly considerable: as the literature review has 
repeatedly shown, new and more efficient ways of giving patients complex and voluminous 
information are required if patients’ needs are to be adequately addressed. There remains a 
difference between health care professionals’ and patients’ perceptions of what information is 
considered ‘essential’. Furthermore, as Marc (2005) stressed, the increase in ambulatory 
chemotherapy requires that patients and their carers involved in ambulatory chemotherapy are 
adequately prepared for the experience to enable them to cope at home, as explored in the next 
section. Marc (2005) and AETMIS (2004) stressed the importance of providing information to 
patients and their carers when undergoing ambulatory chemotherapy although it would appear 
that this is not being adequately provided. When considered in light of the problems 
highlighted by this study regarding information giving in this group of patients, it may be that 
the information is being given but not understood or retained by patients
6.3.2 Responsibility for the PICC line/coping at home
In this study, participants generally coped well at home with their PICC lines and most appeared 
happy to take on the additional responsibility. There was an acceptance that although having a 
PICC line impacted upon their daily lives, the bonus of not being hospitalised to receive 
chemotherapy outweighed the drawback. This was in keeping with Chernecky (2001) and Borst 
et al (1992) who found that the advantages associated with a CVAD in the home setting more 
than compensated for the difficulties. Several of the participants in Phase 1 of this study also 
commented that the PICC line gave them freedom which was particularly important now that 
they were living with a terminal illness. Similarly, the questionnaire results showed that the 
majority of patients felt the PICC line gave them independence and made chemotherapy 
administration easier and supports the findings of Goossens et al (2001) whose study patients 
reported ease of chemotherapy administration and increased freedom during administration with 
a CVAD in situ.
Despite the overall positive views towards coping at home with a PICC line, a number of 
concerns were evident, again in keeping with the findings from the literature review. The most 
common perceived fears in this study were of the chemotherapy spilling, malfunction of the 
PICC line or the PICC line falling out. One of the key findings of AETMIS (2004) was that 
concerns over safety for patients on home therapy were a significant source of distress to both 
the patient and their informal carers. Similarly, Dougherty et al (1998) stated that treatment in 
the home setting can be a daunting experience and can place a significant pressure on patients
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and families. Dougherty et al (1998) also stated that some patients are unwilling to take on this 
added responsibility and may opt to have treatment as an in-patient instead. Although a desire 
for in-patient treatment was not evident in this study, patients felt that their families/friends 
worried about the PICC line. It may be that PICC-line patients’ friends and families had similar 
worries concerning the PICC line and therefore also require a level of help and support to aid 
their coping.
Interestingly, Phase 1 of this study showed that these concerns were very much a fear of what 
might happen as veiy few participants had actually experienced any technological difficulty 
with the PICC line or the chemotherapy pump at home.
Nonetheless, the fear was veiy real for participants to the extent that they questioned how 
prepared they would be to deal with such a malfunction should one occur and was tied in with 
the participants’ perceptions that they required to stay close to specialist help at all times. This 
was a common finding from the interviews particularly in those who were geographically 
distant from the specialist centre. Several of the participants lived less than five miles from the 
specialist centre and commented that if they had a problem, they could ‘pop up’ and see a health 
care professional, although again none had actually needed to do this. Those who lived further a 
field did not have this luxuiy and appeared to worry more about malfunction and what to do in 
the event of something going wrong. The demographic data from the questionnaire similarly 
suggested that ease of getting to the specialist unit may influence the perceived level of help and 
support available. Those who live fairly elose by and/or find it easy to get to the specialist unit 
may feel that more help is readily available.
The difficulties experienced by some participants when they required assistance at a health-care 
facility other than the specialist centre may have added to these fears. A number of participants 
came into contact with health care professionals who had no skills or experience in dealing with 
PICC lines which served to further undermine the participant’s confidence. The reluctance of 
non-specialist health care personnel to access a CVAD was also highlighted as a key 
disadvantage in Chernecky’s (2001) study. This suggests that the training and education of non­
specialist staff that may come into contact with devices such as PICC lines is crucial to the 
patient’s care. However, it must be remembered that this study was conducted when PICC lines 
were not commonly used in the UK and therefore the majority of health care staff would be 
unfamiliar with them. As the number of PICC lines continues to increase, it is likely that more 
staff will become adept in PICC-line care however it remains a key consideration when 
developing PICC-line services.
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Despite the fears outlined, generally most patients were happy to take on the added 
responsibility associated with the PICC line in keeping with Rowe et al (2002) and Thompson et 
al (1989). Christopoulou (1993) found that the degree of support available in the home setting 
was a crucial factor in how readily patients accepted home chemotherapy. The patients in this 
study felt veiy well supported therefore it may be that they felt able to cope at home with the 
PICC line despite the underlying fears. Furthermore, there was strong evidence in this study 
that patients did not want to receive their chemotherapy in hospital which may have influenced 
their acceptance to take on the responsibility for the PICC line. However a desire to be treated 
external to the hospital setting does not necessarily imply a willingness or competence to take 
on board the added responsibility necessary. This study has also shown that in keeping with 
AETMIS (2004), Dobson (2001), Cole (1999), and Dougherty et al (1998), not all patients can 
be assumed to have the necessaiy competence and confidence to cope at home with a PICC line 
or other CVAD, although it is likely that this will be true of only a minority of patients.
6.3.3 Adaptation/acceptance
The majority of participants in this study were able to adapt to the experience of living with a 
PICC and stated that they would recommend a PICC line to other patients. This concept of 
adaptation and acceptance has been previously demonstrated in other studies investigating 
patients’ experiences with a variety of CVADs. Daniels (1996) in her overview of the impaet of 
a skin-tumielled CVC on patients with cancer concluded that they had less impact than she had 
previously imagined and that patients adapted well to the experienee. Later work by Gabriel 
(2003 and 2000), Rowe et al (2002) and Oakley et al (2000) endorsed these findings.
The potential advantages associated with a PICC line appear to be factors in helping patients 
accept PICC lines, hiterview participants in this study commonly commented on the advantage 
of not requiring multiple peripheral venous cannulations in order to receive chemotherapy 
which was highlighted in the literature review as being one of the most prominent positive 
indicators for acceptance of a CVAD (AETMIS 2004; Gabriel 2003; Rowe et al 2002; 
Chernecky 2001; Goossens et al 2001; Bow et al 1999; Daniels 1996; Borst et al 1992; Claessen 
et al 1990). Similarly the questionnaire results showed that the majority of patients had a fear of 
needles and that the PICC line had made chemotherapy administration easier so this positive 
indicator is to be expected. Many cancer patients require intensive and/or lengthy
chemotherapy regimens using irritating agents which can irreparably damage peripheral venous 
access, and may have or develop needle phobia. Therefore insertion of a PICC line earlier on in 
the chemotherapy journey may facilitate chemotherapy administration for a number of patients. 
Indeed, it may be that this advantage alone merits the insertion of a PICC line for some patients.
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There also appeared to be an almost philosophical belief amongst participants of accepting the 
hand they were dealt so to speak. Interview participants talked of “just getting on with it” and 
of having “no option but to accept it” as this was the reality of their situation. The questionnaire 
responses also indicated that the majority of patients would do whatever was necessary to 
receive chemotherapy therefore it may be that the PICC line was accepted as simply being a 
necessary part of this process.
It was also evident from this study that despite the initial difficulties experienced, patients felt 
that the benefits in having a PICC line outweighed the drawbacks. The literature review had 
demonstrated that the length of time a CVAD was in situ could both positively and negatively 
impact on patient acceptance (Dobson 2001) although in this study, participants generally felt 
more positive as time went on. It was apparent that more help was required at the start of the 
PICC-line experience which again has implications for the support of PICC-line patients and is 
discussed in section 7.2.
This study’s findings on how a PICC line impacted upon patients’ body image were 
inconclusive. It would appear that to some patients, the PICC line represented a ‘badge’ of 
illness that they were unhappy to reveal to others whilst other patients had no such concerns. 
The literature review equally demonstrated mixed findings on how a PICC line or other CVAD 
may impact on patients’ body image. Dobson (2001), Borst et al (1992) and Thompson et al 
(1989) reported a potential negative impact on body image although Daniels (1996) failed to 
reveal a link between negative body image and the presence of a CVAD.
Interestingly, Oakley et al (2000) found that this may be more of an issue when the 
chemotherapy pump is attached and during hot weather when the PICC line/pump is more 
difficult to conceal under clothing. It will be recalled that section 5.9.10 detailed additional 
comments provided on the patient questionnaires. A small number of patients indicated that 
attachment of the chemotherapy pump exacerbated difficulties with DLAs and that visibility of 
the PICC line during the summer months was a drawback. Since the main questionnaire data 
collection was carried out during the winter months, it may be that most participants had not 
experienced living with a PICC line during the summer therefore had been less conscious of the 
visibility of the PICC line/pump under winter clothing. It is feasible that more patients would 
have reported unease with others seeing the device if data collection had taken place during 
warmer weather.
Another noteworthy finding from this study was that many participants perceived they must 
avoid crowded areas such as shopping centres for fear of the PICC line being damaged. This
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was apparent from both the interview findings and questionnaire results. Oakley et al (2000) 
and Daniels (1996) also found that patients had a fear of being in a crowd for the same reasons. 
This is an area of concern as it could potentially lead to patients withdrawing from certain social 
situations that they may have otherwise enjoyed, arguably even more of a concern with 
terminally ill patients who do not have the promise of future health to look forward to.
Overall, this study showed that most patients adapt well to the experience of having a PICC line 
and view a PICC line as a benefit rather than a burden. However, almost one third of patients 
felt that having a PICC line was frightening and a sizeable minority also felt that they would 
never get used to having a PICC line. This is in keeping with one of the key findings from the 
literature review: whilst the insertion of a CVAD such as a PICC line to undergo ambulatory 
chemotherapy is acceptable to the majority, there is a minority of patients who struggle with the 
situation and who may require more individualised help and support to adapt to the experience.
6.4 Summary of discussion
The results from this study show that overall the participants generally viewed the PICC line as 
a benefit rather than a burden and coped well with the PICC line experience although a number 
of difficulties or challenges arose.
The aspects of daily life that PICC-line patients experienced most difficulty with were 
showering, hair washing, bathing and sleeping. It was evident that patients needed more help at 
the beginning of the experience therefore ways of facilitating early adaptation may reduce the 
number of worries or concerns that patients cany with them as time goes on. Overall, the 
majority were able to adapt to the changes required and found the experience easier as time 
progressed. To this extent, familiarity with the PICC line brought confidence and an acceptance 
of it as a necessary part of their overall chemotherapy care.
A number of advantages in having a PICC line were reported by participants and included the 
reduced need for venepuncture and cannulation, the ease of chemotherapy administration and 
not requiring hospital admission to receive chemotherapy. Despite the generally positive views, 
a number of concerns associated with having a PICC line in the ambulatory setting were also 
identified and were a concern as they had the potential to impact negatively on the lives of 
patients and also because they highlighted the uncertainties patients with PICC lines faced on a 
daily basis. Arguably the area of greatest concern related to information giving in relation to a 
PICC line.
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It would appear from this study that good, appropriate information giving when a patient 
requires a PICC lines remains a challenge. This study along with others has shown that whilst 
PICC-line patients have a high information need, the information supplied is not necessarily in 
keeping with that which they would find helpful. Interestingly, this study showed that some of 
the difficulties experienced by patients related more to the attached chemotherapy pump than 
the PICC line itself. Since not all PICC-line patients will require a pump attachment, it is likely 
that the information needs of different gi oups of PICC-line patients will vary.
6.5 Study robustness
The concepts of validity and reliability and how they relate to both qualitative and quantitative 
methodologies were discussed in Chapter three.
Overall, the mixed methods approach added to the validity of the study findings since the 
questionnaire used in Phase 2 was developed from the qualitative data collected in Phase 1 and 
from the findings of previous research carried out into the patient-impact of PICC lines or other 
CVADs. In addition, the use of an expert panel to select the items for inclusion in the 
questionnaire and the full consideration of both positive and negative statements from the 
interview transcripts meant that the content was both relevant and served as a true reflection of 
the participants’ realities and therefore the questionnaire demonstrates both face and content 
validity.
It was not possible to demonstrate criterion validity (see 3.5) in this study since no other 
previously validated tool measuring the same variables exists. Similarly, construct validity (see 
3.5) could not be achieved as no existing research based evidence was available which could be 
used to formulate a hypothesis. Further use of the questionnaire could allow external validity to 
be demonstrated in the future.
Reliability is equivalent to consistency (see 3.5) and methods of increasing consistency in 
interviews were the use of the same interviewer; adherence to the interview schedule and taking 
a neutral stance during interviews. Furthermore, the questionnaires used in Phase 2 of the study 
were structured and all distributed in the same way which gives consistency.
Other methods of demonstrating reliability include test-retest reliability and inter-obseiver 
reliability (Bryman 2004; Gibbon 1998). However these were inconsistent with the study 
design. Furthermore, the use of a statistical test such as Cronbach’s alpha to measure internal 
reliability was also considered inappropriate since the questionnaire was not designed to
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measure one underlying attitude towards a PICC line but rather to assess respondents’ views on 
a number of PICC-line associated themes. However, it is recognised that difficulties exist in 
determining the reliability of Likert-type scales as the views, opinions or attitudes measured by 
them are dynamic and there is no ‘true’ answer to the questions posed (Oppenheim 1992). This 
means that many researchers are unable to apply rigorously all the principles of reliability in a 
given study (Bryman 2004) and the most important considerations are the purpose of the 
instrument and the claims made from the results (Oppenheim 1992).
The purpose of the instrument used in this study was to explore the views of patients receiving 
MdG cytotoxic chemotherapy via a PICC line to contribute to the current understanding and 
research on the subject matter. The study design maximised how representative of the target 
population the data was therefore it is claimed that the results of the study are valid and 
representative of the population at the time of the study and in the place where the study took 
place. Whilst these results may be transferable to other comparable oncology/PICC-line units, it 
is not possible to claim that the results are representative of the PICC-line population generally.
6.6 Researcher reflexivitv
The author has an extensive background in cancer and chemotherapy nursing and had carried 
out much reading in relation to the study subject matter therefore it stands to reason that a 
number of opinions regarding patients with PICC lines were already formed. Indeed, one of the 
initial prompts for carrying out the study was the observation that PICC lines posed an 
additional burden on patients and furthermore, the literature review carried out during the study 
had highlighted the potential added difficulties for patients. It was therefore crucial that self­
reflection was practised to reduce potential interviewer bias or bias in the qualitative data 
analysis. Thus in Phase 1 of the study, analysis of the data was deferred until all interviews 
were completed and vigilance in including both positive and negative comments made in 
relation to PICC lines was taken when analysing the interview findings. A fiill list of the 
important themes from the interview data was circulated to the expert panel involved in 
selecting items for inclusion in Phase 2, and as can be seen from the appendices, included a 
range of both positive and negative comments towards PICC lines.
Included in the field notes were comments made regarding whether or not the participants were 
experiencing the difficulties anticipated. Thus by continually reflecting on why decisions were 
made to include or omit potential data, the author can demonstrate that she has included all the 
pertinent themes and not just those which would have confirmed her initial concerns. 
Examination of the initial interview important sentences, end list of themes and completed
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questionnaire data demonstrate that the researcher has made every attempt to obtain a true 
picture of the experience including both positive and negative aspects.
As a novice researcher, undertaking this study resulted in a great deal of personal learning both 
in relation to the study subject matter and the research process. With regard to the impact of a 
PICC line on the patient receiving MdG ambulatory chemotherapy, the study demonstrated that 
the author’s initial concerns while well-intentioned were not fully founded. This study showed 
that most patients adapted well to the experience with only a small number of patients 
experiencing major difficulties. Prior to the study, it was the author’s belief that a larger 
number of patients were experiencing considerable difficulty when in fact the results show this 
not to be the case. It may be that when dealing with ehemotherapy patients, the more 
challenging cases are the more memorable and hence the importance of using research evidence 
rather than personal experience to influence practice and develop policy is reinforced.
An in-depth understanding of the research process has been gained through the undertaking of 
this study. The triangulated design allowed the opportunity to experience both qualitative and 
quantitative research processes although it has also added to the challenges in carrying out the 
study. One surprise was the relative ease of obtaining ethics approval for both phases of the 
study although it is appreciated that this may not always be the case. Other key areas of 
learning have been the importance of having specific research aims and to exercise caution 
when inteipreting the results from the study. The author believes the learning that has occurred 
as a result of undertaking this study will influence future personal research practice and will also 
help in supporting other researchers.
6.7 Limitations of the study
The main limitation of this study is that the results can only be interpreted against the sample 
frame, i.e. MdG patients receiving ambulatory chemotherapy at the oncology unit where data 
collection took place. The limitations in study robustness (see section 6.7) mean that the 
experiences and views of other PICC-line patients could differ according to where and when 
they received their chemotherapy. To generalise the conclusions from this research to other 
groups of PICC-line patients would require further research, for example a multi-centred study 
sampling PICC-line patients undergoing a variety of chemotherapy regimens.
The interview data analysis also had limitations as the author was an inexperienced researcher 
undertaking this process for the first time. This was addressed by transcribing the interviews 
verbatim to insure that all possible statements of note were pulled out from the data. The use of 
the reflexive approach as described in section 6.8 meant that all the interview themes were 
considered by the expert panel to insure accuracy prior to questionnaire construction.
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Nonetheless, it is possible that some themes were missed by the researcher which may have 
been picked up if an independent researcher had reviewed some of the interview transcripts.
Another limitation was apparent in the questionnaire content. The interviews revealed that 
participants often stated that some of the problems they had living with a PICC line related 
more to the chemotherapy pump than the PICC line itself. Several questionnaire respondents 
also commented on this and on reflection, it would have been helpful if the questionnaire had 
been designed to specifically address this, hi the event, it was not possible to ascertain which 
difficulties were caused by the PICC line and which were caused by the chemotherapy pump. 
This has implications for practice as not all PICC-line patients will require a chemotherapy 
pump and would require further research to address.
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CHAPTER SEVEN - CONCLUSION AND RECOMMENDATIONS
7.1 Conclusion
The study was designed to explore the views and experiences of patients receiving ambulatory 
MdG chemotherapy via a PICC line. The results demonstrate that the majority of PICC-line 
patients held favourable views towards having a PICC line and adapted well overall to the 
experience. The study highlighted that the main challenges for patients centred on showering, 
bathing, hair washing and sleeping and that a number of worries remained with them during the 
time the PICC line was in situ. Furthermore, the challenges in providing optimal information to 
this group of patients were evident as patients reported some of the information given to them 
was unhelpful and at times frightening. Nonetheless, the vast majority of patients adapted well 
to the experience and viewed the PICC line as a benefit rather than a burden.
The study results are generally in keeping with previous research into the impact of CVADs on 
patients in that the potential difficulties were highlighted but also that most patients coped well. 
The value of this study was its ability to document the specific difficulties faced by patients 
with PICC lines in the home environment in relation to a number of key areas. This was one of 
only a few studies which examined the impact of a PICC line on ambulatoiy patients and the 
findings are both important and timely as PICC-line usage continues to increase.
7.2 Recommendations
1. The current information given to patients requiring a PICC line should be reviewed locally 
and different methods of providing information explored.
2. Patients should be assessed formally as to their ability to cope with a PICC line at home.
3. Ways of providing maximum support at the beginning of the PICC line experience should 
be explored.
4. PICC lines should be considered for use in more chemotherapy patients. ^
5. Further research should be carried out into the specific needs of different groups of PICC- 
line patients.
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APPENDIX I
tm rVERSITY GréaW r ^
GLASGOW
Doreen Molloy
Chemotherapy Clinical Educator 
G6&7 Mezzanine Office 
G block
Western Infirmary 
Glasgow G12 6NT
Tel: 0141 211 2918 e-mail: Doreen.molloy@northglasgow.scot.nhs.uk 
Dd/Mm/Yy
Dear Doctor
MSc Research study “The impact of a PICC line on the patient receiving MdG  
ambulatory chemotherapy”
I am writing to you regarding the above study that seeks to examine the impact of PICC 
lines on the patients requiring them for MdG and also to discover any ways in which we 
can improve the overall experience. As you currently send patients for PICC line 
insertion, I am asking you to grant me access to your patients for the purposes of this 
study.
I have enclosed a copy of the research proposal, which includes details of the aims of 
the study, methodology, sample size, inclusion/exclusion criteria and so forth. I would 
draw your attention in particular to pages 1 1 - 1 5  which are perhaps the areas of most 
relevance to you. Full attention will be paid to all necessary ethical requirements to 
insure that no patients are inappropriately approached nor any emotional upset or 
inconvenience placed upon them.
I would be grateful if you would consider this request and let me know if you have any 
objection to any of your patients being approached to take part in this study.
Please contact me if you have any questions regarding this request.
Thank you for taking the time to consider this request.
Yours sincerely
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UXIVRRSITYGreater ofGlasgow GLASGOW
Doreen Molloy
Chemotherapy Clinical Educator 
G6&7 Mezzanine Office 
G block
Western Infirmary 
Glasgow G12 6NT
Tel: 0141 211 2918 e-mail: Doreen.molloy@northglasgow.scot.nhs.uk
Dd/Mm/Yy
Dear
MSc Research study “The impact of a PICC line on the patient receiving MdG  
chemotherapy”
I am writing to you regarding the above study that seeks to examine the impact of PICC 
lines on the patients requiring them for MdG chemotherapy and also to discover any 
ways in which we can improve the overall experience., As you are currently involved in 
the management of the PICC line service, I am asking you to grant me access to the 
service and the associated nursing staff for the purposes of this study.
I have enclosed a copy of the research proposal, which includes details of the aims of 
the study, methodology, sample size, inclusion/exclusion criteria and so forth. I would 
draw your attention in particular to pages 1 1 - 1 5  which are perhaps the areas of most 
relevance to you. Full attention will be paid to all necessary ethics requirements to 
insure that no patients are inappropriately approached nor any emotional upset or 
inconvenience placed upon them.
I would be grateful if you would consider this request and let me know if you have any 
objection to my request. Please contact me if you have any further questions.
Thank you for taking the time to consider this request.
Yours sincerely
APPENDIX n i
■ Greater Glasgow
THIS SHEET HAS BEEN APPROVED BY THE WEST ETHICS 
COMMITTEE
INFORMATION SHEET FOR PATIENTS/VOLUNTEERS IN CLINICAL  
RESEARCH PROJECT
Brief Title of Project
The impact of a PICC line on the patient receiving cytotoxic 
chemotherapy.
Patient’s Summary
This is an information sheet inviting you to take part in a research study
being carried out at the ........................................  The research is being
undertaken as part of a Master’s degree course that the researcher is 
undertaking at the University of Glasgow. The purpose of this study is to find 
out more about the ways in which the PICC line (which was put into your 
arm in order for you to receive your chemotherapy) has affected your life.
During the interview, you will be asked questions about how your life has 
been since the PICC line was put it. You will also be given an opportunity to
We are committed to ensuring that patients have the information they need to 
help them cope with the experience of receiving chemotherapy through a 
PICC line. It is very important therefore that we are able to find out as much 
as we can about the experiences people have so that we can improve the 
information given to patients. Although you will not benefit directly from 
taking part in this research study, it may improve the care given to patients in 
the future.
You have been asked to consider taking part in this study because you have a 
PICC line. This would involve being interviewed by the nurse carrying out 
the study. The interview will take place in a room separate from the
chemotherapy rooms i n .....................................Hospital either during one of
your planned visits or at a different time if you wish.
The interview will last approximately 30 -  45 minutes and will be tape- 
recorded so that the nurse carrying out the study can go over and understand 
what you have said. The tapes will be transcribed and all material will be 
destroyed at the end of the study.
___________________
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tell the nurse anything you feel is important regarding the PICC line. The 
researcher will use the information you give to produce a report on patients’ 
experiences, which will be read by other people with an interest in this 
subject. Please be as honest as you can as your views are very important. 
Any information you might give will be anonymized and at no time will you 
be identified.
Please be assured that if you do not wish to participate in this study, or wish 
to withdraw at any time, your care will in no way be affected.
Thank you for considering this request.
If  you are interested in taking part in this study and have any questions 
regarding this, please contact;
Doreen Molloy
Chemotherapy Clinical Educator 
G6&7 Mezzanine Office 
G block
Western Infirmary 
Glasgow G12 6NT
Tel: 0141 211 2918
e-mail: Doreen.molloy@northglasgow.scot.nhs.uk
APPENDIX IV
Greater
THIS SHEET HAS BEEN APPROVED BY THE WEST ETHICS 
COMMITTEE  
INFORMATION SHEET FOR PATIENTS/VOLUNTEERS IN CLINICAL 
RESEARCH PROJECT  
Brief Title of Project 
The impact o f a PICC line on the patient receiving cytotoxic chemotherapy.
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part.
Thank you for reading this.
What is the purpose of the study?
The research is being undertaken as part of a Master’s degree course that the researcher is 
undertaking at the University of Glasgow. The purpose of this study is to find out more about 
the ways in which the PICC line (which was put into your ann in order for you to receive your 
chemotherapy) has affected your life. We are committed to ensuring that patients have the 
information they need to help them cope with the experience of receiving chemotherapy 
through a PICC line. It is very important therefore that we are able to find out how the PICC 
line has affected your life so that we can improve the information we give to patients.
Why have I been chosen?
You have been asked to consider taking part in this study because you have a PICC line and are 
receiving chemotherapy. About 100 patients will be asked to participate in the study.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep. If you decide to take part, you are still free to withdraw at 
any time and without giving a reason. A decision to withdraw at any time, or a decision not to 
take part, will not affect the standard of care you receive.
W hat will I have to do?
Participation in the study will involve the completion of one questionnaire. The questionnaire 
will be filled in after the PICC line has been in your arm for about 8 weeks. It will take
_ _ _ _ _ _     __
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approximately 20 minutes to complete the questionnaire. A stamped, addressed envelope is 
included with the questionnaire for you to send it back once completed.
W hat are the possible benefits of taking part in the study?
Although you will not benefit directly from taking part in this research study, we hope that the 
information obtained will improve the care given to patients in the future.
W ill my taking part in the study be kept confidential?
If you decide to take part in the study, any information you give will be kept strictly 
confidential. At no time will you be identified from the information you may give.
W hat w ill happen to the results o f the research study?
The researcher will use the information you give to produce a report on patients’ experiences, 
which will be read by other people with an interest in this subject. A summary of the findings
of the study will also be available in W ard  Again, you will not be identified in any way
in the report.
W hat happens next?
If after reading this and thinking about your involvement you decide you want to take part, 
please complete the enclosed questionnaire and consent form and post back to me in the 
envelope provided. If you decide you do not wish to take part, you do not need to do anything 
else or let anyone know. If you have any questions or concerns at all about any aspect of the 
study, please contact (details below).
Thank you for considering this request.
Doreen Molloy 
Education Department 
Marie Curie Centre 
1 Belmont Road 
Glasgow G21 3 AY
Tel: 0141 531 1386
e-mail: doreen.mollov@mariecurie.org.uk
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WEST ETHICS COMMITTEE
FORM OF CONSENT FOR PATIENTS/VOLUNTEERS IN CLINICAL 
RESEACH PROJECT
Title of Project:
The impact of a PICC line on the patient receiving cytotoxic chemotherapy.
By signing this from you give consent to your participation in the project whose title is at 
the top of this page. You should have been given a complete explanation of the project to 
your satisfaction and have been given the opportunity to ask questions. You should have 
been given a copy of the patient information sheet approved by the West Ethics Committee 
to read and keep. Even though you have agreed to take part in the research procedures you 
may withdraw this consent at nay time without the need to explain why and without any 
prejudice to your care.
Consent:
I , .......................................................................................................................................... (PRINT)
of.
give my consent to the research procedures above, the nature, purpose and possible 
consequences of which have been described to me
b y ..............................................................................................................................................
Patient’s signature....................................................................D a te ..........................
Researcher’s signature.................................................................................................
North G lasgow University Hospitals 
NHS Trust
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West Ethics Committee 
Western Infirmary 
Dumbarton Road 
Glasgow 011 6NT
Telephone: 0141 211 6238 
Fax: 01412111920
Date 12^ ’’January 2004 
Our Ref: AHT/JM
Enquiries to Andrea Torrie 
Extension A s above
Direct Line A s above
GreaterGlasgow
Ms D Molloy
Chemotherapy Clinical Educator, 
Beatson Oncology Centre 
Western Infirmary 
Glasgow
e-mail address:
Andrea.torrie@,noi1:hglasgow.
scot.nlis.uk
Dear Ms Molloy
PROJECT NO: 04/157(1) (Please quote on all correspondence) 
R&D No: 030N044CAW
PROJECT TITLE: Ms D Molloy -  The psychosocial impact of a PICC line on the 
patient receiving cytotoxic chemotherapy._______________________________________
As Administrator of the West Research Ethics Committee I have considered the 
amendments submitted in response to the Committee’s earlier review of your 
application on 6^  ^January 2004 as set nut in my letter dated 8^ ’’ Jan 2004. The 
documents considered by me as Administrator were as follows:
• Letter from you dated 12^  ^January 2004
• Amended Patient Information Sheet v.
As Administrator, acting under delegated authority, 1 am satisfied that these accord with 
the decision of the Committee and I have agreed that there is no objection on ethical 
grounds to the proposed study. I am therefore happy to give you the favourable opinion 
of the Committee on the understanding that you will follow the conditions as set out 
below:
Conditions
• You do not recruit any research subjects within a research site unless favourable 
opinion has been obtained from the relevant REC.
01811
• You do not undertake this research in an NHS organisation until the relevant NHS 
management approval has been gained as set out in the Framework for Research 
Governance in  Health and Social Care.
• You do not deviate from, or make changes to the protocol without prior written 
approval of the Research Ethics Committee except where this is necessary to 
eliminate immediate hazards to research participants or when the change involves 
only logistical or administrative aspects of the research. In such cases the REC 
should be informed within seven days of the implementation of the change.
• You should complete and return the standard progress report form to the REC one 
year from the date of this letter and thereafter oh an annual basis. This form should 
also be used to notify the REC when your research is complete and in this case 
should be sent to this REC within three months of completion.
• If you decide to terminate your research prematurely, you should send a report to the 
REC within 15 days, indicating the reason for the early termination. .'•■'f
• You should advise the REC of any unusual or unexpected results that raise questions 
about the safety of the research.
• This Committee conforms to and abides by the ICH Guideline for Good Clinical 
Practice.
The project must be started within three years of the date of this letter.
Kind Regards
Yours sincerely,
Andrea H Torrie
ADM INISTRATOR -  W EST ETHICS COMMITTEE
SL5 Favourable opinion at first review 
Version 2, October 2004
North Glasgow University Hospitals 
Division
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NHS
14 January 2005 
Mrs Doreen Molioy
Lecturer in Cancer and Palliative Care
Marie Curie Cancer Care
Education Department
Marie Curie Cancer Care, 1 Belmont Road
Glasgow
G21 3AY
Greater Glasgow
West Glasgow Ethics Committee 1
Telephone: 0141 211 6238  
Facsimile: 0141 211 1920
Email: andrea.torrie@northglasgow.scot.nhs.uk
Dear Mrs Molioy
Full title of study: The impact of a PICC line on the patient receiving cytotoxic
chemotherapy.(PiCC: Peripherally Inserted Centra! Catheter) 
REC reference number: 05/S0703/4 
Protocol number:
The Research Ethics Committee reviewed the above application at the meeting held on 11 
January 2005.
The Committee wished to thank you for attending the meeting to discuss your study.
The Committee only had one minor comment to make i.e. that they were of the opinion thht a 
clinician from the Beatson should be added to the application - i.e. Prof. Cassidy or 
someone similar.
The Patient information sheet should be amended as follows
a) Under Section "What is the Purpose etc" - delete "We are committed to ensuring - direct 
to the end of that para". The second sentence should now read " affected your life so we can 
improve the information we give to patients".
b) Under Section "What happens next" - 2nd line should read - "Please complete the 
enclosed questionnaire and Consent Form and post both of these back to me in the 
envelope provided.
The investigator agreed these minor amendments.
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation.
w 01811
SL5 Favourable opinion at first review 
Version 2, October 2004
With the Committee’s best wishes for the success of this project, 
Yours sincerely,
Andrea H Torrie
Administrator - West Ethics Committeee
E-mail: andrea.torrie@northglasgow.scotnhs.uk
Enclosures List of names and professions of members who were present at the
meeting and those who submitted written comments
Standard approval conditions
Site approval form (SF1)
CHEMOTHERAPY ASSESSMENT CHART
APPENDIX V m
TOXICITY
GRADE TOXICITY GRADE 0 GRADE 1 GRADE 2 GRADES GRADE 4
Nausea None Able to eat 
reasonable intake
Intake significantly 
decreased but can eat
No significant intake
Vomiting None Once in 24 hours 2-5 times in 24 hours 6-10 times in 24 
hours
>10 times in 24 
hour requiring IV 
support
Diarrhoea None Increase of 2-3 
stools/day over 
pre-RX
Increase of 4-6 
stools/day or 
nocturnal stools or 
moderate cramping
Increase of 7-9 
stools/day or 
incontinence or 
severe cramping
Increase o f>10 
stools/day or 
grossly bloody 
diarrhoea or need 
for parental 
support
Constipation None Requiring stool 
softener or dietary 
modification
Requiring laxatives Constipation 
requiring manual 
evacuation or enema
Obstruction or 
toxic megacolon
Stomatitis None Painless ulcers, 
erythema or mild 
soreness
Painful erythema, 
oedema or ulcers, but 
can eat
Painful erythema, 
oedema or ulcers and 
cannot eat
Required 
parenteral or 
enteral support
Skin None or No 
change
Scattered macular 
or popular 
eruption or 
erythema that is 
asymptomatic
Scattered macular or 
popular eruption or 
erythema with 
purities or other 
associated symptoms
Generalised 
symptomatic macular 
or popular or 
vesicular eruption
Exfoliative 
dermatitis or 
ulcerating 
dermatitis
Hand & foot 
Syndrome
None Skin changes or 
dermatitis without 
pain (eg 
erythema, 
peeling)
Skin changes with 
pain, not interfering 
with function
Skin changes with 
pain, interfering with 
function
Alopecia No loss Mild hair loss Pronounced or total 
hair loss
"
Neuro-
sensory
None or no 
change
Mild paresthesia, 
loss of deep 
tendon reflexes
Mild or moderate 
objective sensory 
loss; moderate 
paresthesia
Severe objective 
sensory loss or 
paresthesia that 
interfere with 
function
Fatigue None Increased fatigue 
over baseline, but 
not altering 
normal activities
Moderate or causing 
difficulty performing 
some activities
Severe or loss of 
ability to perform 
some activities
Bedridden or 
disabling
Toxicity filled in within 
protocol
YES NO
Medical Comments
Name Signature
WHO Performance Status 0 1 2 3 4
Tumour Response
Unable to 
Assess
Progression Stable Disease Partial Response Complete
Response
Adjuvant
Chemotherapy
Prescribed
Yes □ No □ Signed
Outpatient
Appointment
Consultant : Date Has Appt To be Made
Next
Chemotherapy
Place; Date: Has Appt To be Made
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Phase 1 semi-structured interview schedule
Before starting this interview, I would like to remind you that this study is interested in
finding out how your life has been since the PICC line was put in, and not the effects of
the chemotherapy itself. Try to think of how you feel about the line itself rather than
any side effects you might be having because of the treatment.
1. I’d like to start by asking you if you knew what a PICC line was before the nurse or 
doctor said you might need one?
2. If yes -  how did you know?
3. How did you feel about getting the line in?
4. I’d like to find out more now about how the line has changed, if at all, your life on a 
day today basis. Could you describe to me anything that you find more difficult to 
do because of the PICC line?
5. Is there anything you find easier to do with the PICC line in?
6. What about other people who live in the house with you or people who may visit 
you -  how do you think they feel about the line?
7. Could you tell me on the whole how the experience of having a PICC line has been?
8. From your experience, what do you think would be useful to tell other patients about 
having a PICC line in?
9. Is there anything else you would like to tell me about your experience of having a 
PICC line?
APPENDIX X
Field-notes Interview.
Observation Comments
Overall opinion of interview
My performance
Anything I felt uncomfortable 
about
Participant observations;
• Tone of voice
• Body language
• When happy
• When sad
• Wlien 
angry/uncomfortable
• When avoiding
Any questions which 
appeared
difficult/misunderstood
Any unexpected findings
Anything else of note
APPENDIX XI
Initial coding of keywords/significant statements 
Keyword/statement
Liked to help (interview)
Never knew what PICC was (2 knew what PICC was) 
Staying out of hospital was good thing 
Uncertainty about procedure prior to placement 
Fear of cancer 
Dressing affected 
“Could be worse”
Fear of cannulation 
Family concerned 
Grateful to be getting treatment 
“you get used to it”
Fear of pulling line/line falling out
Fear about being away from hospital/professional help
Added difficulty with pump attached
Problems washing
Feeling unclean
DN visits restrictive
“Pm not complaining”
Protecting others from PICC 
Didn’t like others to see PICC 
Good support from DN’s 
Insertion unpleasant 
Problems sleeping
Frequency
111
m i l l
11111
111
1111111
111111
111111
11111111
11
1 1 1
111111
11111111
1111111
11111
111111
1
1
111
11
111
1
n i l
"I
APPENDIX XI
Need more practical advice 
Fear of spillage 
Unprepared for spillage
Too much information/information overwhelming 
Other hep’s didn’t know what to do with PICC 
Too much responsibility in patient/family 
Fear of chemotherapy 
Poor information giving re disease/cancer 
Problems driving
Problems playing golf/hill-walking
Life restricted
Wife affected by line
Uncertainty re coping at home
Information too technical
Doctors/nurses responsibilities
Doctors/nurses giving information just for the sake of it
“Scary”/”frightening” experience
“serious” ness of situation
Isolation
Not understanding information/feel stupid 
Don’t like line 
Badge of cancer
Guilt re complaining about situation/everyone is so nice 
Life not normal 
Confidence down
1111111
11111
11
11111111
m i l l
111
m i l
1
111
11
11
1
1111
m i l
11
1111111
111111
1111
1
1
11
111
1111
1 1 1 1
1
APPENDIX XI
Too much negative information/what might go wrong 11111
Fighting spirit 111
Would take PICC again if needed 1111
PICC a good thing/advantages outweigh disadvantages 111
Line becomes part of you 1 1
f
No pain during insertion/ease of insertion 1111 f
Difficulty doing housework/shopping 11
Not able to go on holiday 1 |
'■'t
Fear of pump not working 111111
Did not cause problems at all 1
APPENDIX Xn
Revised coding of 22 broader categories
Never knew what PICC was
Willingness to help researcher (important for reflexivity)
Fear of disease/treatment
Hobbies affected
Activities of living affected
Affect on family/friends/neighbours/strangers
Grateful for treatment
Fear of cannulation
Need more practical advice
Protecting line
Pump an additional problem
Being out of hospital good
Fear of being away from professional help
Too much responsibility on patient/family
Frightening situation
Life not normal
Unprepared for insertion but ease of insertion 
Body image/badge of cancer 
Struggle but acceptance/get used to it 
Seriousness of situation
Too much information/not the right information 
Advantages outweigh disadvantages
APPENDIX XIII
Themes identified reflecting interview content
1. effect on daily life
2. information giving
3. coping at home/responsibility
4. adaptation/acceptance
APPENDIX XIV
Greater UNIVERSITYof
GLASGOW
The impact of a PICC line on the patient receiving cytotoxic 
chemotherapy.
Before completing this questionnaire, please read the accompanying letter and tick ^  
the boxes beside the statements below to show that you agree with the statements and are 
happy to take part in the study. Please complete and return the questionnaire to me 
within two weeks.
By completing and returning this questionnaire (version 1.0, October 2004) I understand 
that I am giving consent for my responses to be used for the purposes of this research 
project.
I confirm that I have read and understood the information sheet and have had the 
opportunity to ask questions.
I understand that my participation is voluntary and that I am free to withdrav^ at any time 
without giving any reason and without my care being affected in any way.
Ï.a
Researcher: Doreen Molioy
Education Department 
Marie Curie Centre 
1 Belmont Road 
Glasgow G21 3 AY
Tel: 0141 531 1386
e-mail: doreen.mollov@,mariecurie.org.uk
Section 1
This section is about you. Please answer the questions as accurately as possible and 
remember that any information you give will be anonymized.
Please put a tick in the relevant box.
Q l. Are you? Male Female □
For office
use only
Ql
Q2. What is your age group? 1 8 -3 9  years | | 1
40 -  59 years | | 2
60 -  79 years | | 3
80 + years | | 4 Q2 □
Q3. Approximately how many miles do you live away from Ward 4C? 
Less than 10 miles I  I  1
Between 10 and 20 miles I    I  2
Between 21 and 30 miles I  I  3
More than 30 miles I  I  4 Q3□
Q4. Would you say it is easy or difficult for you to get to ward 4C?
Easy □ Difficult r n  2 Q 4 n
Q5. When you were first told you might need a PICC line, did you know what 
a PICC line was?
Yes □ □N o  2 Can’t remember □ Q5 □
Q6. How many PICC lines have you had FOR THIS COURSE OF CHEMOTHERAPY?
For office
use only
1 O  2 O  S o rm o re Q
Q7. FOR THIS COURSE OF CHEMOTHERAPY ONLY when was your PICC line 
first put in?
Date of in sertion  /  / _____
D D MM YEAR
If you don’t remember the date that the line was put in, can please estimate how many 
weeks you have had a PICC line in for this course of chemotherapy.
Number of weeks | |
Please tell me the date you filled in this questionnaire. / ___/ ______
D D MM YEAR
Q7 □
Section 2
This section is about how you felt when at home with the PICC line.
Please read the statements below. For each statement, please tick the box to show how much 
you agree or disagree with the statement.
Statement strongly
agree
agree neither
agree
nor
disagree
disagree strongly
disagree
8. Having a PICC line gives me 
independence.
9 .1 worry that things could go wrong 
with my PICC line.
10.1 worry about the 
chemotherapy spilling.
11.1 am happy to take 
responsibility for my PICC line.
12. My life is restricted 
because of the PICC line.
13.1 am relaxed at home 
with my PICC line.
14. The PICC line has made my 
chemotherapy easier to get.
15. My friends/family worry 
about my PICC line.
16.1 would have preferred
to get my chemotherapy in hospital.
17. PICC lines give me extra worries 
when getting chemotherapy.
18. There is plenty of help and 
support for people with PICC lines.
19.1 worry that the PICC 
line will fall out.
office
8 0  
9 0  
10 □
11 O
12 0
13 0
14 0
15 0
16 0
17 0
18 0  
19 0
Section 3
This section is about the information you were given about your PICC line.
Please read the statements below. For each statement, please tick the box to show how much 
you agree or disagree with the statement.
Statement strongly
agree
agree neither
agree
nor
disagree
disagree strongly
disagree
20 .1 knew what to expect when the 
PICC line was put in.
21 .1 like to know as much as possible 
about what is happening to me.
22. Doctors and nurses tell you things 
just because they feel they have to.
23 .1 had all the information I needed 
to cope with my PICC line at home.
24. Too much information is a bad 
thing.
25.1 was given the choice to have 
a PICC line or not.
26.1 do not like to be told too much 
about things that could go "wrong.
27. It is impossible to remember all 
the information you are given.
28. The information I was given about 
my PICC line was just right.
29. Patients should be told absolutely 
everything about their PICC line.
30. Some of the information I was 
given about my PICC line was quite 
scary.
office
20 □
21 □
22 □
23 □
24 □
25 □
26 □
27 □
28 □
29 □
30 □
Section 4
This section is about how the PICC line has affected your day to day life.
Please look at the activities below. For every activity, please put a tick ^  in the 
box to show if you found the activity any more difficult to do because of the PICC line.
If you did not carry out the activity before you had the PICC line, please tick the box 
marked N/A.
office
Activity about
the
same
a little
more
difficult
a lot
more
difficult
can’t do 
because of the 
PICC
N/A
31. washing 
myself
32. bathing
33. showering
34. dressing
35. housework
36. hobbies
37. looking 
after children
38. relaxing
39. driving
40. shopping
41. sleeping
42. washing 
my hair
43. cooking
44. other 
(write below)
31 □
32 □
33 □
34 □
35 □
36 □
37 □
38 □
39 □
40 □
41 □
42 □
43 □
44 □
Section 5
This final section is about your thoughts and feelings about having a PICC line in. Again, please 
look at the statements below and tick ^  the box to show how much you agree or disagree with 
each statement.
Statement strongly
agree
agree neither
agree
nor
disagree
disagree strongly
disagree
45. Having a PICC line is not the sort 
of thing you ever get used to.
46 .1 will do whatever it takes to get 
my chemotherapy.
47. It bothers me if strangers see 
my PICC line.
48. Having a PICC line is a 
frightening experience.
49.1 am frightened of needles.
50. Having a PICC line gets easier 
the longer you have it.
51. Having a PICC line is more 
trouble than it is worth.
52.1 am happy to show my PICC 
line to anyone.
53. The good things about a PICC 
line are more than the bad.
54.1 would recommend a PICC line 
to other patients.
55. Patients with PICC lines need 
more help at the beginning.
56. It is best to avoid crowds if you 
have a PICC line.
45 □
46 □
47 □
48 □
49 □
50 □
51 □
52 □
53 1
54 □
55 □
56 □
Is there anything else you would like to tell me about PICC lines?.
The questionnaire is now complete. Thank you for your honesty and for taking the time to 
complete it. Please now post the questionnaire back to me in the envelope provided. Thank you.
. . . ' f  ...
APPENDIX XV
Greater u m v f æ s j t y
Glasgow g i.asgow
Doreen Molioy 
Education Department 
Marie Curie Centre 
1 Belmont Road 
Glasgow G21 3 AY
Tel: 0141 531 1386
e-mail: doreen.mollov@mariecurie.org.uk
Dd/Mm/Yy
Dear
You were recently approached in .............................................  Hospital to ask if you
would take part in a research study looking into the impact of a PICC lines on patients.
At that time, you stated your willingness to complete a research questionnaire which 
you took away with you at the time. As yet I have not received your completed 
questionnaire.
I have included another questionnaire with this letter in case you have lost the one you 
were given. If this is the case, please complete the questionnaire and return it to me in 
the envelope provided as soon as you can.
If for any reason you are unable to complete the questionnaire, then no further action is 
required.
Yours sincerely
APPENDIX XVI
Potential Likert scale statements
Statcnicnt/theme
Responsibility for line/coping at home
I feel anxious with my PICC line at home
Having a PICC line gives me independence
Being able to get your chemotherapy at home is a good thing
I am relaxed when I am at home with my PICC line
I would have preferred to get my chemotherapy in hospital
A person with a PICC line needs 24 hour support from the hospital even if they are at home
I worry about the chemotherapy spilling
The PICC line has made my chemotherapy easier to get
My life is restricted because of the PICC line
I worry that things could go wrong with my PICC line
There is plenty of help and support for people with PICC lines
I am happy to take responsibility for my PICC line
It is up to the doctors and nurses to look out for problems with the PICC line
Patients are just as capable of knowing when something is wrong as the doctor/nurse
I worry that the PICC line will fall out
My family/friends worry about my PICC line
PICC lines give you extra worries when you are getting chemotherapy
Adaptalion/acccptance
It is best to avoid crowds if you have a PICC line
It bothers me if strangers see my PICC line
I would recommend a PICC line to other patients
Having a PICC line gets easier the longer you have it
Having a PICC line is not the kind of thing you ever get used to
Having a PICC line in is a frightening experience
Patients with PICC lines need more help at the beginning
I am frightened of needles
I do not mind getting an injection
I will do whatever it takes to get my chemotherapy
Having a PICC line is more trouble than it is worth
Getting chemotherapy would be easier without a PICC line
On the whole, the good things about a PICC line are more than the bad
I do not like other people to see my PICC line
I am happy to show my PICC line to anyone
APPENDIX XVI
Information sfalements
I felt as though I had all the information I needed to cope with my PICC line at home
The information I was given about my PICC line was just right
Some of the information I was given about my PICC line was quite scaiy 
It is important that patients are told absolutely everything about their PICC line 
I would have liked more information about coping with my PICC line at home 
Doctors and nurses tell you things just because they feel they have to 
It is impossible to remember all the information you are given 
I would have liked more information about my PICC line
Getting information before the PICC line is put in makes you less nervous 
I do not like to be told too much about things that could go wrong 
Too much information is a bad thing
Doctors and nurses should ask the patients how much they want to know about PICC lines
I was given the choice to have a PICC line or not
I felt as if I had to take a PICC line
Patients need to know as much about PICC lines as the doctors and nurses do 
I wanted to know more about things that could go wrong with my PICC line 
I always like to know as much as possible about things that are happening to me 
Getting the PICC line put in was worse than I expected
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